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Abstract 
Background: Obesity is a major threat to public health given its strong links with cardiometabolic 
morbidity and premature mortality. One-third of obese adults are metabolically healthy, but 
little is known about modifiable determinants of this state or its progression over time. 
Aims: To determine whether physical activity and sedentary behaviour distinguish healthy from 
unhealthy obesity, and whether healthy obese adults have increased risk for developing 
metabolic ill-health and type 2 diabetes. 
Methods: Data were drawn from up to 5427 men and women participating in the Whitehall II 
cohort study. Normal-weight, overweight, and obese adults were considered healthy if they had 
<2 of 5 metabolic risk factors (hypertension, low HDL-cholesterol, high triglycerides, high blood 
glucose, and insulin resistance). Associations of self-reported moderate-to-vigorous physical 
activity and leisure sitting time with prevalence and 15-year incidence of metabolic risk factor 
clustering were examined among healthy obese adults. Differences in accelerometer-assessed 
total physical activity were also examined between healthy and unhealthy obese groups. 
Metabolic risk factor incidence among initially healthy obese adults was described, and 
published risk estimates of incident type 2 diabetes were systematically searched and meta-
analysed.  
Results: Neither high self-reported moderate-to-vigorous physical activity nor low self-reported 
leisure sitting was associated with health among obese adults. Higher total physical activity 
among healthy versus unhealthy obese adults was evident through accelerometer assessment 
only (p=0.002). After 20 years, 52% of initially healthy obese adults were unhealthy obese, with 
insulin resistance being most commonly incident. Meta-analyses of 8 studies indicated that 
healthy obese adults have 4.03 (95% CI=2.66-6.09) times greater risk of incident type 2 diabetes 
than healthy normal-weight adults.  
Conclusions: Higher physical activity rather than lower sedentary behaviour distinguishes 
healthy from unhealthy obesity. Healthy obesity is strongly linked with future insulin resistance 
and type 2 diabetes, suggesting that it is not a harmless condition.  
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Section 1: Introduction 
 
This section will first introduce obesity as a public health issue, along with its aetiology and 
associated chronic disease outcomes. The idea of a ‘healthy’ type of obesity will be introduced, 
along with its characterising features and known disease risks. The potential role of physical 
activity and sedentary behaviour in healthy obesity will be discussed based on their known 
associations with metabolic health. This section ends with research priorities for improving the 
evidence base on healthy obesity which together inspired the aims and objectives of this thesis. 
 
1.1 Obesity: a public health priority 
 
 
Human life requires the consumption of energy in the form of food, and optimal living requires 
that this consumption be balanced by the expenditure of energy in the form of physical activity 
and internal metabolic processes (1). When energy intake exceeds energy expenditure for a 
prolonged period of time, energy is stored in the form of excess adipose tissue, also known as 
fat. When this positive energy balance becomes high, this results in a condition clinically known 
as obesity (2). Obesity is most commonly measured at the individual and the population level 
through an anthropometric ratio known as the body mass index (BMI), which is calculated by 
dividing an individual’s weight in kilograms by the square of their height in meters. Individuals 
are considered obese if their BMI is 30 kg/m² or higher (3).  
Obesity is a major threat to public health. Higher BMI is strongly and consistently associated 
with a greater risk of premature all-cause mortality (4) as well as for the leading causes of death 
in modern societies including ischaemic heart disease, stroke, and some types of cancer (5). 
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These excess risks are evident for both sexes but are highest among men, and are robust to 
adjustment for other factors including age, prevalent disease, and smoking status. Obesity is also 
strongly linked with the incidence of numerous conditions including type 2 diabetes, 
atherosclerosis, cancers, and musculoskeletal conditions (6), which together act to reduce the 
quality of life for individuals affected while also placing a substantial economic burden on health 
and social care systems in developed countries. Annual treatment costs for chronic diseases 
directly attributable to obesity are projected to increase by $66 billion in the US and £2 billion in 
the UK by 2030 (7). 
The primary pathway linking obesity with the development of disease and early death is 
dysregulated metabolism, which pertains to inefficiencies in the balancing and use of energy in 
the body. Carrying excess body fat is thought to result in a series of metabolic disturbances 
including impaired circulation of blood throughout the body as indicated by higher than normal 
systolic or diastolic blood pressure, impaired use of glucose by body tissues as indicated by 
abnormally high levels of glucose in the blood, and impaired use of lipids as indicated by 
unbalanced levels of cholesterol and triglycerides in the blood (1). These risk factors are closely 
linked and often appear together. When they do, they collectively form a condition known as 
metabolic risk factor clustering (1).  
Prevalence of obesity has increased dramatically over the past three decades in both developed 
and developing countries, with upwards of 205 million men and 297 million women considered 
obese as of 2008 (8). The United Kingdom stands near the forefront of the obesity epidemic, 
with a dramatic increase in prevalence observed since 1980. As of 2012, 24% of men and 25% of 
women in England were considered obese, with prevalence being highest among adults of 
middle age (9). It has also been estimated that 11 million new cases of obesity in the UK are to 
be expected by 2030 (7). In light of demographic transitions taking place in developed countries 
including the United Kingdom, a higher proportion of the general population is entering middle-
age (10). A better understanding of the aetiology and consequences of obesity in mid-life could 
have important implications for preventing an array of deleterious chronic diseases that 
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commonly emerge at this time in the life-course, and could thus have direct implications for 
supporting a healthy ageing process.  
The range of factors considered aetiologically relevant to obesity is wide. Individual-level factors 
known to increase obesity risk include behaviours related to lifestyle; most predominantly an 
energy-dense/nutrient-poor diet and low levels of physical activity (11). These direct 
determinants may interact with other individual-level factors including genetic susceptibilities 
for the storage of body fat (12, 13), increased appetite, and decreased satiety responsiveness 
(14). Other susceptibilities include ethnicity (15) and socioeconomic factors of low educational 
attainment and low income (16) which may influence patterns of energy consumption and 
expenditure. Aspects of the wider contextual environment  may also increase obesity risk, 
including residential deprivation (17) which may influence the deposition and distribution of 
body fat either directly through psychosocial stress pathways or indirectly through structuring 
patterns of diet and physical activity (11, 18-20). 
Despite substantial advances in the knowledge base in recent decades, obesity remains 
notoriously difficult to manage. Individual-level strategies aimed at promoting a negative energy 
balance through decreasing energy intake and increasing energy expenditure tend to show only 
modest reductions in body weight (21), with effects rarely maintained in the long term (22). 
Population-level obesity management strategies are thought to have the greatest potential for 
success, such as those involving public intervention and market regulation of obesogenic food 
environments (23), but require greater investment and coordination among stakeholders to 
improve effectiveness (24). Thus, with the increasing prevalence of obesity in England as well as 
in numerous other developed and developing countries, and with the limited success of 
individual-level weight-reduction strategies, there is a clear need to look deeper into the 
aetiology and consequences of obesity and challenge traditional views held by researchers, 
clinicians, and the public alike.  
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1.2 A ‘healthy’ type of obesity 
 
One recent approach to understanding obesity has involved conceptualising it as a separate 
entity from ‘health’, by partitioning the components of metabolic risk factor clustering from 
obesity status as defined by BMI. Viewing obesity in this way offers some intriguing insights. 
Estimates using nationally representative data from the United States and Italy indicate that 
obesity is a heterogeneous condition with regards to metabolic health; nearly one-third of obese 
adults in the general population present without a clustering of metabolic abnormalities that 
typically accompany excess body fat and display normal levels of blood glucose, insulin 
sensitivity, blood pressure, and blood lipids – forming what is known as metabolically healthy 
obesity (25, 26) (referred to as ‘healthy obesity’ from this point forward). Likewise, about one 
quarter of the non-obese population presents with a clustering of the same metabolic 
abnormalities – known as the metabolically unhealthy non-obese, or normal weight-
metabolically obese phenotype (25), depending on the BMI group specified.  
There is no single universal definition of healthy obesity. However, most studies in the literature 
define healthy obesity either based on insulin profiles alone such as being highly insulin 
sensitive, or based on some measure of metabolic risk factor clustering. Several consensus 
organizations have favoured the latter method. For example, the National Cholesterol Education 
Program’s Adult Treatment Panel (ATP) III criteria considers an obese individual to be 
metabolically healthy if they have a BMI ≥ 30 kg/m² and also display ≤ 2 of the following risk 
factors (27): high sex-specific waist circumference, high triglycerides, low sex-specific HDL 
cholesterol, high blood pressure, and high fasting glucose. The International Diabetes Federation 
(IDF) criterion is slightly more stringent, considering an obese individual to be healthy if they 
display < 2 of the same risk factors, but while also considering prescription drug use as a 
surrogate risk factor for hypertension and dyslipidaemia (28). Yet another criterion proposed 
independently by Wildman et al. (2008) (25) defines an obese individual to be healthy if they 
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display < 2 of the same risk factors, but also considers the homeostatic model assessment 
(HOMA) of insulin resistance and C-reactive protein (CRP)  as a marker of systemic inflammation 
(25). Insulin  is particularly important to include in such criteria, as it is considered a central 
factor in human metabolism, with a role in regulating absorption of glucose from the blood for 
use in skeletal muscle and in the clearance of triglycerides in the blood for appropriate storage in 
adipose tissue (1). Evidence so far on the role of inflammation in healthy obesity is mixed. Low-
grade systemic inflammation has been shown to be lower among healthy than among unhealthy 
obese adults (29-31), while another study reported that healthy and unhealthy obese adults, as 
defined by metabolic risk factor clustering, had similar levels of inflammation in adipose tissue as 
measured by CRP, fibrinogen, leukocyte count, and hepatic enzymes, as well as comparable 
adipokine levels (32). A comparison of different candidate definitions of healthy obesity is 
provided below in Box 1. 
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Box 1: Candidate definitions of healthy obesity 
 
World Health Organization, 1999 
 
Healthy if no glucose intolerance, impaired glucose tolerance or 
diabetes and/or insulin resistance, and < 2 of: 
 
 Blood pressure ≥ 140/ 90 mmHg 
 Triglycerides ≥ 1.7 mmol/l and/or HDL cholesterol < 0.9 
mmol/l (Men); < 1.00 mmol/l (Women) 
 Waist-hip ratio > 0.9 (Men); > 0.85 (Women) and/or BMI > 
30 kg/m² 
 Urinary albumin excretion rate ≥ 20 μg/min or 
albumin:creatinine ratio ≥ 30 mg/g 
 
National Cholesterol Education 
Program Adult Treatment Panel 
(ATP) III, 2001 
 
Healthy if ≤ 2 of: 
 
 Fasting plasma glucose ≥ 5.6 mmol/l 
 Blood pressure ≥ 130/ 85 mmHg 
 Triglycerides ≥ 1.7 mmol/l 
 HDL cholesterol < 1.03 mmol/l (Men); < 1.29 mmol/l 
(Women) 
 Waist circumference > 102 cm (Men); > 88 cm (Women) 
 
International Diabetes Federation, 
2006 
 
Healthy if waist circumference not > 102 cm (Men); > 88 cm 
(Women), and <2 of: 
 
 Fasting plasma glucose ≥ 5.6 mmol/ l or previously 
diagnosed type 2 diabetes 
 Blood pressure ≥ 130 / 85 mmHg or treatment of previously 
diagnosed hypertension 
 Triglycerides ≥ 1.7 mmol/l 
 HDL-cholesterol < 1.03 mmol/l (Men); < 1.29 mmol/ l 
(Women) (or specific treatment for these lipid 
abnormalities) 
 
Wildman et al., 2008 
 
Healthy if < 2 of: 
 
 Fasting glucose ≥100 mg/dL or antidiabetic medication use 
 Homeostatic model assessment of insulin resistance 
(HOMA-IR) > 5.13 (ie, the 90th percentile) 
 Blood pressure ≥130/85 mmHg or antihypertensive 
medication use 
 Fasting triglycerides ≥150 mg/dL 
 HDL cholesterol < 40 mg/dL (Men); < 50 mg/dL (Women) or 
lipid-lowering medication use 
 C-reactive protein (CRP) > 0.1 mg/L (ie, the 90th percentile) 
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Each criterion aims to estimate an individual’s overall metabolic risk, yet none are perfect. For 
instance waist circumference is often considered an important component of metabolic 
clustering (33) and is included in both NCEP ATPIII and IDF criteria, but not in the Wildman et al. 
criterion. However, the inclusion of waist circumference may be problematic when examining 
metabolic phenotypes of obesity as defined by BMI, given that BMI and waist circumference are 
highly correlated, often at 0.9 on a 0-1 scale (34). This may introduce an upward bias on the 
classification of ill-health given that most obese adults may be assigned a high waist 
circumference by default. Systemic inflammation may also be an important component of 
metabolic risk factor clustering (35), and is absent from both NCEP ATPIII and IDF criteria, but is 
included in the Wildman et al. criterion. A harmonized definition of metabolic health in obese 
populations would certainly improve comparability between studies; however in practice, the 
ability to follow any criterion is determined by the availability of data, given that most studies in 
the literature draw upon data from cohort studies that were collected in the past for broader 
purposes. It is also important to note that while the binary categorization of people as either 
‘healthy’ or ‘unhealthy’ has practical value for researchers and clinicians, individual metabolic 
risk factors are measured on a continuous scale and thus true metabolic risk is continuous rather 
than dichotomous in nature.  
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1.3 Distinguishing features of healthy obesity 
 
Healthy obesity is most commonly defined as obesity in the absence of metabolic risk factor 
clustering, and so healthy obese adults are expected to differ from unhealthy obese adults on 
levels of metabolic risk factors, by definition. However it is of great interest to identify other 
physiological and behavioural factors that distinguish healthy obese adults from their unhealthy 
obese counterparts, as this may reveal modifiable determinants of this preferred state.  
The first candidate distinguishing factor is fat distribution. Body fat can broadly be divided into 
two types: subcutaneous fat located in peripheral regions such as arms and legs, and visceral fat 
located in intra-abdominal regions within or around organs (36-38). Visceral fat is more 
metabolically active than subcutaneous fat and contains a higher density of insulin resistant 
adipocytes resulting in a direct link with system-wide insulin resistance (39-41) which is 
potentially independent of total body fat volume (42). Visceral fat is also linked with higher 
systemic inflammation (43), and when measured objectively using ultrasonography, is strongly 
linked with several markers of impaired glucose metabolism including higher fasting glucose, 
higher oral glucose tolerance values, and higher HbA1c values (44). When measured by 
computerized tomography (CT) or magnetic resonance imaging (MRI), greater visceral fat 
volume is also associated with high blood lipids (45) and hypertension (43). The close proximity 
of visceral fat stores to the portal vein is also thought to result in high rates of deposition of non-
esterified fatty acids to the liver (1). Fat accumulated in the liver is especially toxic, with strong 
links with insulin resistance  documented through previous work on non-alcoholic fatty liver 
disease (46, 47), possibly mediated through protein kinase-induced decreases in insulin 
signalling (48). Fat distribution is thought to involve a high degree of heritability, with as much as 
48% of the variance in fat distribution, as characterised by waist circumference and skinfold 
thickness, being explained by genetic susceptibilities (49).  
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Early studies suggest that healthy obese adults have a more favourable fat distribution than 
unhealthy obese adults, with at least 3 population-based studies reporting a lower waist 
circumference, indicating lower levels of abdominal visceral fat (25, 50, 51). Other more detailed 
studies have shown that while the healthy obese had similar levels of total body fat and 
subcutaneous fat as the unhealthy obese, they demonstrated lower visceral fat (29, 52-54), and 
less ectopic and liver fat (55, 56). Healthy obese adults also appear to have greater thigh 
subcutaneous fat compared with unhealthy obese adults (51, 57, 58), which may reflect the 
lower inflammatory nature of lower body fat (58) or higher levels of subcutaneous fat relative to 
visceral fat in general. Thus, a more favourable fat distribution, characterised mostly by lower 
visceral, ectopic, and muscle fat, may be key features distinguishing healthy from unhealthy 
obesity.  
Health behaviours are other attractive candidates distinguishing healthy from unhealthy obesity. 
A higher diet quality may be a factor, given known protective effects of fruit, vegetable, and 
whole-grain consumption against abnormal glucose metabolism and risk of type 2 diabetes (59, 
60), as well as apparently inverse associations of high-fat diary intake with obesity and metabolic 
ill-health (61). One study, however, compared the consumption of an extensive array of dietary 
components including proteins, carbohydrates, sugar-sweetened beverages, and vitamins 
between healthy and unhealthy obese men and women, and found no differences in dietary 
intake or quality (62). Another study comparing the dietary intake of healthy and unhealthy 
obese adults found that healthy obese women consumed more fruit, more whole grains, and 
more meat and beans as protein sources, but these differences were only evident among young 
adult women, and not among women of older ages or among men of any age (63). Thus, 
evidence supporting a higher diet quality among healthy obese adults is mixed and is limited to 
only two studies, which do not form a sufficiently large body of evidence from which to draw 
firm conclusions.  
Sleep duration is another candidate factor, given known adverse associations of short sleeping 
duration with glucose intolerance, insulin resistance, and increased risk of type 2 diabetes, which 
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may act directly or indirectly through disrupting appetite regulation (64). There is some 
indication that sleep duration may differ between healthy and unhealthy obese groups, with 
unhealthy obese women reporting a shorter daily sleeping duration than their healthy obese 
counterparts in one study (65). However, the small evidence base as it relates to healthy obesity 
again prevents firm conclusions. Based on the breadth and depth of evidence available on 
energy expenditure and human metabolism, the strongest and perhaps most plausible candidate 
for distinguishing healthy from unhealthy obesity is the behaviour of physical activity. 
 
1.3.1 Physical activity and metabolic health 
 
Physical activity is a behaviour which directly induces energy expenditure and which therefore 
has a key role in balancing energy stores within the body (1). Measurements of physical activity 
comprise 2 main components: duration, referring to the amount of time it is performed, and 
intensity, referring to the extent to which energy is expended per unit of time (66). Activity 
intensity is expressed as a metabolic equivalent (MET) value assigned from a standard 
compendium of energy costs, which estimates how much energy is expended relative to lying 
down quietly (66). According to this compendium, a physical activity is considered to be of a light 
intensity if the energy expended is between 1.5 and 3 METs, of a moderate intensity if the 
energy expended is between 3 and 6 METs, and of a vigorous intensity if the energy expended is 
6 METs or higher. Large-scale observational studies consistently link greater engagement in 
moderate-to-vigorous physical activity with reduced risk of developing metabolic risk factor 
clustering (67-69) and important clinical outcomes including type 2 diabetes (70) and 
cardiovascular disease (71). These protective effects appear to be dose-response with regards to 
intensity, with the greatest protection observed for physical activity of a vigorous intensity; but 
with those of a moderate intensity also conferring substantial benefits (68, 72, 73).  
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Associations of moderate-to-vigorous physical activity with a healthy metabolic status are 
thought to be explained by several key mechanisms. First, physical activity promotes the 
sensitivity of body tissues to the hormone insulin, which in turn allows for efficient absorption of 
glucose into tissues and balancing of glucose levels in the blood. This is done directly by 
activating key proteins and genes involved in glucose metabolism (74-76) and indirectly through 
inducing the contraction and expansion of skeletal muscle, which as the primary site of glucose 
absorption from the blood, determines system-wide capacity for insulin sensitivity and resting 
energy expenditure (74). Physical activity also promotes the postprandial balancing of lipids in 
the blood after consumption of food through mediating effects of lipoprotein-lipase activation; a 
protein released from skeletal muscle during contraction which decreases concentrations of 
triglycerides (a deleterious lipid compound), and increases concentrations of high density 
lipoprotein (HDL) cholesterol (a beneficial lipid compound) (77, 78). Importantly, the beneficial 
effects of physical activity on lipid metabolism have been shown to decrease or disappear after 
only several days of abstaining from physical activity (77, 79, 80), indicating that physical activity 
must be done on a regular basis for benefits to be sustained. 
Physical activity is also thought to promote a healthy circulatory system. This is done by 
preventing endothelial dysfunction and reducing stiffness of the arterial walls which together 
provide the structural basics for the efficient circulation of blood throughout the body (81). 
Good circulatory health is most commonly indicated by systolic and diastolic blood pressure in a 
normal range, with a recent meta-analysis examining over 5000 participants from 98 
randomised controlled trials finding consistent evidence for lowered blood pressure in response 
to resistance training; activities which involve the contraction and expansion of muscle (82). 
However there appears to be some heterogeneity in these effects, with another meta-analysis 
reporting that such improvements in blood pressure were only among normotensive or pre-
hypertensive groups, and not among those who were hypertensive at baseline (83). It is 
presently unclear whether this reflects a true lack of effect, or just a smaller body of high quality 
evidence on resistance training among initially hypertensive adults. Endurance activities 
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involving some form of aerobic training have also been shown to consistently reduce ambulatory 
daytime blood pressure (84), and thus engaging in both endurance and muscle strengthening 
activities is commonly recommended to extract the maximum benefit from physical activity for 
circulation (85).    
There is also evidence that physical activity helps to reduce systemic low-grade inflammation 
(86), a factor which is linked to risk of cardiovascular disease (87, 88). This is mediated through 
the contraction of skeletal muscle which triggers the release of beneficial compounds such as 
regulatory T-cells and anti-inflammatory cytokines known as myokines (89, 90), while inhibiting 
the release of pro-inflammatory cytokines such as interleukin (IL)-6 and tumour necrosis factor 
(TNF) from tissues (89) and toll-like receptors (91). However, these beneficial effects of physical 
activity on inflammation are not entirely consistent among the obese population, with several 
randomised controlled trials failing to show reductions in markers of systemic inflammation, 
including CRP or IL-6, despite improvements in fitness (92, 93). The anti-inflammatory effects of 
physical activity among obese adults are more evident in studies which examine differences in 
body composition more precisely and which demonstrate selective reductions in visceral fat. For 
example, in a ten-month randomised trial of older adults, aerobic exercise training resulted in 
reduced C-reactive protein (CRP), and these effects were partly mediated through a reduction in 
central adiposity (94). Similarly, in a year-long trial of moderate exercise training, CRP was 
lowered only in women that were obese at study entry and only in participants who lost greater 
than 2% body fat (95). Such interventions suggest that the anti-inflammatory effects of physical 
activity are partly explained by adiposity-related mechanisms involved in selective reductions of 
visceral fat, such as a decrease in adipose-tissue macrophages in the production of IL-6. Indeed, 
fat distribution is itself another key factor explaining associations of physical activity with better 
metabolic health, with intervention studies demonstrating reductions in visceral fat in response 
to engagement in physical activity even in the absence of weight-loss (96, 97). As mentioned, 
visceral fat is highly insulin resistant and inflammatory in nature (98), and so its reduction is 
directly beneficial.  
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Physical activity may also improve the body’s capacity to utilise oxygen, known as 
cardiorespiratory fitness (99, 100). There is a known dose-response association between 
engagement in physical activity and fitness level (101), and low fitness has been associated with 
a higher risk of having metabolic abnormalities including inflammation, hypertension, poor lipid 
metabolism, and insulin resistance (40, 41, 77), as well as developing metabolic risk factor 
clustering (102), abnormal glucose regulation, type 2 diabetes (103), cardiovascular disease, and 
all-cause mortality (104, 105). Such reductions in risk may be independent of BMI (102, 106), 
while adjusting for fitness level has removed associations between obesity status and all-cause 
mortality (107), together suggesting that much of the increased risk for developing chronic 
disease among the obese is explained by a lack of fitness and not excess body fat per se. 
Although an attractive idea, the role of obesity cannot be discounted entirely. Although it is true 
that obese men with high fitness show lower risk of cardiovascular disease and all-cause 
mortality than non-obese men with low fitness (108), and fit obese men have nearly half the risk 
of developing type 2 diabetes as unfit obese men, the excess risk among the obese who are fit is 
still substantially elevated compared with normal-weight adults who are fit (109). Indeed, the 
very measure of fitness requires fitness and obesity to be conceptually linked. Cardiorespiratory 
fitness is best measured through a maximal oxygen uptake test which involves exercising the 
participant until volitional exhaustion (110), resulting in a unit of measurement of millilitres of 
oxygen, per kilogram of body weight, per minute (mL O2/kg/min). Thus, by definition, fitness is a 
function of body weight, and an increase in fitness (the numerator) requires a decrease in body 
weight (the denominator). Furthermore, while physical activity remains an important modifiable 
factor for fitness (72), an individual’s capacity for fitness also depends upon genetic 
susceptibilities with the degree of heritability in fitness estimated to be as high as 50% (111).  
At this point, it is important to distinguish healthy obesity from the widely used term ‘fat and fit’, 
as these are not the same construct. Healthy obesity, as most commonly defined in the 
literature, is obesity without metabolic risk factor clustering (25, 56), while ‘fat and fit’ is obesity 
with a high level of cardiorespiratory fitness (112), as specifically measured in studies for this 
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classification. About 33% of obese adults in the general population are considered healthy (25, 
26), while only about 10% of obese adults are considered fit (113). Healthy obesity is therefore a 
broader classification within which many fat and fit individuals likely fall, while few healthy 
obese adults likely meet the criteria for fat and fit. Several studies have examined 
cardiorespiratory fitness or its components in relation to the healthy obese phenotype as 
reviewed by Ortega et al (114); the largest and most recent study of which showed healthy 
obese adults to have significantly higher levels of cardiorespiratory fitness than unhealthy obese 
adults as measured by VO2 maximum uptake testing (115). However, as expected, healthy obese 
adults showed substantially lower levels of fitness than healthy normal-weight adults, indicating 
that the capacity for fitness is still impaired by the presence of excess body fat, and that normal-
weight therefore remains the ideal body type for optimal fitness and metabolic health.  
There is also emerging evidence that one’s ethnic origin may influence the degree to which 
metabolic health is benefited by physical activity. For instance, a recent cross-sectional study of 
75 South Asian men and 83 European men demonstrated that South Asians needed to perform 
266 minutes of moderate-to-vigorous physical activity per week in order to realise the same 
reduction in metabolic risk that Europeans realised with 150 minutes per week (116). Metabolic 
risk in this study was based on a clustered metabolic risk score summarising all of glycaemia, 
insulin resistance, lipid metabolism, and blood pressure. However, the South Asian group did 
demonstrate more adverse levels of metabolic risk factors including higher insulin, higher 
HbA1c, higher blood pressure, lower HDL cholesterol, as well as lower average durations in 
moderate physical activity than the European group at the study outset, and so it is unclear 
whether this difference in risk reduction is explained by innate ethnic differences in the 
metabolic response to physical activity, or to differences in population burden such as greater 
comorbidities experienced among ethnic minorities in Western contexts (117).  
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1.3.2 The role of physical activity in healthy obesity 
 
Physical activity is clearly important for metabolic health, and would therefore seem to be a 
strong candidate as a distinguishing factor for healthy obesity. Evidence on its role in healthy 
obesity, however, has been surprisingly inconsistent. When considering durations in self-
reported total physical activity, the sum of time spent in light, moderate, and vigorous intensity 
activities, studies to date have found no differences between healthy and unhealthy obese 
groups (51, 118, 119). When considering self-reported moderate-to-vigorous physical activity 
specifically, healthy obese men and women have reported higher durations than their unhealthy 
obese counterparts in some studies (25, 118), whilst not in others (51, 65). Furthermore, findings 
on measures of physical activity in relation of healthy obesity are so far based entirely on cross-
sectional differences, and associations of physical activity with reduced risk of becoming 
unhealthy among initially healthy obese adults have not been investigated prospectively. 
Comparisons of durations in total and moderate-to-vigorous physical activity between healthy 
and unhealthy obese groups have also relied upon self-reported questionnaire-based measures 
of physical activity (25, 51, 65, 118, 119). These measures are known to have only modest 
correlations with objective assessments, often on the magnitude of 0.3 on a 0-to-1 scale (120, 
121), possibly due to measurement errors related to inaccurate recall and social desirability 
(121). Although the correlation between self-reported and objectively assessed total physical 
activity did not appear to differ across BMI categories in a sample of the Whitehall II cohort 
(122), measurement error related to inaccurate recall has been shown to be lower among obese 
than among normal-weight adults in other studies (123). Previous studies reporting weak or null 
findings for differences in physical activity between healthy and unhealthy obese groups may 
therefore have been unable to detect true differences due to reliance on imprecise measures of 
activity. Differential recall bias between metabolically healthy and unhealthy obese groups may 
also be expected if unhealthy adults show a greater degree of measurement error, however this 
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has not previously been examined. Newly-developed tri-axial accelerometers have the potential 
to capture total physical activity in a more complete manner by recording incidental movements 
without relying on participant recall (124), and thus may offer valuable insight into the role of 
physical activity as a distinguishing feature of healthy obesity. There is also some evidence that 
light intensity physical activity, measured objectively, may reduce metabolic risk factor clustering 
independently of moderate-to-vigorous intensity activity (125), however differences in light 
intensity physical activity between healthy and unhealthy obese groups have not been 
specifically examined. This may be due to difficulties in distinguishing light intensity activity from 
sedentary time and moderate intensity activities (126), although light activities are captured in 
measures of total physical activity. 
 
1.3.3 Sedentary behaviour and metabolic health 
 
Previous discussions have pertained to physical activity – behaviour which involves the 
contraction of skeletal muscle to support movement and which expends energy at a rate greater 
than 1.5 METs. Sedentary behaviour, in contrast, refers specifically to seated and reclining 
postures performed while awake which expend energy at a rate of ≤ 1.5 METs (127, 128). This 
consensus definition of ‘sedentary behaviour’ requires both a sedentary posture and a low 
energy expenditure, as there may be instances where these do not occur together. Indeed, it has 
been shown that energy expenditure exceeds 1.5 METs if the upper body moves actively while 
seated such as while playing interactive video games (129, 130), while conversely, energy 
expenditure may be lower than 1.5 METs if standing without ambulating, especially if body 
weight is high (129). Sedentary behaviour represents a substantial proportion of adults’ waking 
hours in modern societies (131), and is theorized to represent a distinct state of muscle inactivity 
which may influence health risk through increasing inflammation (132), preventing the release 
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of lipoprotein lipase from contracting skeletal muscle, and impairing insulin sensitivity and 
glucose absorption (78, 131, 132).  Higher levels of sedentary behaviour are widely associated 
cross-sectionally with individual metabolic risk factors including blood pressure, plasma lipids, 
and blood glucose (78, 133, 134), and with a clustering of these factors  (135, 136). Strong 
associations have also been reported between sitting and all-cause and cardiovascular-related 
mortality, incidence of cardiovascular disease and cancer, and with particularly high incidence of 
type 2 diabetes (78, 137, 138). Intriguingly, these adverse associations are evident after 
adjusting for engagement in moderate-to-vigorous physical activity (138), suggesting an 
independent influence of sitting on metabolic processes.  
These reportedly independent associations have attracted much attention, driving academics 
(139-141), public health practitioners, and governments (142) to recommend reduced sitting 
time in addition to increased moderate-to-vigorous physical activity in order to promote adult 
health. A critical view of the evidence base, however, leads to several alternative ways of 
viewing associations of sitting time with metabolic health. For instance, there is evidence that 
the effect of sitting time on mortality risk may be modified by duration in moderate-to-vigorous 
physical activity, such that the excess risk associated with sitting is lower among adults with high 
activity than among adults with low activity (143). This particular study used television (TV) 
viewing as an indicator of sitting, and the effect modification observed pertained only to the 
magnitude of the effect, as associations of high TV viewing among highly active groups were still 
statistically significant. When considering other studies collectively, a recent meta-analysis found 
that engagement in moderate-to-vigorous physical activity does indeed modify the excess all-
cause mortality risk associated with high sitting time, with excess risk observed only among 
those who are least active, and not among those who are most active (138). All-cause mortality 
is, of course, a crude outcome which does not describe the incidence or burden of disease. 
There is some cross-sectional evidence to suggest that moderate-to-vigorous physical activity 
modifies the effect of sitting on metabolic risk factors, with several studies finding high leisure 
sitting time to be associated with excess risk for having metabolic risk factor clustering only 
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among those who were physically inactive (69, 144, 145), with 2 studies finding evidence for 
effect modification by activity level among women but not among men (69, 146). However, most 
studies of this association do not test for interaction and instead adjust for moderate-to-
vigorous physical activity as part of an a priori hypothesis of independence.  
The strength of associations between sitting time and metabolic risk factors also appear to vary 
by the context in which sitting is measured. Associations appear to be weak or non-existent 
when using sitting duration in an occupational context as a marker of sedentary time (147-149), 
while associations with abnormal glucose metabolism (150, 151), insulin resistance, 
hypertension, and dyslipidaemia (69, 147, 152), as well as with metabolic risk factor clustering 
(69, 144, 146, 153-155) have been widely reported when using self-reported duration in TV 
viewing as a marker, with these associations being independent of engagement in moderate-to-
vigorous physical activity. Possible reasons for these context-specific associations may include 
the tendency for screen-based activities to encourage more prolonged sitting, in contrast to 
occupational sitting which may involve more frequent breaks and bouts of standing, which are 
known to have beneficial effects on insulin sensitivity and glucose metabolism (156). 
Associations may also be confounded by certain eating behaviours, given the tendency for adults 
to consume energy-dense snack foods while viewing TV (157). Questions focusing on TV viewing 
also have the highest validity and reliability among leisure-time sitting questions (158), and so 
stronger associations with TV viewing time may also reflect a better ability to recall sitting time 
accurately. For example, the known duration of TV programmes that were viewed (i.e. 1 hour 
long) may improve the accuracy of participants’ estimates for sitting duration, while work-
related sitting may be more sporadic, less likely to be stored in memory, and harder to recall. 
The result may be a clearer patterning of data for TV viewing than for occupational sitting in 
relation to health outcomes and a higher likelihood of detecting associations.  
When viewed prospectively, higher objectively-measured sitting time was associated with 
worsening insulin profiles (159) and metabolic risk factor clustering after 6 years (160), while 
other studies reported that increased TV viewing time (161, 162) and low physical activity (162) 
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independently predicted worsening metabolic health after several years of follow-up. Although 
cross-sectional studies suggest that the strength of associations between sitting and metabolic 
risk depends upon engagement in physical activity (69, 144, 145), there is no longitudinal 
evidence on these interactive effects as they relate to developing metabolic risk factor clustering 
over time. 
The use of habitual moderate-to-vigorous physical activity in statistical adjustments may not 
adequately reflect total physical activity time, which consists of light intensity activity and 
incidental movements of any intensity which are not likely stored in and recalled from memory, 
and thus may exaggerate or misattribute observed independent effects of sitting. Mayer et al. 
(163) recently showed that when adjusting for total physical activity as measured objectively 
using accelerometry, associations between total sitting time and metabolic risk factors including 
inflammatory markers and blood lipids were no longer evident. This suggests that the adverse 
effects of sitting time which are commonly reported in other studies may reflect less 
engagement in light intensity activity rather than an effect of sitting itself. However, sitting time 
and light intensity physical activity are highly negatively correlated (r=-0.96 in one study (136)), 
and this complicates efforts to model these associations accurately.  
Another alternative explanation for the health risks of sitting is that sitting reflects a 
displacement of time spent in physical activity (164). Two recent studies using objective 
measures of sitting time and physical activity with novel isotemporal substitution methods 
support this idea. In the first study, replacing 10 minutes of sitting time with an equal duration of 
moderate-to-vigorous physical activity was associated with improvements in HbA1C, HDL-
cholesterol and triglycerides, but associations were not seen when sitting was displaced with 
light intensity activity  (165). Similar effects were seen for improved insulin sensitivity and blood 
glucose in a second study which tested the displacement of a longer 30-minute duration of 
sitting time with an equal amount of moderate-to-vigorous activity, with associations again 
appearing weaker and less consistent for light intensity activity (166).  
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Thus, although a wealth of literature documents associations of higher leisure sitting time with 
metabolic risk factors independently of engagement in moderate-to-vigorous physical activity, 
this does not necessarily reveal the true nature of these associations as most studies do not 
formally test for interaction between sitting time and moderate-to-vigorous physical activity in 
relation to metabolic risk factors, and therefore cannot rule out the possibility of effect 
modification by physical activity. This is an important limitation in the evidence base, as these 
results would directly affect public health messaging. If high sitting time is truly associated with 
metabolic ill-health independently of moderate-to-vigorous physical activity, the public health 
message is ‘Even if you exercise regularly, still limit your sitting time’, while on the other hand, if 
moderate-to-vigorous physical activity greatly modifies or removes associations of high sitting 
time with ill-health, the public health message becomes ‘As long as you exercise regularly, sit all 
you want’. These are very different messages, and from a public health practitioner’s point of 
view, the former message is more conservative and likely preferable, as its implication would 
only be to increase total activity, and not to limit total activity as the latter message risks doing. 
 
1.3.4 The role of sedentary behaviour in healthy obesity 
 
Despite widely reported cross-sectional associations between sedentary behaviour and 
metabolic health, the role of sedentary behaviour in distinguishing healthy from unhealthy 
obesity has not been thoroughly investigated. Given theoretical mechanisms of inflammation, 
lipoprotein lipase inhibition, and glucose control (78), lower levels of sedentary behaviour may 
plausibly help explain why some obese individuals are able to maintain metabolic health. 
Furthermore, evidence on the nature of sedentary behaviour and metabolic health suggests that 
associations of low sitting time may be independent of engagement in moderate-to-vigorous 
physical activity (147, 151), or alternatively, low sitting time may interact with moderate-to-
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vigorous physical activity such that low sitting may only be protective among certain levels of 
activity.  
No differences in sitting time as indicated by self-reported TV viewing or other sedentary 
activities were observed between healthy and unhealthy obese adults in one study (65), while 
one other study reported lower sedentariness among healthy than among unhealthy obese 
adults. Sedentary behaviour in this latter study was based on a low ranking in a combination of 
self-reported activity duration, intensity, and frequency, and did not isolate sedentary behaviour 
as a distinct state of muscle inactivity as induced by sitting (51). Furthermore, no prior studies 
specifically hypothesised sitting time as a distinct contributor to metabolic health among the 
obese, and therefore did not apply an a priori model adjustment strategy appropriate to address 
this research question, such as adjusting for engagement in moderate-to-vigorous activity to test 
an independent association, or examining interaction to test modifying effects of moderate-to-
vigorous activity. Likewise, it has not been examined prospectively whether low levels of leisure 
sitting are protective against developing future metabolic risk factor clustering among initially 
healthy obese adults, and whether this protective effect is independent of or interactive with 
moderate-to-vigorous physical activity.  
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1.4 Healthy obesity and metabolic decline  
 
 
 
The recognition of an apparently healthy type of obesity has naturally been followed by an 
interest in its long-term clinical consequences. Building on the most widely recognised health 
threats linked with obesity, clinical outcomes for healthy obesity considered thus far include 
incident metabolic risk factor clustering, type 2 diabetes, cardiovascular morbidity, and all-cause 
or cardiovascular-related mortality.   
 
1.4.1 Progressions from healthy to unhealthy obesity 
 
The conceptual validity and clinical value of healthy obesity rest upon the assumption that it is a 
stable state, and not a transient phase of metabolic decline. A fundamental question therefore is 
whether healthy obese adults maintain this metabolically healthy profile in the long-term, or 
naturally transition into unhealthy obesity over time. Few studies have examined this issue, with 
two showing that about one-third of healthy obese adults were unhealthy obese after a period 
of 6 years (167) (51). Interestingly, the proportion of initially healthy obese adults who progress 
to unhealthy obesity seems to increase with increasing follow-up times, with 43% of initially 
healthy obese adults transitioning to unhealthy obesity over 7 years (168), nearly half (47.6%) 
progressing over 8 years (169), and half progressing over 10 years (170). Such analyses are 
descriptive and simply compare metabolic status at baseline with metabolic status at follow-up, 
irrespective of what transitions may have taken place in any intermediate follow-up periods, and 
thus do not examine cumulative incidence. This simple approach is preferable when addressing 
the question of stability, as healthy obese adults may also improve their status over subsequent 
follow-ups, and this would otherwise be ignored by cumulative analyses of decline.  
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Follow-up times used thus far in studies have not exceeded 10 years which may miss key parts of 
a longer-term trend. Crucially, no studies have compared the tendency for metabolic decline 
between initially healthy obese adults and initially healthy normal-weight adults, and thus it has 
not been clear whether healthy obesity carries a risk for progressing to unhealthy obesity that is 
far in excess of healthy normal-weight adults; such evidence would firmly support the view of 
healthy obesity as a phase. Furthermore, no studies have used long follow-up periods to identify 
the specific metabolic risk factors responsible for declines to ill-health, which is necessary for 
informing the management of healthy obese adults in clinical practice.   
 
1.4.2 Healthy obesity and risk of incident type 2 diabetes 
 
The prevalence of type 2 diabetes is immense, with upwards of 370 million diabetics globally; 
half of whom may be unaware of their condition (171). Type 2 diabetes confers a substantial 
burden for health and quality of life and has long been considered a consequence of obesity 
(172). While characteristics of adipose tissue play a direct role (173), much of the increased risk 
for type 2 diabetes among the obese is thought to stem from metabolic abnormalities 
associated with excess fat, such as islet beta-cell dysfunction, insulin resistance and resultant 
hyperglycaemia (173), as well as high chronic systemic inflammation (174, 175). Other 
contributing factors may include higher levels of visceral fat (176), an energy-dense/nutrient-
poor diet including excessive sugar intake (177-179), and physical inactivity (180, 181) along with 
genetic, ethnic, and socioeconomic susceptibilities (182, 183).  
Given that healthy obese adults display favourable levels of metabolic risk factors which are 
relevant to type 2 diabetes development including normal insulin sensitivity, normoglycemia, 
and low systemic inflammation (184, 185), it has been questioned whether this group also faces 
an increased risk. Several prospective studies have reported a substantially increased risk for 
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incident type 2 diabetes among healthy obese compared with healthy normal-weight adults (51, 
186, 187); however estimates of this association have not yet been systematically searched and 
synthesized in a meta-analysis. Given that type 2 diabetes is itself a strong risk factor for a range 
of cardiovascular complications including atherosclerosis (188, 189), and with risk for premature 
mortality among diabetics being much higher among those who are obese (190), a consistently 
strong link between healthy obesity and type 2 diabetes incidence may signal serious problems 
for this group in the more distant future.  
Previous work examining trajectories of insulin and glucose among adults in the British Whitehall 
II cohort study strongly supports a multistage model of type 2 diabetes development (191). In 
this model, the first noticeable sign of metabolic dysfunction is a long period of insulin 
resistance, with simultaneous increases in pancreatic beta-cell functioning in an effort to secrete 
more insulin to compensate for impaired insulin sensitivity and to promote continued 
absorption of glucose into skeletal tissue (191). This is then followed by a substantial decline in 
beta-cell functioning together with a reduction in beta-call mass as these beta-cells start to 
become exhausted and expire through apoptosis (192). The final result is an abrupt spike in 
blood glucose levels, at which point type 2 diabetes is detectable in a clinical setting. According 
to this model, initial changes in insulin resistance occur many years before blood glucose levels 
rise and a diagnosis of type 2 diabetes is made (191, 193), and trajectories of insulin resistance 
are highly distinct between those adults who eventually develop type 2 diabetes and those who 
do not, revealing key opportunities for early detection (191). Other key factors thought to 
determine risk of type 2 diabetes among obese adults are the robustness of pancreatic beta-cells 
in their ability to secrete insulin at higher volumes to compensate for a chronic overconsumption 
of energy, as well as levels of visceral and ectopic fat located in and around organs (194, 195). 
Type 2 diabetes is therefore viewed both as a disease of pancreatic beta-cell failure as well as a 
disease of ectopic fat deposition, and these complementary factors may determine an 
individual’s likelihood of developing type 2 diabetes in response to accumulating body fat.  
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Despite these well-studied pathways linking insulin resistance with the development of type 2 
diabetes in obesity, it has not been examined whether healthy obese adults carry a high excess 
risk for future insulin resistance. Furthermore, studies conducted thus far on healthy obesity and 
risk of incident type 2 diabetes have defined healthy obesity based on the absence of metabolic 
risk factor clustering, thus allowing for 1 or sometimes 2 metabolic risk factors to be present at 
baseline. It is possible that these baseline risk factors may be insulin resistance or high blood 
glucose which is elevated just below the clinical cut-point for type 2 diabetes but which still 
qualifies as prediabetic (193). It would be useful to examine whether obese adults without any 
metabolic abnormalities (a strictly healthy sample) also face an excess risk for developing type 2 
diabetes. Excess risk among this strictly healthy sample would indicate an inherent link between 
excess fat and poor glucose control, and would be strong evidence against the idea that obesity 
can really be healthy.   
 
1.4.3 Healthy obesity and risk of incident cardiovascular disease 
 
Recent evidence suggests that, compared with healthy normal-weight adults, healthy obese 
adults show an increased risk for incident hypertension (196) and subclinical cardiovascular 
disease including elevated common carotid artery intima media thickness, elevated coronary 
artery calcification (197, 198), and poor ventricular structure and function (199). Recent large-
scale work using a nationally representative sample of 71, 527 adults from the general 
population of Norway demonstrated that obese adults also face a significantly increased risk for 
both incident myocardial infarction and ischemic heart disease after a median of 3.6 years 
follow-up, regardless of their metabolic health profile (200). The overall trend for the healthy 
obese mirrored that shown in previous smaller scale studies, which showed an excess risk for 
cardiovascular outcomes which is intermediate between healthy normal-weight and unhealthy 
obese adults, and which is on the magnitude of 50-100%.  
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Two meta-analyses recently demonstrated that healthy obese adults face a 2-fold increased risk 
for cardiovascular-related events compared with healthy normal-weight adults (201, 202), with 
excess risk again appearing to be lower than among the unhealthy obese, but still greater than 
among healthy normal-weight adults. Importantly, it was observed in both meta-analyses that 
studies which used longer follow-up durations (greater than 15 years in Fan et al. (202) and 
greater than 10 years in Kramer et al. (201)) demonstrated greater risk, indicating that the 
tendency for healthy obese adults to develop cardiovascular disease gets stronger with time. 
Although Kramer et al. also considered all-cause mortality as an outcome, it is important to note 
that all of the studies which used longer than 10 years of follow-up and which were therefore 
isolated from other studies to show excess risk pertained to incident cardiovascular events, not 
all-cause mortality.   
 
1.4.4 Healthy obesity and risk of all-cause and cardiovascular 
disease mortality 
 
Evidence on risk of premature mortality among healthy obese adults is less consistent than for 
incident disease. Using a nationally representative sample of Italian middle-aged adults, Calori et 
al. (50) demonstrated no increased risk for all-cause or cardiovascular-related mortality among 
healthy obese compared with healthy normal-weight adults over 15-years follow-up, when 
defining metabolic health by lack of insulin resistance only. Another study using nationally 
representative data from England and Scotland also reported no increased risk for all-cause or 
cardiovascular mortality in healthy obese compared with healthy normal-weight adults, with 
health defined as the absence of metabolic risk factor clustering (203). This finding was evident 
regardless of whether obesity was defined according to BMI (indicating total body obesity) or 
waist circumference (indicating abdominal obesity). However, in contrast, at least two other 
studies suggest that obese adults who are metabolically healthy have a greater risk for all-cause 
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mortality compared with healthy normal-weight adults, when the phenotype is defined as being 
free of metabolic risk factor clustering or being highly insulin sensitive only (204, 205). Others 
report that the healthy obese have a substantially increased risk of death from major 
cardiovascular events such as acute myocardial infarction, ischemic stroke or heart failure, as 
compared with healthy non-obese adults over a median of 30 years follow-up (205). 
Furthermore, a systematic review and meta-analysis did not find significant summary evidence 
for excess risk for all-cause or cause-specific mortality among healthy obese adults, with only 
cardiovascular events being evident after at least 10 years of follow-up (201). It may be possible 
that longer-term follow-ups may be required to see excess risk of death, as may be expected, 
while shorter follow-ups are sufficient to see increased risk of incident disease. 
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1.5 Research priorities 
 
1.5.1 Characteristics of healthy obesity  
 
Several key gaps in knowledge regarding the characteristics of healthy obesity have been 
identified. First, although physical activity is known to be important for metabolic health among 
the adult population at large, it remains unclear whether higher physical activity distinguishes 
healthy from unhealthy types of obesity. Despite established associations of sedentary 
behaviour with metabolic health, the role of sedentary behaviour in distinguishing healthy obese 
adults from their unhealthy obese counterparts is also unknown, and it has not been 
investigated whether associations of high physical activity and low leisure sitting time in relation 
to healthy obesity are truly independent or interactive in nature. Additionally, no studies have 
examined differences in total physical activity between healthy and unhealthy obese groups 
using objective physical activity assessments, and thus the degree to which reliance on self-
reported measures of physical activity have limited our understanding of its role in promoting 
metabolic health within obese populations is unknown.  
Physiological factors such as fat distribution and fitness are strong candidates as determinants of 
healthy obesity, but these are known to carry genetic susceptibilities (49, 111) and are 
themselves influenced by engagement in physical activity (97, 98). Thus, focusing on physical 
activity and sedentary behaviour seem ideal, as these are the most readily modifiable and 
universally achievable factors, and ones which may have beneficial downstream effects on fat 
distribution and fitness. Evidence suggesting that a healthy type of obesity can be promoted by 
physical activity may provide clinicians and public health practitioners with a target for focusing 
their efforts, and may ultimately confer substantial reductions in disease burden for the wider 
population through public health interventions.  
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1.5.2 Clinical outcomes of healthy obesity 
 
Likewise, several important gaps in knowledge regarding the clinical outcomes of healthy obesity 
have been identified. First, despite recent efforts in literature to examine the cardiovascular 
consequences of healthy obesity, the natural course of the healthy obese state itself has not 
been well described using repeat clinical data over long follow-ups to determine whether it is 
truly a stable state or a transient phase of metabolic decline. Second, the individual metabolic 
risk factors most responsible for transitions from healthy to unhealthy obesity have not been 
identified over long follow-ups, which is necessary to inform the management of healthy obesity 
in clinical practice. It has also not been established whether healthy obese adults have an 
increased risk of developing type 2 diabetes compared with healthy normal-weight adults. 
Furthermore, given that previous studies have most commonly defined healthy obesity as having 
< 2 metabolic risk factors, there is concern that estimates for diabetes risk may be biased by the 
baseline prevalence of insulin resistance or high blood glucose.  
Given that initiating and maintaining weight-loss is difficult, it is of great interest whether 
keeping metabolic risk factors in check is sufficient to prevent the onset of disease. If so, this 
may lead to the allocation of limited clinical resources towards those obese individuals with the 
greatest risk of adverse health outcomes, and to more personalised approaches to delivering 
health services. If, however, healthy obesity is seen to be largely unstable and is seen to carry a 
consistently high risk for type 2 diabetes, including among those with no signs of metabolic 
dysfunction (0 metabolic risk factors), this would strongly link healthy obesity with future decline 
and support inseparable links between excess fat and disease. It is therefore important to clarify 
the long-term nature of healthy obesity in order to strengthen the academic literature, to inform 
clinicians who encounter these patients in practice, and to ensure appropriate public health 
messages. 
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1.7 Summary of introduction 
 
Obesity is a great threat to public health, owing to its strong links with metabolic dysfunction 
and early mortality. However, nearly one-third of obese adults does not show a clustering of 
metabolic risk factors and are considered ‘healthy’. Whether high physical activity and low 
sedentary behaviour distinguish healthy from unhealthy obesity is unknown, and it is not clear 
whether the role of these behaviours in promoting healthy obesity is independent or interactive. 
Additionally, no studies have examined differences in total physical activity between healthy and 
unhealthy obese groups using objective accelerometer assessments, and thus the evidence to 
date may be based upon imprecise measures of activity. Addressing these gaps in knowledge 
may help identify modifiable and achievable factors for improving metabolic health among 
obese populations.  
Healthy obese adults have a greater risk for developing cardiovascular events than healthy 
normal-weight adults, but whether healthy obesity itself is a stable state or a transient phase of 
metabolic decline has not been described using repeat clinical data over sufficiently long follow-
ups, nor has it been identified which metabolic risk factors drive progressions from healthy to 
unhealthy obesity. Furthermore, it has not been established whether healthy obese adults have 
an increased risk of developing type 2 diabetes compared with healthy normal-weight adults, or 
whether obese adults who are strictly healthy (with 0 metabolic risk factors) also face an 
increased risk of type 2 diabetes. Addressing these knowledge gaps may inform the effective 
management of healthy obese patients in clinical practice and appropriate public health 
messages about adult obesity. 
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Section 2: Thesis Aims & Objectives 
 
 
This thesis will be divided into two parts. The first part will investigate physical activity and 
sedentary behaviour as distinguishing features of healthy obesity. The second part will 
investigate the risk of future metabolic decline among initially healthy obese adults with regards 
to incident metabolic risk factor clustering and type 2 diabetes. Although the primary interest is 
in obese adults, analyses will include normal-weight and overweight counterparts in order to 
provide reference groups, view trends across phenotypes, and provide context for interpreting 
results.  
 
2.1 Part 1: Physical activity and sedentary 
behaviour in relation to healthy obesity 
 
 
 
Aims 
1. To determine whether high physical activity and low sedentary behaviour contribute to a 
healthy metabolic status among obese adults 
2. To determine whether high physical activity and low sedentary behaviour reduce the risk of 
becoming metabolically unhealthy over time among initially healthy obese adults 
 
Objectives 
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1. To examine cross-sectional associations of self-reported high moderate-to-vigorous physical 
activity and self-reported low leisure sitting time, separately and in combination, with 
prevalence of a metabolically healthy profile among normal-weight, overweight, and obese 
adults 
2. To examine prospective associations of self-reported high moderate-to-vigorous physical 
activity and self-reported low leisure sitting time, separately and in combination, with 
incident metabolic risk factor clustering among initially healthy normal-weight, overweight, 
and obese adults 
3. To examine cross-sectional associations of self-reported high moderate-to-vigorous physical 
activity and self-reported low TV viewing time, separately and in combination, with 
prevalence of a metabolically healthy profile among normal-weight, overweight, and obese 
adults 
4. To examine cross-sectional differences in questionnaire- and accelerometer-assessed total 
physical activity between healthy and unhealthy normal-weight, overweight, and obese 
adults 
5. To examine cross-sectional differences in the likelihood of meeting recommendations for 
moderate-to-vigorous physical activity, based on questionnaire and accelerometer 
assessments, between healthy and unhealthy normal-weight, overweight, and obese adults 
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2.2 Part 2: Healthy obesity and metabolic decline 
 
Aims 
1. To examine the natural course of healthy obesity in terms of its long-term metabolic stability 
and change 
2. To identify the individual metabolic risk factors most responsible for progressions from 
healthy to unhealthy obesity   
3. To establish whether healthy obese adults have an increased risk of developing type 2 
diabetes compared with healthy normal-weight adults 
 
Objectives 
1. To describe the proportion of healthy obese adults who develop metabolic risk factor 
clustering over 20 years of follow-up using repeat clinical measures, and to compare the 
likelihood of development with that of healthy normal-weight adults 
2. To describe incidence of individual metabolic risk factors over 20 years among initially 
healthy obese adults using repeat clinical measures, and to compare incidence with that of 
healthy normal-weight adults    
3. To systematically search the literature for published prospective studies on the risk of 
incident type 2 diabetes among obese adults who are metabolically healthy 
4. To synthesize estimates obtained from the literature using random-effects meta-analysis 
and to examine whether age, ethnicity, duration of follow-up, and study quality explain any 
observed between-study heterogeneity in effects 
5. To produce an original effect estimate for the risk of incident type 2 diabetes among obese 
adults who initially have 0 metabolic risk factors (a strictly healthy sample) 
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Section 3: Data & Methods 
 
 
This section describes the sources of data and the research methods used to meet the aims and 
objectives of this thesis. A description of the Whitehall II cohort study is first presented, followed 
by the assessment of healthy obesity, assessments of physical activity and sedentary behaviour 
(the behavioural features of interest), assessment of incident metabolic risk factor clustering and 
type 2 diabetes (the clinical outcomes of interest), and assessment of covariates considered in 
models. The statistical methods used to meet each objective are then described. 
 
3.1 Study population: The Whitehall II cohort study 
 
The Whitehall II cohort study is an occupational cohort study of London-based British civil 
servants (government workers). The study recruited 10,308 men and women in 1985/88 (67% 
male; 89% white ethnicity). The age of participants at baseline ranged from 34-56 years, with a 
mean age of 44.5 years; thus, Whitehall II was initially comprised of predominantly middle aged 
adults (206). The study was initially designed in the 1980s with the broad aim of understanding 
the biological mechanisms underlying work-related stress and disease risk, and the mechanisms 
underlying socioeconomic inequalities in health more generally. Since its inception, the 
Whitehall II cohort study has been a pioneering source of evidence on inequalities in health 
between socioeconomic groups based on middle-aged adults in Britain (206), with recent 
contributions focusing more on age-related health conditions as the cohort enters retirement 
and later stages of life.  
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Since 1985/88, participants have been followed-up every 2-3 years with questionnaires, and 
every 5 years with clinical examinations which include comprehensive assessments of metabolic 
health indicators. Clinical data was gathered for the first time in 1991/94, and was subsequently 
gathered in 1997/99, 2002/04, 2007/09 and 2012/13. This cohort study is therefore ideally, and 
perhaps uniquely, suited to meet the aims of this thesis, which involve investigating the long-
term nature of healthy obesity, as clinical assessments are repeatedly made on the same 
individuals over a period of 20 years. Ethical approval for the study was obtained from the 
University College London research ethics committee, and participants gave written informed 
consent for their data to be used for bona fide research purposes at each phase of data 
collection. 
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3.2 Assessment of healthy obesity 
 
Objectively measured anthropometrics (height and weight) and metabolic risk factors were used 
to define metabolic and obesity phenotype status at each respective phase in 1991/94, 1997/99, 
2002/04, 2007/09 and 2012/13. Body mass index (BMI) was calculated by dividing participants’ 
weight in kilograms (kg) by height in meters-squared (m²). Assessments of height and weight are 
known to involve high inter-observer reliability (207) and BMI as an adiposity indicator has been 
well-validated against levels of total body fat as measured objectively by dual-energy X-ray 
absorptiometry (DXA) (208, 209). Normal-weight (BMI 18.50-24.99 kg/m²), overweight (BMI 25-
29.99 kg/m²), and obesity (BMI ≥ 30 kg/m²), were defined based on World Health Organization 
International Classifications (2). Underweight participants (BMI < 18.5 kg/m²) were excluded 
from all analyses, as these adults represent an extreme minority in terms of sample size and can 
bias a theoretically healthy normal-weight group as a point of reference given known increased 
mortality risks among underweight adults, due largely to higher prevalence of chronic 
obstructive pulmonary disease and cancers (5).  
A healthy metabolic profile was defined as the absence of metabolic risk factor clustering. The 
criteria for metabolic risk factor clustering proposed independently by Wildman et al. (2008) was 
used to define participants’ metabolic status, as this criteria includes insulin resistance alongside 
other core metabolic risk factors and is more stringent than some other criteria, allowing for 
only 1 metabolic risk factor to be present at the point of classification (25). Normal-weight, 
overweight, and obese adults were considered healthy if they had < 2 of the following risk 
factors: HDL-cholesterol ≤ 1.03 mmol/L for men and ≤ 1.29 mmol/L for women or use of lipid 
lowering drugs; blood pressure ≥ 130/85 mmHg or use of anti-hypertension medication; fasting 
plasma glucose ≥ 5.6 mmol/L or use of diabetic medication; triglycerides ≥ 1.7 mmol/L; 
homeostatic model assessment (HOMA) of insulin resistance (fasting insulin * fasting glucose / 
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22.5) > 90th percentile value at baseline in the respective analytical sample. C-reactive protein 
(CRP) was excluded from criteria as this factor was not measured at the 2007/09 or 2012/13 
phase of data collection, and the aim was to keep criteria consistent over follow-up periods. 
Data on the use of lipid lowering drugs was not collected in 1991/94, and this factor was 
excluded from classifications of metabolic status at this phase only, as this formed only part of 
one component (HDL cholesterol). The study population therefore comprised 6 groups for 
analyses, including the healthy obese, which are outlined in Box 2 below. 
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Box 2: Definition of healthy obesity 
 
Obesity status  
 
Normal-weight 
 
BMI 18.50 – 24.99 kg/m² 
 
Overweight 
 
BMI 25.00 – 29.99 kg/m² 
 
Obese 
 
BMI ≥ 30 kg/m² 
Metabolic status  
    
  Healthy 
 
<2 (0 or 1) of: 
 
 HDL-cholesterol ≤ 1.03 mmol/L for men and ≤ 1.29 mmol/L for 
women, or use of lipid lowering drugs 
 Blood pressure ≥ 130/85 mmHg or use of anti-hypertension 
medication 
 Fasting plasma glucose ≥ 5.6 mmol/L or use of diabetic medication 
 Triglycerides ≥ 1.7 mmol/L 
 Homeostatic model assessed insulin-resistance (fasting insulin * 
fasting glucose / 22.5) > 90th percentile value in respective analytical 
sample 
  
    
  Unhealthy 
 
≥2 (2 or more) of: 
 
 HDL-cholesterol ≤ 1.03 mmol/L for men and ≤ 1.29 mmol/L for 
women, or use of lipid lowering drugs 
 Blood pressure ≥ 130/85 mmHg or use of anti-hypertension 
medication 
 Fasting plasma glucose ≥ 5.6 mmol/L or use of diabetic medication 
 Triglycerides ≥ 1.7 mmol/L 
 Homeostatic model assessed insulin-resistance (fasting insulin * 
fasting glucose / 22.5) > 90th percentile value in respective analytical 
sample 
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As noted, the chosen criteria for a metabolically healthy status allowed for 1 metabolic risk 
factor to be present at baseline. When analysing incidence of individual metabolic risk factors 
among initially healthy obese adults, this definition was modified to create on a ‘strictly healthy’ 
sample defined as having none of the 5 metabolic risk factors of interest, in order to create a 
consistent sample for analyses. This strictly healthy sample was also used for original analyses of 
incident type 2 diabetes in order to reduce the possibility of insulin resistance or hyperglycaemia 
being present at baseline, which could bias risk estimates.    
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3.3 Assessment of physical activity 
 
3.3.1 Questionnaire-assessed total and moderate-to-vigorous 
physical activity 
 
From phase 5 (1997/99) onward, physical activity was assessed using a modified 20-item version 
of the validated Minnesota leisure-time physical activity questionnaire (210-214). Participants 
reported the frequency (number of occasions per week) and duration (number of hours per 
week) of various activities including sports, walking, cycling, home maintenance, and gardening, 
with two open-ended questions included to allow reporting of activities not listed. Participants 
were required to take into account activity patterns over the past four weeks to indicate their 
usual activity and asked to provide the total number of hours spent in each activity per week 
(original questionnaire items are included in Appendix 1). A MET value was assigned to each 
activity using a compendium of activity energy costs (66), representing the amount of energy 
expended for each activity relative to lying down quietly (examples of reported activities and 
associated MET values are included in Appendix 2). Total physical activity was estimated as MET-
hours/week, the sum of the product of the intensity (MET) and weekly duration (hours/week) of 
all reported activities. This self-reported measure of total physical activity therefore considers 
activities of all intensities (light, moderate, or vigorous), and has previously demonstrated 
predictive validity for mortality and clinical risk factors including systemic inflammation in the 
Whitehall II cohort (215, 216).  
The duration (hours/week) in activities with MET values of 3 or more, representing moderate-to-
vigorous activities (66), was calculated. Additionally, participants were considered to be meeting 
recommendations for moderate-to-vigorous physical activity if they reported engaging in ≥ 2.5 
hours of moderate or vigorous activity per week based on 2010 World Health Organization 
recommendations and current physical activity guidelines in England (142, 217). Although full 
guidelines allow for either ≥ 150 min/week of moderate intensity activity or ≥ 75 min/week of 
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vigorous intensity activity,  or an equivalent combination of both, as well as requiring days for 
muscle-strengthening, balance and coordination-enhancing activities, as well as requiring 
limiting time spent sitting, this simplified cut-point was chosen for the purposes of making 
questionnaire and accelerometer assessments of physical activity comparable, given current 
limitations of separating moderate from vigorous intensity activities using raw tri-axial 
acceleration (124).  
 
 
3.3.2 Accelerometer-assessed total and moderate-to-vigorous 
physical activity 
 
At phase 11 (2012/13), an objective measure of physical activity was taken for the first time. 
Participants with no contraindications (i.e. allergies to plastic or metal; travelling abroad over 
the following week) were asked to wear a wrist-worn tri-axial accelerometer (Figure 1; 
GENEActiv, Activinsights Ltd., UK; www.geneactiv.org) on their non-dominant wrist, non-stop for 
9 consecutive (24-hour) days.  
 
Figure 1 The GENEActiv wrist-worn tri-axial accelerometer device 
 
 
 
The accelerometer was sampled at 87.5 Hz and data were stored in gravity (g) units (1 g=9.81 
m.s-²). Calibration error was estimated based on static periods in the data and corrected if 
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necessary (218). The Euclidean norm, or vector magnitude, was used to quantify acceleration 
related to movement registered and expressed in milligravity (mg) units (1 mg = 0.00981 
m/second²). This norm was based on the total amount of acceleration captured from each of 3 
axes according to the standard deviation of the sum of acceleration of the X axis-squared, 
acceleration of the Y axis-squared, and acceleration of the Z axis-squared, minus 1 g, with 
negative numbers rounded to zero (120, 219).  
Accelerometer data were processed in R using the GGIR package (http://cran.r-project.org). 
Data extracted between the first and last midnight were retained for analyses leading to a 
maximum of 24-hour measurements for 8 days. Participants with valid data (≥ 16 hours/day) for 
at least 2 weekdays and 2 week-end days were included in analyses. This predefined 16-hour 
cut-point aimed to capture a standard waking time of 16 hours per day (allowing 8 hours for 
sleep). Previous studies which used waking hour accelerometers (e.g. National Health and 
Nutrition Examination Survey (NHANES) in the US, Health Survey for England in the UK) used a 
10 hours/day cut point which corresponds to about two-thirds of the waking period. As the 
accelerometer is supposed to be worn for 24 hours in the present study, a day was considered 
valid if the device was worn for at least 16 hours, which corresponds to two-thirds of a day. In 
this cohort, the definition of valid daily wear-time is unlikely to influence results as adherence to 
the accelerometer study protocol was very high. As noted in a previous publication using the 
same cohort (120), only 72 participants were excluded due to significant non wear time. Non-
wear time was estimated on the basis of the standard deviation (SD) and value range of each 
accelerometer axis (X, Y, and Z), calculated for moving windows of 60 minutes with 15-minute 
increments (124), a window limit which was chosen to minimise the chance of detecting 
sedentary bouts as non-wear time. Given that the standard deviation of the acceleration signal 
of a GENEActiv device when motionless has been found to be 2.6 mg in a laboratory study (219), 
a time window was classified as non-wear time if the standard deviation of the acceleration 
signal was less than 3.0 mg to allow a minor 0.4 standard deviation increase due to device noise, 
or if the value range was less than 50 mg, for at least 2 out of the 3 axes. For each 15 minute 
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period of time detected as non-wear time over the valid days, missing data were replaced by the 
mean acceleration calculated from measurement on other days at the same time of day (120, 
218); a person-specific method which is less prone to bias than those which assume non-wear 
time reflects inactivity or is representative of the rest of the day (220).  
For each participant, duration in moderate-to-vigorous physical activity was also calculated. No 
established cut-point for moderate-to-vigorous physical activity using wrist acceleration in older 
adults is currently available; thus a 100 mg threshold was chosen based on the fact that walking 
at 4 kilometers/hour is classified as moderate physical activity (66) and was equivalent to an 
acceleration of 100 mg in a laboratory based study on 30 adults (221). This cut-point has been 
used in previous publications using the Whitehall II cohort (120, 122) and in a study based on 3 
Brazilian birth cohorts (222). In order to qualify as moderate-to-vigorous activity, at least 80% of 
the activity needed to be ≥ 100 mg, for at least a period (bout) of 10 minutes, using moving 10-
minute windows. An alternative cut-point of 120 mg was used in sensitivity analyses as this was 
the mid-point between mean acceleration for walking at 3 km/h and 5 km/h (221). This 120 mg 
cut-point is more stringent, and captures activities which are more likely to be within the more 
intense, and not in the less intense, moderate-to-vigorous range, but reducing the possibility of 
contamination by light intensity activity.    
As the observation period covered 8 days, the data were recoded so that the measure reflected 
physical activity over one week to match questionnaire-assessed physical activity. If a participant 
had 3 valid week-end days or 6 weekdays, the wrist acceleration of the first and last full day of 
measurement (for example, two Tuesdays a week apart) were averaged to represent one unique 
day. Thus, the mean accelerometer-assessed total physical activity (mg) over a week was 
calculated as: [(5 × mean daily weekday wrist acceleration) + (2 × mean daily week-end wrist 
acceleration)] / 7. The same rescaling was done for duration in moderate-to-vigorous physical 
activity per week (minutes/week). Participants undertaking ≥ 2.5 hours (150 minutes) of 
moderate or vigorous activity per week were considered to meet 2010 World Health 
Organization recommendations (217). 
56 
 
 
3.4 Assessment of sedentary behaviour 
 
 
3.4.1 Self-reported total leisure sitting time 
 
As part of the phase 5 (1997/99) questionnaire, participants were asked ‘On average, how many 
hours a week do you spend sitting at home e.g. watching TV, sewing, at a desk?’, for which 
participants selected one of 8 responses: none, 1, 2-5, 6-10, 11-20, 21-30, 31-40, 40+ hours. As 
response options represented a range of time values, the mid-point for each response option 
was summed to form a continuous scale with each unit representing a 1-hour change in sitting 
time. As no established cut-point currently exists to define high vs low levels of leisure sitting 
time, total leisure sitting time was divided into tertiles for analyses. Similar comprehensive 
measures which consider a range of leisure sitting behaviours have shown acceptable validity, 
the highest validity being for computer use and TV viewing (223). 
 
3.4.2 Self-reported TV viewing time 
 
As part of the phase 11 (2012/13) questionnaire, participants were asked, ‘In the last four 
weeks, how much time did you spend sitting down watching TV (including DVDs and videos)?’, 
and were given space to record the amount of hours and minutes on each weekday, and on each 
week-end day. Responses were then combined to form a single estimate of total time sitting 
while viewing TV (hours/week). Similar measures have been validated in studies of TV viewing 
and metabolic risk factors and have shown a high degree of reliability (158).   
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3.5 Assessment of incident metabolic risk factor 
clustering 
 
 
Incident metabolic risk factor clustering from phase 3 (1991/94) to phase 5 (1997/99), phase 7 
(2002/04), phase 9 (2007/09), and phase 11 (2012/13) was defined based on consistent criteria 
for metabolic risk factor clustering, defined as having ≥2 of the following risk factors: HDL-
cholesterol ≤ 1.03 mmol/L for men and ≤ 1.29 mmol/L for women, or use of lipid lowering drugs; 
blood pressure ≥ 130/85 mmHg or use of anti-hypertension medication; fasting plasma glucose ≥ 
5.6 mmol/L or use of diabetic medication; triglycerides ≥ 1.7 mmol/L; homeostatic model 
assessed insulin-resistance (fasting insulin * fasting glucose / 22.5)  > 90th percentile value in the 
respective baseline analytical sample, among participants without metabolic risk factor 
clustering at baseline.  
Each of the 5 metabolic risk factors (hypertension, low HDL cholesterol, high triglycerides, high 
blood glucose, and insulin resistance) were also examined as separate outcomes in analyses of 
individual metabolic risk factor incidence, among those participants without any metabolic risk 
factors at baseline.  
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3.6 Assessment of incident type 2 diabetes 
 
Incident type 2 diabetes from phase 3 (1991/94) to phase 11 (2012/13) was defined based on 
fasting glucose ≥ 7.0 mmol/L, or self-reported doctor diagnosis, or diabetic medication use, 
among participants without type 2 diabetes at baseline. This definition, as used previously in the 
Whitehall II cohort (191), was supported by recommendations of the World Health Organization 
in 2006 (224) and of the American Diabetes Association in 2010 (225). Fasting glucose was 
measured at each follow-up clinical phase of the Whitehall II study, allowing for consistency in 
diabetes definition across the full study period. 
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3.7 Assessment of covariates 
 
 
 
Covariates were measured at baseline for respective analyses unless otherwise noted.  
 
3.7.1 Basic demographic factors 
 
 
Age was measured continuously in years. Sex (‘male’ or ‘female’) and ethnicity (‘non-white’; 
‘white’) were assessed at the first phase of data collection (1985/88).   
 
3.7.2 Socioeconomic factors 
 
 
Socioeconomic status was indicated by occupational position (employment grade) in the British 
civil service (‘administrative’; ‘professional/executive’; ‘clerical/support’). This occupational 
indicator has been used in previous work on the same cohort to describe social inequalities in 
cardiovascular disease risk (226, 227). As many participants entered retirement before the 
2012/13 assessment (n=2246, or 65% of this sample), data on pre-retirement occupational 
position was used from the 2002/04 assessment if required. 
 
3.7.3 Health factors 
 
The presence of a physically limiting illness at baseline was indicated by responses to 2 questions 
on the presence of an illness which limits moderate or vigorous physical activity (grouped into 
‘does not limit moderate or vigorous activity at all’; ‘limits moderate or vigorous activity a little’; 
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‘limits moderate or vigorous activity a lot’). This variable was chosen to indicate current health 
status as this measure focuses on participants’ perceived limitations to engaging in moderate-to-
vigorous physical activity, which is of central interest in respective analyses.   
 
3.7.4 Health behaviours 
 
 
Cigarette smoking status was grouped as ‘never smoker’; ‘ex-smoker’; ‘current smoker’. Alcohol 
consumption in the previous week was initially assessed in a continuous form, and then grouped 
into ‘abstainer’ (0 units/week); ‘moderate’ (1-14 units/week for women and 1-21 units/week for 
men; ‘high’ (> 14 units/week for women, > 21 units/week for men), given known non-linear 
associations between alcohol consumption and mortality risk (228).    
Data on 3 dietary components (fruit and vegetable consumption, milk consumption, and bread 
consumption) were used to create a summary indicator of diet quality as done in a previous 
publication using the Whitehall II cohort study (229). Participants were assigned an individual 
diet component score of 0 for each of: consuming fruit and vegetables less than daily, 
consuming whole/full-cream milk most often, and consuming white bread most often; a score of 
1 for each of: consuming fruit and vegetables daily, consuming semi-skimmed milk most often, 
and consuming a combination of white and brown bread or not consuming bread; and a score of 
2 for each of: consuming fruit and vegetables twice or more per day, consuming skimmed/fat-
free milk or other kind of milk most often, and consuming wholemeal, granary, or other brown 
bread most often. A total diet score was obtained by summing these individual diet components 
(range=0–6). Participants were considered to have an unhealthy diet if this total diet score was 
between 0 and 2, a moderately healthy diet if this was between 3 and 4, and a healthy diet if this 
was between 5 and 6. When data on milk use was not available (1991/94), frequency of fruit and 
vegetable consumption (‘at least daily’; ‘less than daily’) was used alone as an indicator of diet 
quality.  
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Sleep duration was included as a covariate, and was assessed by asking participants how many 
hours they sleep on an average weeknight (‘≤ 5 hours’; ‘6 hours’; ‘7 hours’; ‘8 hours’; ‘≥ 9 
hours’). Both high and low levels of usual sleep duration based on this indicator have been 
associated with increased risk for all-cause and cardiovascular mortality in the Whitehall II 
cohort study (230).  
If participants were missing data on health behaviours at the 2012/13 assessment, data from the 
previous assessment (2007/09) were used to make maximum use of data. Sensitivity analyses 
were performed to check the potential for this approach to bias results by repeating analyses 
with such participants excluded.  
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3.8 Statistical approach 
 
This section first describes the statistical methods used to examine physical activity and 
sedentary behaviour in relation to healthy obesity (Part 1) according to each previously defined 
study objective.  
 
3.8.1 Part 1: Physical activity and sedentary behaviour in relation 
to healthy obesity 
 
 
 
Objective 1: To examine cross-sectional associations of self-reported high moderate-to-
vigorous physical activity and self-reported low leisure sitting time, separately and in 
combination, with prevalence of a metabolically healthy profile among normal-weight, 
overweight, and obese adults 
 
Cross-sectional analyses utilised data from phase 5 (1997/99) as this was the first occasion that 
physical activity, leisure sitting time, anthropometrics, and metabolic risk factors were measured 
all together.  
As the prevalence of a metabolically healthy profile was relatively high among all BMI groups 
(>20%), odds ratios obtained from logistic regression models are likely to inflate approximations 
of relative risk (231). Log binomial models are often used to approximate relative risks but these 
are prone to failures in model convergence, especially when dealing with continuously measured 
covariates (232). Poisson regression models with robust error variances are well-supported as 
suitable approximations of relative risks for binary outcomes (233, 234), and so, for analyses of 
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separate associations, Poisson regression models with robust error variances were used to 
compute prevalence ratios (PR) with accompanying 95% confidence intervals (CI) for mutually-
adjusted associations of tertiles of moderate-to-vigorous physical activity and of leisure sitting 
time with the prevalence of a metabolically healthy profile among normal-weight, overweight, 
and obese adults.  
For analyses of combined associations, tertiles of moderate-to-vigorous physical activity and of 
total leisure-time sitting were combined to form a 9-level exposure variable: ‘Lowest 
activity/highest sitting’ (reference group), ‘lowest activity/intermediate sitting’, ‘lowest 
activity/lowest sitting’, intermediate activity/highest sitting’, ‘intermediate activity/intermediate 
sitting’, ‘intermediate activity/lowest sitting’, ‘highest activity/highest sitting’, highest 
activity/intermediate sitting, ‘highest activity/lowest sitting’, with group ordering based on 
assumed increases in energy expenditure. Associations of activity/sitting tertiles with the 
prevalence of a metabolically healthy profile were examined separately among normal-weight, 
overweight, and obese adults. Statistical interaction between moderate-to-vigorous physical 
activity and leisure sitting time was tested by including the product term of the corresponding 
tertiles in relation to metabolic health status in Poisson regression models. Given that the obese 
group is expected to comprise fewer participants than normal-weight and overweight groups, 
and that stratification by BMI group may therefore limit the detection of associations among the 
obese due to lower statistical power, statistical interaction was also tested between moderate-
to-vigorous physical activity tertile and BMI group and between leisure sitting time tertile and 
BMI group, both in relation to metabolic health status in models adjusted for BMI group. A triple 
interaction was also examined between moderate-to-vigorous physical activity tertile, leisure 
sitting tertile, and BMI group, in relation to metabolic health status. 
Additionally, analyses for prevalent metabolic health were repeated with moderate-to-vigorous 
physical activity and leisure sitting time each measured continuously (hours per week), in order 
to allow greater statistical power and improve model interpretations. The same interactions 
described above were tested based on these continuously measured variables. For each set of 
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analyses, the first models adjusted for age, sex, and ethnicity. The second models further 
adjusted for occupational position, smoking, alcohol consumption, diet quality, sleep duration, 
and presence of an illness which limits moderate or vigorous intensity physical activity. 
 
Objective 2: To examine prospective associations of self-reported high moderate-to-vigorous 
physical activity and self-reported low leisure sitting time, separately and in combination, with 
incident metabolic risk factor clustering among initially healthy normal-weight, overweight, 
and obese adults 
 
Phase 5 (1997/99) served as the baseline for prospective analyses. Participants who were 
metabolically unhealthy at baseline were excluded. Poisson regression models with robust error 
variances were used to compute incidence ratios (IR) with accompanying 95% confidence 
intervals (CI) for associations of moderate-to-vigorous physical activity and sitting time, 
separately and in combination, with incident metabolic risk factor clustering over 15 years of 
follow-up. This 15-year follow-up assessed cumulative incidence over 5-year intervals, 
considering incident metabolic risk factor clustering after 5 years (2002/04), 10 years (2007/09), 
or 15 years (2012/13).  
For analyses of separate associations, mutually-adjusted associations of tertiles of moderate-to-
vigorous physical activity and of leisure sitting time with incidence of metabolic risk factor 
clustering were examined among normal-weight, overweight, and obese adults. 
For analyses of combined associations, tertiles of moderate-to-vigorous physical activity and of 
leisure sitting time were combined to form a 9-level exposure variable: ‘Lowest activity/highest 
sitting’ (reference group), ‘lowest activity/intermediate sitting’, ‘lowest activity/lowest sitting’, 
intermediate activity/highest sitting’, ‘intermediate activity/intermediate sitting’, ‘intermediate 
activity/lowest sitting’, ‘highest activity/highest sitting’, highest activity/intermediate sitting, 
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‘highest activity/lowest sitting’, with group ordering based on assumed increases in energy 
expenditure. Associations of activity/sitting tertiles with incidence of metabolic risk factor 
clustering were examined among normal-weight, overweight, and obese adults. Statistical 
interaction between moderate-to-vigorous physical activity and leisure sitting time was tested 
by including the product term of the corresponding tertiles in relation to incident metabolic risk 
factor clustering in Poisson regression models. Statistical interaction was also tested between 
moderate-to-vigorous physical activity tertile and BMI group and between leisure sitting time 
tertile and BMI group, both in relation to incident metabolic risk factor clustering, adjusted for 
BMI group.  A triple interaction was also examined between moderate-to-vigorous physical 
activity tertile, leisure sitting tertile, and BMI group, in relation to incident metabolic risk factor 
clustering. 
Additionally, analyses for incident metabolic risk factor clustering were repeated with moderate-
to-vigorous physical activity and leisure sitting time each measured continuously (hours per 
week), in order to allow greater statistical power and improve model interpretations. The same 
interactions described above were tested based on these continuously measured variables. For 
each set of analyses, the first models adjusted for age, sex, and ethnicity. The second models 
further adjusted for occupational position, smoking, alcohol consumption, diet quality, sleep 
duration, and presence of an illness which limits moderate or vigorous intensity physical activity. 
 
Objective 3: To examine cross-sectional associations of self-reported high moderate-to-
vigorous physical activity and self-reported low TV viewing time, separately and in 
combination, with prevalence of a metabolically healthy profile among normal-weight, 
overweight, and obese adults 
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Cross-sectional analyses utilised data from phase 11 (2011/12) as this was the first occasion that 
TV viewing time was assessed separately alongside moderate-to-vigorous physical activity, 
anthropometrics, and metabolic risk factors. Data on total number of minutes of TV viewing per 
week appeared normally distributed; however several extreme positive values were identified 
which were judged as outliers. Assuming 480 minutes (8 hours) of sleep per 1440-minute (24-
hour) day, the realistic maximum viewing time was assumed to be 6720 minutes per 7-day week. 
Data values higher than this maximum value were considered missing. Values were then 
converted from minutes into hours for ease of interpretation.  
For analyses of separate associations, Poisson regression models with robust error variances 
were used to compute prevalence ratios (PR) with accompanying 95% confidence intervals (CI) 
for mutually-adjusted associations of tertiles of moderate-to-vigorous physical activity and of TV 
viewing time with the prevalence of a metabolically healthy profile among normal-weight, 
overweight, and obese adults.  
For analyses of combined associations, tertiles of moderate-to-vigorous physical activity and of 
TV viewing time were combined to form a 9-level exposure variable: ‘Lowest activity/highest TV 
viewing’ (reference group), ‘lowest activity/intermediate TV viewing’, ‘lowest activity/lowest TV 
viewing’, intermediate activity/highest TV viewing’, ‘intermediate activity/intermediate TV 
viewing’, ‘intermediate activity/lowest TV viewing’, ‘highest activity/highest TV viewing’, highest 
activity/intermediate TV viewing, ‘highest activity/lowest TV viewing’, with group ordering based 
on assumed increases in energy expenditure. Associations of activity/TV viewing tertiles with the 
prevalence of a metabolically healthy profile were examined among normal-weight, overweight, 
and obese adults. Statistical interaction between moderate-to-vigorous physical activity and TV 
viewing time was tested by including the product term of the corresponding tertiles in relation 
to metabolic health status in Poisson regression models. Statistical interaction was also tested 
between moderate-to-vigorous physical activity tertile and BMI group and between TV viewing 
tertile and BMI group, both in relation to metabolic health status. A triple interaction was also 
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examined between moderate-to-vigorous physical activity tertile, TV viewing tertile, and BMI 
group, in relation to metabolic health status. 
Additionally, analyses for prevalent metabolic health were repeated with moderate-to-vigorous 
physical activity and TV viewing time each measured continuously (hours per week) in order to 
allow greater statistical power and improve model interpretations. The same interactions 
described above were tested based on these continuously measured variables. For each set of 
analyses, the first models adjusted for age, sex, and ethnicity. The second models further 
adjusted for occupational position, smoking, alcohol consumption, diet quality, sleep duration, 
and presence of an illness which limits moderate or vigorous intensity physical activity. 
General linear regression models were used in additional analyses to examine differences in 
continuously measured TV viewing time across metabolic and obesity groups, with healthy 
normal-weight as the reference group. Differences in TV viewing between healthy and unhealthy 
obese groups were examined through pairwise comparisons. These models were adjusted for 
the same covariates as considered in previous analyses in addition to moderate-to-vigorous 
physical activity duration. 
 
Objective 4: To examine cross-sectional differences in questionnaire- and accelerometer-
assessed total physical activity between healthy and unhealthy normal-weight, overweight, 
and obese adults 
 
Questionnaire and accelerometer-assessed total physical activity variables were standardised 
using Z scores (mean=0.00; standard deviation=1.00) to allow comparison between measures. 
Regression coefficients from general linear models and accompanying 95% confidence intervals 
were used to examine cross-sectional differences in questionnaire- and accelerometer-assessed 
total physical activity across 6 phenotypes: healthy normal-weight (reference group), unhealthy 
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normal-weight, healthy overweight, unhealthy overweight, healthy obese, and unhealthy obese. 
The first model adjusted for age, sex, and ethnicity. The second model further adjusted for 
occupational position, smoking status, alcohol consumption, diet quality, sleep duration, and 
presence of an illness which limits moderate or vigorous physical activity. Models were 
additionally adjusted for continuous BMI to examine whether between-group differences in 
total physical activity were explained by residual within-group differences in BMI.  
Associations of a standard deviation increase in questionnaire- and accelerometer-assessed total 
physical activity with the prevalence of obesity and of each individual metabolic risk factor 
(hypertension, high blood glucose, insulin resistance, high triglycerides, low HDL-cholesterol) 
were also assessed, based on Poisson regression-derived prevalence ratios. These models were 
adjusted for age, sex, and ethnicity. 
 
Objective 5: To examine cross-sectional differences in the likelihood of meeting 
recommendations for moderate-to-vigorous physical activity, based on questionnaire and 
accelerometer assessments, between healthy and unhealthy normal-weight, overweight, and 
obese adults 
 
Objectively assessed moderate-to-vigorous physical activity was not normally distributed, and 
thus was not suitable for standardisation with Z scores for comparisons with questionnaire 
assessments. Data on questionnaire- and accelerometer-assessed moderate-to-vigorous physical 
activity were therefore categorised into binary variables to compare differences in the likelihood 
of meeting recommendations for moderate-to-vigorous physical activity (≥ 2.5 hours/week) 
between metabolic groups.   
The number of participants undertaking ≥ 2.5 hours/week of moderate-to-vigorous physical 
activity was high (54.5% based on questionnaire; 28.9% based on accelerometer); therefore, 
Poisson regression models with robust error variances and accompanying 95% confidence 
69 
 
intervals were used to estimate prevalence ratios for meeting recommendations for each group 
compared with healthy normal-weight adults. Akaike Information Criteria (AIC) statistics were 
used to compare the fit of models based on questionnaire and accelerometer assessments 
(comparatively lower values indicating better model fit). As in previous analyses, the first model 
adjusted for age, sex, and ethnicity. The second model further adjusted for occupational 
position, smoking status, alcohol consumption, diet quality, sleep duration, and presence of an 
illness which limits moderate or vigorous physical activity. 
In sensitivity analyses, the likelihood of meeting physical activity recommendations based on 
accelerometer assessment was compared between metabolic groups using data on moderate-
to-vigorous physical activity in bouts of at least 1 minute (instead of at least 10 minutes in main 
analyses) to examine whether bout duration of moderate-to-vigorous physical activity may 
influence results. Each analysis was also repeated using a more stringent cut-point of 120 mg 
(instead of 100 mg) to define moderate-to-vigorous physical activity, requiring at least 80% of 
the activity to be at 120 mg for at least 10 minutes. As mentioned, this 120 mg cut-point 
captures activity which is more likely to be within the more intense moderate-to-vigorous range, 
reducing the possibility of contamination by light intensity activity.    
 
3.8.2 Part 2: Healthy obesity and metabolic decline 
 
 
This section will describe the statistical methods used to examine healthy obesity and future 
metabolic decline, again according to each previously defined study objective. 
 
Objective 1: To describe the proportion of healthy obese adults who develop metabolic risk 
factor clustering over 20 years of follow-up using repeat clinical measures, and to compare the 
likelihood of development with that of healthy normal-weight adults 
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Phase 3 (1991/94) served as the baseline for these analyses. Participants with data on obesity 
and metabolic status at this baseline and at all 4 subsequent follow-ups were analysed. Cross-
tabulations were used to describe the proportion of participants according to their baseline 
metabolic and obesity status in each category after 5- (1997/99), 10- (2002/04), 15- (2007/09), 
and 20- (2012/14) years. Poisson regression models with robust error variances were used to 
estimate incidence ratios with 95% confidence intervals for unhealthy obesity at each follow-up, 
excluding unhealthy obese adults at baseline. Models were adjusted for age, sex, and ethnicity.  
Given that main analyses were based on complete case samples, requiring complete metabolic 
risk factor data at all 4 follow-up phases, absolute numbers of healthy obese adults were 
expected to be relatively low. Thus, sensitivity analyses were planned with the aim of examining 
patterns of metabolic decline using maximum samples for each metabolic and obesity group 
based on participant observations. For example, a 5-year transition from healthy to unhealthy 
obesity was considered if this took place either: 
 From phase 3 to phase 5 
 From phase 5 to phase 7 (among those who were not healthy obese at phase 3) 
 From phase 7 to phase 9 (among those who were not healthy obese at phase 3 or phase 
5) 
 From phase 9 to phase 11 (among those who were not healthy obese at phase 3, phase 
5, phase 7) 
This procedure allowed for the consideration of new transitions that initiate after the first 
measurement phase. This process was done for 10-, 15-, and 20-year follow-ups for healthy 
obese adults, and for each of the 5 other metabolic and obesity groups. The 20-year follow-up 
sample remained the same as in original analyses, as no other variations are possible to 
construct within the 20-year maximum time period. These categories are not expected to be 
mutually exclusive as it is possible for participants to contribute more than 1 observation to any 
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given phenotype transition within and across time periods. Incidence ratios were therefore not 
deemed appropriate to construct, given that observations were not expected to be 
independent, resulting in a likely violation of model assumptions.  
 
Objective 2: To describe incidence of individual metabolic risk factors over 20 years among 
initially healthy obese adults using repeat clinical measures, and to compare incidence with 
that of healthy normal-weight adults    
 
Phase 3 (1991/94) served as the baseline for these analyses. Normal-weight, overweight, and 
obese participants were included in analyses if they were healthy at baseline (defined as having 
none of the 5 previously defined metabolic risk factors of interest), and had data on all 
metabolic risk factors at all 4 subsequent follow-ups. Cross-tabulations were used to describe 
incidence of each metabolic risk factor at 5- (1997/99), 10- (2002/04), 15- (2007/09), and 20- 
(2012/14) year follow-ups, and Poisson regression models with robust error variances were used 
to estimate incidence ratios and 95% confidence intervals for having each metabolic risk factor 
at follow-up for initially healthy obese compared with initially healthy normal-weight adults at 
baseline. 
Given that main analyses were based on complete case samples, requiring complete metabolic 
risk factor data at all 4 subsequent follow-ups, absolute numbers of healthy obese adults were 
expected to be relatively low. Thus, as done previously, sensitivity analyses aimed to examine 
metabolic risk factor incidence using maximum samples based on participant observations. For 
example, 5-year incidence of hypertension among initially healthy obese adults was considered 
if this took place either: 
 From phase 3 to phase 5 
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 From phase 5 to phase 7 (among healthy obese adults who did not have hypertension at 
phase 3) 
 From phase 7 to phase 9 (among healthy obese adults who did not have hypertension at 
phase 3 or phase 5) 
 From phase 9 to phase 11 (among healthy obese adults who did not have hypertension 
at phase 3, phase 5, phase 7)  
This procedure allowed for the consideration of new cases of metabolic risk factor incidence that 
initiate after the first measurement phase. This process was done for 10-, 15-, and 20-year 
follow-ups for incidence of each of the 5 metabolic risk factors, separately for initially healthy 
normal-weight, overweight, and obese groups. The 20-year follow-up sample remained the 
same as in original analyses as no other variations are possible to construct within the 20-year 
maximum time period. These categories are not expected to be mutually exclusive as it is 
possible for participants to contribute more than 1 observation within and across time periods. 
Incidence ratios were therefore not deemed appropriate to construct given that observations 
were not expected to be independent and that model assumptions would likely be violated. 
 
Objective 3: To systematically search the literature for published prospective studies on the 
risk of incident type 2 diabetes among obese adults who are metabolically healthy 
 
An OvidSP-led systematic search of Medline (date range 1946 to August 2013) and Embase (date 
range 1947 to August 2013) was performed in August 2013. Truncated search terms included 
‘obese’, ‘body mass index’, ‘metabolic’, ‘diabetes’, ‘type 2’, ‘risk’, and ‘incidence’. No language 
restrictions were applied. The specific search formula was as follows: 
obes* and metabolic* and type 2 and diabetes and risk and inciden* and body mass index  
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After removing duplicate results, JAB and MH independently screened search results and agreed 
on studies to be included. Abstracts were scanned, and references within relevant papers were 
hand-searched for additional works. Studies were eligible for inclusion in the meta-analysis if 
they met the full pre-specified criteria for exposure (metabolically healthy obesity defined by 
body mass index and normal metabolic risk factor clustering, insulin profile, or risk score), 
outcome (type 2 diabetes incidence defined by blood glucose levels or self-report), population 
(adults aged ≥ 18 years at baseline), and study design (original prospective estimation).  
As estimates may be presented at more than one stage of statistical adjustment, the most fully 
adjusted estimates were used for analyses, as these were more likely to be the closest 
approximations of true study effects. No standard criteria currently exist for assessing the 
quality of observational studies for meta-analyses, and study quality was therefore assessed 
according to the rigor of the study’s exposure, outcome, and model adjustment strategy. 
Regarding the exposure, 2 points were assigned if the study considered metabolic clustering and 
1 point if the study considered insulin profile alone. For the outcome, 2 points were assigned if 
the diagnosis was based on an objective clinical measurement (I.e. fasting plasma glucose), and 
1 point if the diagnosis was based only on self-report. Based on suggested importance in the 
literature, studies were assigned 1 point if they considered each of the following relevant 
covariates: family history of diabetes, ethnicity, alcohol consumption, smoking status, physical 
activity or cardiorespiratory fitness, dietary sugar intake, and socioeconomic status. Studies 
were therefore scored out of 11 points, with higher scores reflecting better study quality.  
 
Objective 4: To synthesize estimates obtained from the literature using random-effects meta-
analysis and to examine whether age, ethnicity, duration of follow-up, and study quality 
explain any observed between-study heterogeneity in effects 
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A meta-analysis was conducted according to the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) criteria (235). Studies identified through the literature search were 
supplemented with previously unpublished individual-level data from the English Longitudinal 
Study of Ageing (ELSA). Details of the methodology and results from these collaborative analyses 
are described elsewhere (236).  
Meta-analysis was used to synthesize data from published studies identified through the 
literature search and ELSA. Natural variation in study effects were expected due to differences in 
factors such as healthy obesity definition, sampling procedure, statistical adjustment strategy, 
and sample demographics. A random effects model was therefore used to estimate the mean of 
the distribution of effects, with the I2 statistic used to describe the percentage of between-study 
heterogeneity (237). Odds ratios, hazard ratios, and relative risk ratios were pooled and log-
transformed for analyses. Random effects meta-regression was planned a priori to examine the 
extent to which age, ethnicity, duration of follow-up, and study quality including phenotype 
criteria explain any observed between-study heterogeneity in effects.  
 
Objective 5: To produce an original effect estimate for the risk of incident type 2 diabetes 
among obese adults who initially have 0 metabolic risk factors (a strictly healthy sample) 
 
Phase 3 (1991/94) of the Whitehall II cohort study was used as the baseline for these analyses, 
when mean participant age was 50 years. Normal-weight, overweight, and obese participants 
were considered healthy if they had none of the 5 metabolic risk factors of interest 
(hypertension, low HDL cholesterol, high triglycerides, insulin resistance, high blood glucose).  
Diabetics at baseline were excluded from analyses, based on the same criteria used to define 
diabetes incidence. Years of follow-up were used as the time scale (range 1-18 years; median=16 
years). Hazard ratios from Cox proportional hazards regression and accompanying 95% 
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confidence intervals were used to estimate excess risk of incident type 2 diabetes among 
metabolic and obesity groups at baseline compared with healthy normal-weight adults. The 
proportional hazards assumption was assessed and confirmed using Kaplan-Meier graphs by 
examining cumulative survival plots grouped on each exposure variable (continuous covariates 
were categorised for this purpose). The first model adjusted for age, sex, and ethnicity. The 
second model additionally adjusted for occupational position, cigarette smoking, alcohol 
consumption, diet quality, moderate-vigorous physical activity, and the presence of an illness 
which limits moderate-to-vigorous physical activity. Data on sleep duration was not available at 
the phase 3 baseline, and so this covariate was not considered. Likewise, data on milk use was 
not available, and so frequency of fruit and vegetable consumption was used alone as an 
indicator of diet quality. 
 
3.8.3 Statistical software 
 
Variables were constructed using SPSS 21, which was also used to fit general linear models and 
Cox regression models. Poisson regression models with robust error variances and random 
effects meta-analyses were performed using Stata 13. In all cases, a two-tailed p<0.05 indicated 
statistical significance. 
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3.9 Summary of data and methods 
Data from the Whitehall II cohort study of British government workers were used for original 
analyses. Healthy obesity was defined as obesity (BMI ≥ 30 kg/m2) without metabolic risk factor 
clustering (<2 of HDL-cholesterol ≤ 1.03 mmol/L for men and ≤ 1.29 mmol/L for women, or use 
of lipid lowering drugs; blood pressure ≥ 130/85 mmHg or use of anti-hypertension medication; 
fasting plasma glucose ≥ 5.6 mmol/L or use of diabetic medication; triglycerides ≥ 1.7 mmol/L; 
homeostatic model assessment (HOMA) of insulin-resistance (fasting insulin * fasting glucose / 
22.5) > 90th percentile value in each respective analytical sample at baseline).  
The first set of analyses investigated physical activity and sedentary behaviour in relation to 
healthy obesity. Cross-sectional associations of high self-reported moderate-to-vigorous physical 
activity and low self-reported leisure sitting time, separately and in combination, with 
prevalence of being metabolically healthy among normal-weight, overweight, and obese adults 
was examined. Prospective associations of these behaviours with risk of incident metabolic risk 
factor clustering were then examined over 15 years among initially healthy participants at 
baseline. Additional analyses examined cross-sectional associations of high moderate-to-
vigorous physical activity and low TV viewing time, separately and in combination, with 
prevalence of being healthy among normal-weight, overweight, and obese adults. Differences in 
questionnaire- and accelerometer-assessed total physical activity were examined across 
metabolic and obesity groups. Differences across groups in meeting current guidelines for 
moderate-to-vigorous physical activity based on questionnaire and accelerometer were also 
examined.  
The second set of analyses investigated healthy obesity and future metabolic decline. The 
proportion of participants according to their baseline obesity and metabolic status in each group 
after 5-, 10-, 15-, and 20- year follow-ups along with incidence ratios for unhealthy obesity at 
each follow-up were estimated. Incidence of each metabolic risk factor over 20 years was 
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examined for initially healthy normal-weight, overweight, and obese participants at baseline. 
Published estimates of the risk of incident type 2 diabetes among healthy obese adults were 
systematically searched in literature and meta-analysed in a random effects model. Original 
analyses of incident type 2 diabetes among healthy obese adults with no metabolic risk factors 
were conducted using Whitehall II data.  
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Section 4: Results 
 
 
Results of this thesis are divided into 2 parts. This first part begins by providing a brief rationale 
for studies of physical activity and sedentary behaviour in relation to healthy obesity, followed 
by results according to previously stated research objectives. For each research objective, a flow 
chart outlining the selection of the analytical sample is provided, followed by descriptive 
characteristics of the analytical sample, followed then by results of main statistical models.  
 
4.1 Part 1: Physical activity and sedentary 
behaviour in relation to healthy obesity 
 
 
 
Rationale 
 
Physical activity is known to be important for metabolic health among the population at large, 
but whether moderate-to-vigorous physical activity distinguishes healthy from unhealthy obesity 
is unclear. The plausible role of sedentary behaviour in promoting healthy obesity has not been 
thoroughly examined, and it has not been investigated whether associations of moderate-to-
vigorous physical activity and leisure sitting time in relation to healthy obesity are truly 
independent or interactive in nature. Additionally, no studies have examined differences in total 
physical activity between healthy and unhealthy obese groups using objective physical activity 
assessments, and thus the degree to which reliance on self-reported measures of physical 
activity has limited our understanding of its role in healthy obesity is unknown.  
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Objective 1: Cross-sectional associations of self-reported high moderate-to-vigorous physical 
activity and self-reported low leisure sitting time, separately and in combination, with 
prevalence of a metabolically healthy profile among normal-weight, overweight, and obese 
adults 
 
Physical activity and sedentary behaviour were measured together for the first time at the 5th 
phase of data collection (1997/99), and this therefore serves as the baseline for the first analysis 
of these behaviours in relation to healthy obesity. A flow chart illustrating the selection of the 
analytical sample is provided in Figure 2.  
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Figure 2 Selection of the analytical sample for cross-sectional analyses of moderate-to-vigorous 
physical activity and leisure sitting time in relation to healthy obesity 
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Table 1 presents baseline descriptive characteristics of participants comprising the analytic 
sample. Among 2991 men and 1186 women aged 45-69 years with complete data on all 
variables required for analyses, 1787 were normal-weight, of which 1481 (82.9%) were 
considered healthy normal-weight. A further 1833 were overweight, of which 1169 (63.8%) were 
considered healthy overweight. A further 557 were obese, of which 237 (42.5%) were 
considered healthy obese. Healthy obese adults were less likely than healthy normal-weight 
adults to be male (50.2% vs. 67.2%, p<0.05), while both healthy and unhealthy obese adults 
were more likely than healthy normal-weight adults to be of the lowest occupational position 
(19.8% and 15.9% versus 9.6% respectively, each p<0.05). Each metabolic characteristic 
appeared more adverse among healthy overweight and healthy obese adults compared with 
healthy normal-weight adults; with the exception of fasting glucose among healthy obese adults.  
Healthy and unhealthy obese adults showed the highest prevalence of an illness which limits 
moderate or vigorous physical activity compared with healthy normal-weight adults (49.7% and 
53.8% vs. 27.3% respectively, each p<0.05). Both healthy and unhealthy obese adults showed 
fewer hours per week of self-reported moderate-to-vigorous physical activity compared with 
healthy normal-weight adults (3 hours and 2.8 hours vs. 3.7 hours respectively, each p<0.05). In 
contrast, only unhealthy obese adults showed higher leisure sitting time compared with healthy 
normal-weight adults (22.8 hours vs. 20.5 hours respectively, p<0.05).  
Compared with those included in the analytic sample (n=4177), those excluded (n=6131) were 
more likely to be female (36.3% vs. 28.4%, p<0.001), of a non-while ethnicity (13.8% vs. 6.7%, 
p<0.001) and in the lowest occupational position (18.6% vs. 11.6%, p<0.001) but did not differ in 
age (mean=55.9 years for those included vs. 56 years for those excluded, p=0.68). Compared 
with those participants included in analyses, those excluded were also more likely to be obese 
(17.5% vs. 13.3% respectively, p<0.001) but were not less likely to be metabolically healthy 
(69.7% vs. 69.1% respectively, p=0.62). Excluded participants also had lower moderate to 
vigorous physical activity (3.0 hours/week vs. 3.5 hours/week respectively, p<0.001) and higher 
leisure sitting time (21.0 hours/week vs. 20.1 hours/week respectively, p=0.01).  
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Table 1 Characteristics of adults aged 45-69 at baseline (71.6% male) at phase 5 (1997/99) by metabolic and obesity status (n=4177) 
       
 Healthy normal-
weight  
(n=1481) 
Unhealthy 
normal-weight 
(n=306) 
Healthy 
overweight 
(n=1169) 
Unhealthy 
overweight 
(n=664) 
Healthy obese  
(n=237) 
Unhealthy 
obese  
(n=320) 
       
Male – n (%)  995 (67.2) 254 (83%)* 866 (74.1)* 538 (81%)* 119 (50.2)* 219 (68.4) 
Age (years)  55.4 (6.1) 57.9 (6.1) 55.8 (6.1) 56.9 (6.0)* 55.2 (5.8) 56 (5.7)* 
Non-white ethnicity – n (%)  81 (5.5) 36 (11.8)* 60 (5.1) 60 (9)* 16 (6.8) 25 (7.8) 
Lowest occupational position – n (%)  142 (9.6) 30 (9.8) 142 (12.1)* 72 (10.8) 47 (19.8)* 51 (15.9)* 
Lowest quality diet – n (%)  298 (20.1) 69 (22.5) 286 (24.5)* 162 (24.4)* 45 (19) 86 (26.9)* 
       Consumes fruit and vegetables < daily – n (%)  322 (21.7) 67 (21.9) 313 (26.8)* 174 (26.2)* 54 (22.8) 102 (31.9)* 
       Consumes whole/full-fat milk most often – n (%)  255 (17.2) 46 (15) 184 (15.7) 95 (14.3) 28 (11.8)* 27 (8.4)* 
       Consumes white bread most often – n (%)  275 (18.6) 69 (22.5) 283 (24.2)* 174 (26.2)* 52 (21.9) 87 (27.2)* 
Current smoker – n (%)  125 (8.4) 29 (9.5) 110 (9.4) 64 (9.6) 22 (9.3) 27 (8.4) 
High alcohol consumption in previous week – n (%)  305 (20.6) 61 (19.9) 310 (26.5)* 185 (27.9)* 58 (24.5) 82 (25.6)* 
Sleeps ≤ 5 hours/night – n (%)  92 (6.2) 19 (6.2) 76 (6.5) 57 (8.6)* 30 (12.7)* 42 (13.1)* 
Has illness that greatly limits moderate or vigorous activity – n (%)  257 (17.4) 96 (31.4)* 224 (19.2) 180 (27.1)* 91 (38.4)* 126 (39.4)* 
Systolic blood pressure (mmHg)  117 (14.8) 130.4 (17.2)* 121.1 (14.9)* 131.1 (16.2)* 126.7 (16.1)* 133.6 (16.3)* 
Diastolic blood pressure (mmHg)  73.5 (9.6) 81.1 (10.6)* 76.7 (9.7)* 82.3 (10.0)* 78.9 (9.5)* 84.4 (11.2)* 
Fasting glucose (mmol/l)  4.9 (0.5) 5.8 (2.0)* 5 (0.5) 5.7 (1.8)* 5 (0.4) 5.9 (2.2)* 
HOMA insulin resistance  1.3 (0.9) 3.4 (5.3)* 1.7 (0.8)* 4.1 (6.5)* 2.2 (0.9)* 6.7 (13.0)* 
Triglycerides (mmol/l) 1 (0.4) 1.8 (0.9)* 1.2 (0.6)* 2.1 (1.1)* 1.2 (0.4)* 2.1 (0.9)* 
HDL cholesterol (mmol/l)  1.6 (0.4) 1.3 (0.4)* 1.5 (0.3)* 1.2 (0.3)* 1.5 (0.3)* 1.2 (0.3)* 
Body mass index (kg/m²) 
       Range 
22.8 (1.6) 
18.56-25.00 
23.5 (1.2)* 
18.78-24.99 
26.9 (1.3)* 
25.01-29.98 
27.3 (1.3)* 
25.00-30.00 
32.9 (2.9)* 
30.00-44.42 
33.6 (3.5)* 
30.01-48.21 
Moderate-to-vigorous activity 
a
 (hours/week)  3.7 (3.3) 3.5 (3.3) 3.7 (3.4) 3.5 (3.4) 3 (2.9)* 2.8 (2.8)* 
       High moderate-to-vigorous activity
 b 
 – n (%)  515 (34.8) 98 (32) 403 (34.5) 212 (31.9) 64 (27)* 82 (25.6)* 
Leisure sitting time (hours/week)  20.5 (12.7) 20.7 (12.6) 20.7 (12.1) 21.3 (13.0) 21.5 (13.8) 22.8 (14.2)* 
      Low leisure sitting time – n (%)  423 (28.6) 85 (27.8) 311 (26.6) 178 (26.8) 63 (26.6) 71 (22.2)* 
       
Data are mean (standard deviation) unless otherwise noted. *Different from healthy normal-weight (p<0.05) based on linear regression (continuous variables) or logistic regression 
(binary variables).  
a
 Units are metabolic equivalent hours/week (duration in moderate-to-vigorous activity multiplied by its metabolic equivalent score). 
b 
Based on highest tertile. 
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Table 2 presents results of analyses examining separate cross-sectional associations between 
levels of moderate-to-vigorous physical activity and leisure sitting with prevalence of a 
metabolically healthy profile among normal-weight, overweight, and obese adults. Among 
normal-weight adults, being in the highest compared with the lowest moderate-to-vigorous 
physical activity group was associated with a 1.09 (95% CI=1.04, 1.15) times higher prevalence of 
being metabolically healthy, adjusting for age, sex, ethnicity, and leisure sitting time. This 
association remained after further adjustment for occupational position, health status, and 
health behaviours (PR=1.07; 1.01, 1.13). A similarly increased prevalence was observed among 
highly active overweight adults, but highly active obese adults showed no increased prevalence 
of a healthy profile compared with the least active group. Being in the lowest compared with the 
highest leisure sitting group was not associated with a higher likelihood of being metabolically 
healthy among normal-weight, overweight or obese adults at any stage of adjustment.  
As shown in Appendix 3, multivariable-adjusted subsidiary analyses found no evidence for an 
interaction between moderate-to-vigorous physical activity tertile and BMI group in relation to 
metabolic health status (p-interaction=0.58). When adjusting for BMI group, the most active 
group showed a 1.10 (95% CI=1.04, 1.15) times higher prevalence of being healthy. Associations 
with metabolic health were not evident for leisure sitting time in these analyses.   
Further subsidiary analyses examining moderate-to-vigorous physical activity as a continuous 
variable indicated that a 1-hour per week increase in such activity was associated with a 1.01 
(95% CI=1.01, 1.02) times higher prevalence of being healthy, adjusting for continuously 
measured BMI and covariates (Appendix 4). Conversely, no association was observed with 
continuously measured leisure sitting time. No interactions with continuously measured BMI 
were found for moderate-to-vigorous physical activity (p-interaction=0.26) or leisure sitting (p-
interaction=0.10).    
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Table 2 Separate associations of moderate-to-vigorous physical activity and leisure sitting with health among adults aged 45-69 (n=4177) 
  
 Prevalence of being healthy 
   
 Among normal-weight (n=1787) Among overweight (n=1833) Among obese (n=557) 
       
 Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Moderate-to-vigorous 
physical activity level* 
      
Lowest 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate 1.05 (1.00, 1.11) 1.04 (0.99, 1.10) 1.05 (0.96, 1.14) 1.04 (0.96, 1.14) 1.13 (0.90, 1.42) 1.11 (0.88, 1.40) 
Highest 1.09 (1.04, 1.15) 1.07 (1.01, 1.13) 1.12 (1.03, 1.22) 1.10 (1.01, 1.20) 1.19 (0.94, 1.52) 1.18 (0.92, 1.51) 
       
Leisure sitting time level*       
Highest 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate 0.97 (0.92, 1.02) 0.96 (0.91, 1.01) 1.07 (0.98, 1.15) 1.07 (0.99, 1.16) 1.07 (0.86, 1.34) 1.03 (0.82, 1.29) 
Lowest 0.97 (0.92, 1.02) 0.96 (0.92, 1.01) 1.03 (0.94, 1.13) 1.01 (0.93, 1.11) 1.18 (0.92, 1.51) 1.15 (0.89, 1.49) 
       
*Associations are mutually adjusted. Model 1 adjusted for age sex, ethnicity. Model 2 additionally adjusted for occupational position, smoking, alcohol 
consumption, diet quality, sleep duration, and presence of an illness which limits moderate or vigorous activity  
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Formal tests of statistical interaction between moderate-to-vigorous physical activity and leisure 
sitting in relation to prevalence of being metabolically healthy were non-significant for all BMI 
groups. As shown in Table 3, compared with normal-weight adults who had both low moderate-
to-vigorous physical activity and high leisure sitting, only those who had an intermediate level of 
physical activity and a high level of leisure sitting showed a marginally increased prevalence of 
being healthy (PR=1.08, 95% CI=1.00, 1.18) adjusting for age, sex, and ethnicity. Among 
overweight adults, those who had intermediate levels of both moderate-to-vigorous physical 
activity and leisure sitting showed a higher prevalence of being healthy (PR=1.23, 95% CI=1.07, 
1.40), as did those overweight adults who had the highest level of physical activity and lowest 
level of leisure-time sitting (PR=1.25, 95% CI=1.08, 1.45) in minimally adjusted models. No 
associations were observed among obese adults. Results remained among overweight adults 
after additional adjustment for other covariates (Table 4). In these multivariable-adjusted 
models, the combination of low moderate-to-vigorous physical activity and low leisure sitting 
was marginally associated with higher prevalence of being healthy among obese adults 
(PR=1.44, 95% CI=1.00, 2.07), as was the combination of high moderate-to-vigorous physical 
activity and low leisure sitting (PR=1.55, 95% CI=1.00, 2.43).   
As shown in Appendix 5, multivariable-adjusted subsidiary analyses found no evidence for a 
triple interaction between moderate-to-vigorous physical activity tertile, leisure sitting tertile, 
and BMI group in relation to metabolic health status (p-interaction=0.12). Adjusting for BMI 
group, adults combining high moderate-to-vigorous physical activity and low leisure sitting 
showed a 1.14 (95% CI=1.05, 1.24) times higher prevalence of being healthy. 
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Table 3 Combined associations of moderate-to-vigorous physical activity and leisure 
sitting with health among adults aged 45-69 (n=4177) 
 
  Prevalence of being healthy 
 
Model 1 
Prevalence Ratio 
(95% CI) 
   
  Among normal-weight (n=1787) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.00 (0.91, 1.09) 0.92 (0.83, 1.02) 
Intermediate  1.08 (1.00, 1.18) 0.97 (0.88, 1.06) 1.05 (0.96, 1.13) 
Highest  1.06 (0.97, 1.15) 1.08 (0.99, 1.17) 1.07 (0.98, 1.17) 
p-interaction  0.16 
   
  Among overweight (n=1833) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.04 (0.90, 1.20) 1.06 (0.91, 1.23) 
Intermediate  1.03 (0.89, 1.19) 1.23 (1.07, 1.40) 0.98 (0.84, 1.16) 
Highest  1.14 (0.99, 1.31) 1.12 (0.97, 1.29) 1.25 (1.08, 1.45) 
p-interaction   0.84  
     
  Among obese (n=557) 
     
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 0.99 (0.68, 1.45) 1.42 (0.99, 2.04) 
Intermediate  1.19 (0.81, 1.75) 1.42 (0.99, 2.02) 1.09 (0.71, 1.67) 
Highest  1.24 (0.84, 1.83) 1.27 (0.86, 1.86) 1.51 (0.96, 2.38) 
p-interaction  0.49 
   
Models adjusted for age, sex, ethnicity 
87 
 
 
Table 4 Combined associations of moderate-to-vigorous physical activity and leisure 
sitting time with health among adults aged 45-69 (n=4177) 
 
  Prevalence of being healthy 
 
Model 2 
Prevalence Ratio 
(95% CI) 
   
  Among normal-weight (n=1787) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 0.98 (0.90, 1.07) 0.92 (0.82, 1.02) 
Intermediate  1.07 (0.98, 1.16) 0.95 (0.86, 1.04) 1.03 (0.94, 1.11) 
Highest  1.03 (0.95, 1.13) 1.05 (0.97, 1.14) 1.04 (0.95, 1.14) 
p-interaction  0.17 
   
  Among overweight (n=1833) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.06 (0.91, 1.22) 1.05 (0.90, 1.22) 
Intermediate  1.03 (0.89, 1.20) 1.24 (1.08, 1.41) 0.96 (0.82, 1.13) 
Highest  1.13 (0.98, 1.31) 1.10 (0.96, 1.27) 1.22 (1.05, 1.42) 
p-interaction   0.93  
     
  Among obese (n=557) 
     
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 0.97 (0.66, 1.41) 1.44 (1.00, 2.07) 
Intermediate  1.24 (0.84, 1.81) 1.37 (0.96, 1.94) 0.99 (0.64, 1.54) 
Highest  1.24 (0.84, 1.82) 1.20 (0.81, 1.78) 1.55 (1.00, 2.43) 
p-interaction  0.46 
   
Models adjusted for age, sex, ethnicity, occupational position, smoking, alcohol 
consumption, diet quality, sleep duration, and presence of an illness which limits 
moderate or vigorous activity 
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Objective 2: Prospective associations of self-reported high moderate-to-vigorous physical 
activity and self-reported low leisure sitting time, separately and in combination, with incident 
metabolic risk factor clustering among initially healthy normal-weight, overweight, and obese 
adults 
 
Phase 5 (1997/99) served as the baseline for these analyses as this was the first time moderate-
to-vigorous physical activity, leisure sitting time, anthropometrics and metabolic risk factors 
were measured together. A flow chart illustrating the selection of the analytical sample is 
provided in Figure 3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
Figure 3 Selection of the analytical sample for the prospective study of moderate-to-vigorous 
physical activity and leisure sitting time in relation to incident metabolic risk factor clustering 
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The baseline for these analyses is the same as for previous cross-sectional analyses, and so 
descriptive characteristics were not repeated. Compared with participants included in the 
analytical sample (n=2128), those excluded (n=8180) were older (56.3 years vs.54.9 years 
respectively, p<0.001), more likely to be female (34.5% vs. 27.7% respectively, p<0.001), of a 
non-white ethnicity (12.3% vs. 5.7% respectively, p<0.001), and of the lowest occupational 
position (17.3% vs. 8.4% respectively, p<0.001). Compared with participants included in 
analyses, those excluded were also more likely to be obese (18.1% vs. 8.4% respectively, 
p<0.001), to have lower moderate-to-vigorous physical activity (3.1 hours/week vs. 3.7 
hours/week respectively, p<0.001) but not higher leisure sitting time (20.6 hours/week vs. 20.6 
hours/week respectively, p=0.86). Differences in the likelihood of being metabolically healthy 
were not relevant to test given that all participants included in the analytical sample were 
healthy.  
Results of analyses examining separate associations between levels of moderate-to-vigorous 
physical activity and leisure-time sitting with incidence of metabolic risk factor clustering over 15 
years among initially healthy normal-weight, overweight, and obese adults are presented in 
Table 5. Having the highest compared with the lowest moderate-to-vigorous physical activity 
was not associated with a lower incidence of metabolic risk factor clustering among normal-
weight, overweight, or obese adults in a model adjusting for age, sex, ethnicity, and leisure 
sitting time; nor in a model additionally adjusting for other covariates. Initially healthy 
overweight adults with an intermediate level of leisure sitting showed a lower incidence of 
metabolic risk factor clustering compared with those with the highest level of sitting (IR=0.88, 
95% CI=0.78, 0.98), which remained unchanged after additional adjustments. Leisure sitting level 
was not associated with risk of incident metabolic risk factor clustering among normal-weight or 
among obese adults at any stage of adjustment.  
Subsidiary analyses also found no evidence for associations of either moderate-to-vigorous 
physical activity tertile or leisure sitting tertile in relation to incident metabolic risk factor 
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clustering when adjusting for BMI group, with no evidence for interaction with BMI group 
(Appendix 6). 
Further subsidiary analyses examining continuously measured moderate-to-vigorous physical 
activity and leisure sitting time indicated that neither was associated with incidence of metabolic 
risk factor clustering, adjusting for continuously measured BMI and covariates (Appendix 7). No 
interactions with continuously measured BMI were found for moderate-to-vigorous physical 
activity (p-interaction=0.67) or leisure sitting (p-interaction=0.30).    
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Table 5 Separate associations of moderate-to-vigorous physical activity and leisure sitting with 
incident metabolic risk factor clustering among initially healthy normal-weight, overweight, and 
obese adults aged 45-69 at baseline (n=2128) 
 
  Risk of incident metabolic risk factor clustering over 15 years 
     
  Among initially 
healthy  
normal-weight  
(n=1077) 
Among initially 
healthy 
overweight  
(n=872) 
Among initially 
healthy  
obese  
(n=179) 
     
  Model 1 
Incidence Ratio 
(95% CI) 
  
Moderate-to-vigorous 
physical activity level* 
 
   
Lowest  1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate  0.92 (0.78, 1.09) 1.00 (0.89, 1.13) 0.90 (0.73, 1.11) 
Highest  1.07 (0.90, 1.25) 0.98 (0.87, 1.11) 1.00 (0.83, 1.22) 
     
Leisure sitting time level*     
Highest  1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate  0.90 (0.77, 1.04) 0.88 (0.78, 0.98) 1.01 (0.82, 1.23) 
Lowest  0.91 (0.78, 1.07) 1.01 (0.89, 1.13) 1.15 (0.93, 1.42) 
     
  Model 2 
Incidence Ratio 
(95% CI) 
  
Moderate-to-vigorous 
physical activity level* 
 
   
Lowest  1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate  0.94 (0.79, 1.11) 1.00 (0.89, 1.13) 0.93 (0.74, 1.17) 
Highest  1.10 (0.94, 1.30) 0.98 (0.87, 1.11) 1.03 (0.83, 1.27) 
     
Leisure sitting time level*     
Highest  1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate  0.93 (0.80, 1.08) 0.88 (0.78, 0.98) 1.00 (0.81, 1.24) 
Lowest  0.94 (0.81, 1.10) 1.01 (0.90, 1.13) 1.12 (0.90, 1.40) 
     
* Associations are mutually adjusted. Follow-up duration is cumulative, considering incidence 
after 5, 10, or 15 years. Model 1 adjusted for age, sex, and ethnicity. Model 2 additionally 
adjusted for occupational position, alcohol, smoking, diet quality, and presence of an illness 
which limits moderate or vigorous physical activity 
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As shown in Table 6 and Table 7, formal tests of statistical interaction between moderate-to-
vigorous physical activity and leisure sitting time in relation to incident metabolic risk factor 
clustering were non-significant for all BMI groups. Compared with initially healthy overweight 
adults who had both low moderate-to-vigorous physical activity and high leisure sitting time, 
only those who had an intermediate level of both physical activity and leisure sitting showed a 
marginally reduced incidence of metabolic risk factor clustering, which remained after 
adjustment for additional covariates (IR=0.80, 95% CI=0.65, 0.98). No combination of moderate-
to-vigorous physical activity and leisure sitting time was associated with lower incidence of 
metabolic risk factor clustering among initially healthy normal-weight or obese adults.  
Subsidiary analyses also found no evidence for associations of any combination of moderate-to-
vigorous physical activity and leisure sitting in relation to incident metabolic risk factor 
clustering, with no evidence for triple interaction with BMI group (Appendix 8). 
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Table 6 Combined associations of moderate-to-vigorous physical activity and leisure 
sitting with incident metabolic risk factor clustering over 15 years among initially healthy 
normal-weight, overweight, and obese adults aged 45-69 at baseline (n=2128) 
 
  Risk of incident metabolic risk factor clustering 
 over 15 years 
 
Model 1 
Incidence Ratio 
(95% CI) 
   
  Among initially healthy normal-weight (n=1077) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.00 (0.76, 1.32) 0.92 (0.67, 1.27) 
Intermediate  1.00 (0.77, 1.28) 0.90 (0.69, 1.18) 0.80 (0.59, 1.07) 
Highest  1.11 (0.88, 1.41) 0.91 (0.71, 1.18) 1.12 (0.87, 1.44) 
p-interaction  0.73 
   
  Among initially healthy overweight (n=872) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 0.85 (0.69, 1.05) 0.98 (0.80, 1.21) 
Intermediate  1.06 (0.89, 1.26) 0.80 (0.65, 0.99) 0.99 (0.80, 1.21) 
Highest  0.88 (0.73, 1.07) 0.91 (0.76, 1.09) 0.97 (0.80, 1.19) 
p-interaction   0.34  
     
  Among initially healthy obese (n=179) 
     
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Highest 
Lowest  1.00 (reference) 1.06 (0.76, 1.47) 1.26 (0.92, 1.73) 
Intermediate  1.01 (0.71, 1.44) 0.90 (0.64, 1.27) 1.05 (0.72, 1.52) 
Highest  1.03 (0.77, 1.39) 1.08 (0.80, 1.46) 1.16 (0.86, 1.56) 
p-interaction  0.61 
   
Follow-up duration is cumulative, considering incidence after 5, 10, or 15 years. Models 
adjusted for age, sex, ethnicity 
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Table 7 Combined associations of moderate-to-vigorous physical activity and leisure sitting 
with incident metabolic risk factor clustering over 15 years among initially healthy normal-
weight, overweight, and obese adults aged 45-69 at baseline (n=2128) 
 
  Risk of incident metabolic risk factor clustering 
 over 15 years 
 
Model 2 
Incidence Ratio 
(95% CI) 
   
  Among initially healthy normal-weight (n=1077) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
Highest Middle Lowest 
Lowest  1.00 (reference) 1.02 (0.78, 1.34) 0.97 (0.71, 1.31) 
Intermediate  1.02 (0.80, 1.30) 0.94 (0.72, 1.24) 0.84 (0.63, 1.13) 
Highest  1.14 (0.90, 1.45) 0.99 (0.77, 1.28) 1.19 (0.92, 1.54) 
p-interaction  0.73 
   
  Among initially healthy overweight (n=872) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Middle Lowest 
Lowest  1.00 (reference) 0.84 (0.68, 1.04) 0.99 (0.80, 1.21) 
Intermediate  1.05 (0.88, 1.25) 0.80 (0.65, 0.98) 0.99 (0.80, 1.21) 
Highest  0.88 (0.73, 1.07) 0.91 (0.75, 1.09) 0.98 (0.79, 1.20) 
p-interaction   0.32  
     
  Among initially healthy obese (n=179) 
     
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Highest Highest 
Lowest  1.00 (reference) 1.06 (0.75, 1.48) 1.29 (0.94, 1.77) 
Intermediate  1.08 (0.74, 1.58) 0.95 (0.66, 1.35) 1.03 (0.69, 1.54) 
Highest  1.07 (0.80, 1.44) 1.12 (0.83, 1.52) 1.17 (0.86, 1.59) 
p-interaction  0.41 
   
Follow-up duration is cumulative, considering incidence after 5, 10, or 15 years. Models 
adjusted for age, sex, ethnicity, occupational position, alcohol, smoking, diet quality, sleep 
duration, and presence of an illness which limits moderate or vigorous physical activity 
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Objective 3: Cross-sectional associations of self-reported high moderate-to-vigorous physical 
activity and self-reported low TV viewing time, separately and in combination, with 
prevalence of a metabolically healthy profile among normal-weight, overweight, and obese 
adults 
 
Analyses utilised data from the 11th phase of data collection (2012/13), as this was the first 
occasion when TV viewing time was measured in addition to moderate-to-vigorous physical 
activity, anthropometrics, and metabolic risk factors. A flow chart illustrating the selection of the 
analytical sample is provided in Figure 4.  
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Figure 4 Selection of the analytical sample for the cross-sectional study of moderate-to-vigorous 
physical activity and TV viewing time in relation to healthy obesity 
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The sample of participants included in analyses was largely the same as in previous cross-
sectional analyses of leisure sitting time, and so descriptive characteristics were not repeated. 
Compared with participants included in the analytical sample (n=4141), those excluded (n=6131) 
were older (71.3 years vs.69.0 years respectively, p<0.001), more likely to be female (39.0% vs. 
24.1% respectively, p<0.001), of a non-white ethnicity (13.6% vs. 7.0% respectively, p<0.001), 
and of the lowest occupational position (15.4% vs. 7.4% respectively, p<0.001). Compared with 
those included in analyses, those excluded were also more likely to be obese (25.7% vs. 17.8% 
respectively, p<0.001), more likely to be metabolically healthy (53.9% vs. 49.0% respectively, 
p=0.04), had lower moderate-to-vigorous physical activity (2.8 hours/week vs. 3.6 hours/week 
respectively, p<0.001) and higher TV viewing time (22.7 hours/week vs. 20.1 hours/week 
respectively, p<0.001). 
Table 8 presents results of separate associations of moderate-to-vigorous physical activity and 
TV viewing with prevalence of being metabolically healthy among normal-weight, overweight, 
and obese adults. In a multivariate-adjusted model considering demographic, illness, and health 
behaviour covariates as well as TV viewing time, high moderate-to-vigorous physical activity was 
associated with a 1.34 (95% CI=1.17, 1.53) times higher likelihood of being healthy among 
overweight adults, but was not associated with a healthy status among normal-weight or obese 
adults. Low TV viewing time was associated with a healthy status among normal-weight adults 
(PR=1.16, 95% CI=1.05, 1.28), but not among overweight or obese adults.  
As shown in Appendix 9, multivariable-adjusted subsidiary analyses found no evidence for 
interaction between moderate-to-vigorous physical activity tertile and BMI group (p-
interaction=0.08) or between TV viewing tertile and BMI group (p-interaction=0.25) in relation 
to metabolic health status. Adjusting for BMI group, adults with the highest vs. the lowest 
moderate-to-vigorous physical activity level showed a 1.16 (95% CI=1.07, 1.25) times higher 
prevalence of being healthy, while adults with the lowest vs. the highest TV viewing level 
showed a 1.12 (95% CI=1.04, 1.20) times higher prevalence of being healthy. 
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Further subsidiary analyses examining continuously measured moderate-to-vigorous physical 
activity indicated that a 1-hour per week increase in such activity was associated with a 1.02 
(95% CI=1.01, 1.03) times higher prevalence of being healthy, adjusting for continuously 
measured BMI and covariates (Appendix 10). Conversely, no association was found with 
continuously measured TV viewing time. No interactions with continuously measured BMI were 
found for moderate-to-vigorous physical activity (p-interaction=0.12) or TV viewing (p-
interaction=0.77) in relation to metabolic health status.    
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Table 8 Separate associations of moderate-to-vigorous physical activity and TV viewing with health among adults aged 60-82 (76% male) (n=4141) 
 
 Prevalence of being healthy 
   
 Among normal-weight (n=1601) Among overweight (n=1803) Among obese (n=737) 
       
 Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Moderate-to-vigorous 
physical activity level* 
      
Lowest 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate 1.07 (0.97, 1.17) 1.06 (0.96, 1.16) 1.17 (1.03, 1.34) 1.18 (1.03, 1.35) 0.84 (0.62, 1.14) 0.79 (0.59, 1.06) 
Highest 1.07 (0.97, 1.17) 1.05 (0.95, 1.15) 1.33 (1.17, 1.52) 1.34 (1.17, 1.53) 1.32 (0.99, 1.77) 1.22 (0.90, 1.64) 
       
TV viewing level*       
Highest 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Intermediate 1.11 (1.00, 1.22) 1.09 (0.98, 1.21) 1.02 (0.89, 1.16) 1.01 (0.89, 1.16) 1.12 (0.84, 1.49) 1.09 (0.82, 1.44) 
Lowest 1.18 (1.08, 1.30) 1.16 (1.05, 1.28) 1.09 (0.97, 1.23) 1.08 (0.95, 1.22) 1.05 (0.77, 1.42) 0.98 (0.72, 1.34) 
       
*Associations are mutually adjusted. Model 1 adjusted for age sex, ethnicity. Model 2 additionally adjusted for occupational position, smoking, 
alcohol consumption, diet quality, sleep duration, and presence of an illness which limits moderate or vigorous activity  
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Table 9 presents results of combined associations of moderate-to-vigorous physical activity and 
TV viewing with the likelihood of being healthy among normal-weight, overweight, and obese 
adults. Formal tests of interaction between tertiles of moderate-to-vigorous physical activity and 
TV viewing in relation to metabolic health status were not significant within any BMI group. In a 
model considering age, sex, and ethnicity, the combination of high moderate-to-vigorous 
physical activity and low TV viewing was associated with the highest likelihood of being healthy 
among normal-weight (PR=1.33, 95% CI=1.12, 1.57), overweight (PR=1.42, 95% CI=1.15, 1.75), 
and obese adults (PR=1.82, 95% CI=1.19, 2.78). In a multivariable-adjusted model (Table 10), the 
combination of high moderate-to-vigorous physical activity and low TV viewing with the 
likelihood of being healthy remained among normal-weight and overweight adults, but became 
non-significant among obese adults (PR=1.55, 95% CI=0.99, 2.42).  
As shown in Appendix 11, multivariable-adjusted subsidiary analyses found no evidence for a 
triple interaction between moderate-to-vigorous physical activity tertile, TV viewing tertile, and 
BMI group in relation to metabolic health status (p-interaction=0.28). Adjusting for BMI group, 
adults combining high moderate-to-vigorous physical activity with low TV viewing showed a 1.31 
(95% CI=1.15, 1.49) times higher prevalence of being healthy.
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Table 9 Combined associations of moderate-to-vigorous physical activity and TV viewing 
with health among adults aged 60-82 (n=4141) 
 
  Prevalence of being healthy 
 
Model 1 
Prevalence Ratio 
(95% CI) 
   
  Among normal-weight (n=1601) 
   
  TV viewing level 
Moderate-to-vigorous 
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.16 (0.95, 1.42) 1.28 (1.07, 1.53) 
Intermediate  1.23 (1.01, 1.49) 1.20 (1.00, 1.44) 1.29 (1.08, 1.53) 
Highest  1.06 (0.85, 1.31) 1.28 (1.06, 1.53) 1.33 (1.12, 1.57) 
p-interaction  0.78 
   
  Among overweight (n=1803) 
   
  TV viewing level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.01 (0.79, 1.30) 1.06 (0.82, 1.35) 
Intermediate  1.15 (0.92, 1.43) 1.16 (0.91, 1.46) 1.29 (1.05, 1.60) 
Highest  1.32 (1.07, 1.63) 1.36 (1.09, 1.71) 1.42 (1.15, 1.75) 
p-interaction   0.94  
     
  Among obese (n=737) 
     
  TV viewing level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.24 (0.85, 1.82) 0.76 (0.45, 1.30) 
Intermediate  0.89 (0.58, 1.37) 0.84 (0.48, 1.47) 0.79 (0.47, 1.35) 
Highest  1.05 (0.63, 1.73) 1.26 (0.78, 2.06) 1.82 (1.19, 2.78) 
p-interaction  0.06 
   
Models adjusted for age, sex, ethnicity 
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Table 10 Combined associations of moderate-to-vigorous physical activity and TV viewing 
with health among adults aged 60-82 (n=4141) 
 
  Prevalence of being healthy 
 
Model 2 
Prevalence Ratio 
(95% CI) 
   
  Among normal-weight (n=1601) 
   
  TV viewing level 
Moderate-to-vigorous 
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.14 (0.93, 1.39) 1.25 (1.04, 1.50) 
Intermediate  1.21 (1.00, 1.47) 1.17 (0.97, 1.42) 1.24 (1.04, 1.48) 
Highest  1.03 (0.83, 1.28) 1.22 (1.02, 1.47) 1.28 (1.07, 1.52) 
p-interaction  0.90 
   
  Among overweight (n=1803) 
   
  TV viewing level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.02 (0.79, 1.31) 1.07 (0.83, 1.37) 
Intermediate  1.16 (0.93, 1.44) 1.16 (0.92, 1.48) 1.31 (1.05, 1.62) 
Highest  1.35 (1.09, 1.67) 1.37 (1.09, 1.73) 1.41 (1.13, 1.75) 
p-interaction   0.85  
     
  Among obese (n=737) 
     
  TV viewing level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.21 (0.83, 1.78) 0.74 (0.43, 1.26) 
Intermediate  0.85 (0.56, 1.30) 0.77 (0.44, 1.34) 0.69 (0.40, 1.19) 
Highest  0.99 (0.59, 1.64) 1.13 (0.69, 1.84) 1.55 (0.99, 2.42) 
p-interaction  0.09 
   
Models adjusted for age, sex, ethnicity, occupational position, alcohol, smoking, diet 
quality, sleep duration, and presence of an illness which limits moderate or vigorous 
physical activity 
104 
 
Additional results of cross-sectional differences in TV viewing time across metabolic and obesity 
groups are presented in Table 11. The mean number of hours per week of viewing TV increased 
steadily across groups (p-trend <0.001). Compared with healthy normal-weight adults, healthy 
obese adults viewed on average 5.30 (95% CI=3.50, 7.11) hours more of TV per week when 
adjusting for age, sex, and ethnicity. This figure reduced to 4.28 (95% CI=2.51, 6.06) hours more 
of TV viewing per week when additionally considering occupational position, health behaviours, 
activity-limiting health status, and duration of self-reported moderate-to-vigorous physical 
activity (hours/week). When viewing differences in TV viewing time between healthy and 
unhealthy obese groups specifically, healthy obese adults did not show lower levels of TV 
viewing than unhealthy obese adults at either stage of model adjustment (B=-0.15, 95% CI=-
2.03, 1.73 in the multivariable-adjusted model).  
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Table 11 Differences in TV viewing duration  (hours/week) across metabolic and 
obesity groups of adults aged 60-82 (n=4141) 
 
 Model 1 
B (95% CI) 
Model 2 
B (95% CI) 
Metabolic and obesity status   
Healthy normal-weight (n=1048) 0.00 (reference) 0.00 (reference) 
Unhealthy normal-weight (n=553) 2.19 (0.98, 3.39) 1.70 (0.52, 2.87) 
Healthy overweight (n=795) 3.58 (2.52, 4.65) 2.85 (1.80, 3.89) 
Unhealthy overweight (n=1008) 3.92 (2.91, 4.93) 3.12 (2.12, 4.12) 
Healthy obese (n=186) 5.30 (3.50, 7.11) 4.28 (2.51, 6.06) 
Unhealthy obese (n=551) 5.82 (4.63, 7.01) 4.43 (3.24, 5.63) 
   
(Reference group reversed)   
Unhealthy obese (n=551) 0.00 (reference) 0.00 (reference) 
Healthy obese (n=186) -0.51 (-2.44, 1.42) -0.15 (-2.03, 1.73) 
Unhealthy overweight (n=1008) -1.90 (-3.11, -0.69) -1.32 (-2.50, -0.13) 
Healthy overweight (n=795) -2.24 (-3.49, -0.98) -1.59 (-2.83, -0.34) 
Unhealthy normal-weight (n=553) -3.63 (-5.00, -2.26) -2.74 (-4.09, -1.38) 
Healthy normal-weight (n=1048) -5.82 (-7.01, -4.63) -4.43 (-5.63, -3.24) 
   
Model 1 adjusted for age, sex, and ethnicity. Model 2 additionally adjusted for 
occupational position, alcohol, smoking, diet quality, sleep duration, presence 
of an illness which limits moderate or vigorous physical activity, and self-
reported moderate-to-vigorous physical activity 
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Objective 4: Cross-sectional differences in questionnaire- and accelerometer-assessed total 
physical activity between healthy and unhealthy normal-weight, overweight, and obese adults 
 
Among the 4880 participants to whom the accelerometer was proposed, 210 had 
contraindications, 4282 consented and 4040 participants had valid accelerometer data (≥16 
hours/day) for at least 2 weekdays and 2 week-end days. Of those, 3457 participants also had 
data on questionnaire-assessed physical activity, body-mass index, metabolic risk factors, and 
covariates. Among the 3457 participants included in analyses, 3359 (97.2%) had valid 
accelerometer data for the 8-day observation period, 63 (1.8%) for 6-7 days, and 34 (1%) for 5-4 
days.  In all, missing data were replaced on average for 0.3% of the observation period, with 103 
(3%) participants having missing data replaced for 1-5% of the period and 22 (0.6%) for 5-27% of 
the period.  A flow chart illustrating the selection of the analytical sample is provided in Figure 5.
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Figure 5 Selection of the analytical sample for the cross-sectional study of questionnaire- and 
accelerometer-assessed total physical activity in relation to healthy obesity 
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Descriptive characteristics of the analytical sample at phase 11 (2012/13), the first time an 
objective measure of physical activity was taken, are shown in Table 12. Among 3457 
participants with complete data on questionnaire- and accelerometer-assessed physical activity, 
anthropometrics, metabolic risk factors, and covariates, 1330 were normal-weight, of which 864 
(65%) were considered healthy normal-weight. A further 1511 were overweight, of which 650 
(43%) were considered healthy overweight. A further 616 were obese, of which 161 (26%) were 
considered healthy obese. Each metabolic factor was more adverse among healthy overweight 
and healthy obese adults compared with healthy normal-weight adults, with the exception of 
fasting glucose among healthy obese adults. Healthy and unhealthy obese adults showed lower 
levels of self-reported total physical activity compared with healthy normal-weight adults (43.8 
and 42.6 MET-hours/week vs. 50.8 MET-hours/week respectively, each p<0.05). Lower levels of 
accelerometer-assessed total physical activity were also seen among healthy and unhealthy 
obese adults compared with healthy normal-weight adults (22.3 mg/week and 20.6 mg/week vs. 
25.8 mg/week respectively, each p<0.05). 
Compared with participants included in the analytical sample (n=3457), those excluded (n=1423) 
were older (mean age=69.6 years vs. 69.2 years, p=0.008), more likely to be female (36.6% vs. 
23.3%, p<0.001), of a non-white ethnicity (10.8% vs. 6.8%, p<0.001), and of the lowest 
occupational position (11.8% vs. 7.8%, p<0.001). Excluded participants also showed lower total 
physical activity as measured by questionnaire (43.5 MET-hours/week vs. 46.9 MET-hours/week, 
p<0.001) but higher total physical activity as assessed by accelerometer (25.2 mg/week vs. 23.5 
mg/week, p=0.01). Excluded participants were more likely to be obese (21.6% vs. 17.8%, 
p=0.003) but also more likely to be metabolically healthy (52.2% vs. 48.5%, p=0.03). 
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Table 12 Characteristics of adults aged 60-82 at baseline (77% male) at phase 11 (2012/13) by metabolic and obesity status (n=3457) 
       
 Healthy normal-
weight  
(n=864) 
Unhealthy 
normal-weight 
(n=466) 
Healthy 
overweight 
(n=650) 
Unhealthy 
overweight 
(n=861) 
Healthy obese  
(n=161) 
Unhealthy obese  
(n=455) 
Male – n (%)  626 (72.5) 378 (81.3)* 513 (78.9)* 724 (84.0)* 83 (51.6)* 325 (71.4) 
Age (years)  68.6 (5.7) 70.6 (5.6)* 68.5 (5.4) 70 (5.6)* 68.2 (5.0) 68.6 (5.5) 
Non-white ethnicity – n (%)  36 (4.2) 49 (10.5)* 23 (3.5) 75 (8.7)* 9 (5.6) 42 (9.2)* 
Lowest occupational position – n (%)  44 (5.1) 38 (8.2)* 52 (8.0)* 56 (6.5) 22 (13.7)* 57 (12.5)* 
Unhealthy diet – n (%)  81 (9.4) 63 (13.5)* 96 (14.8)* 130 (15.1)* 20 (12.4) 70 (15.4)* 
       Consumes fruit and vegetables < daily – n (%)  132 (15.3) 88 (18.9) 134 (20.6)* 196 (22.8)* 38 (23.6)* 110 (24.2)* 
       Consumes whole/full-fat milk most often – n (%)  95 (11.0) 33 (7.1)* 54 (8.3) 60 (7.0)* 7 (4.3)* 41 (9.0) 
       Consumes white bread most often – n (%)  108 (12.5) 82 (17.6)* 118 (18.2)* 158 (18.4)* 26 (16.1) 80 (17.6)* 
Current smoker – n (%)  18 (2.1) 12 (2.6) 21 (3.2) 32 (3.7)* 5 (3.1) 15 (3.3) 
High alcohol consumption in previous week – n (%)  101 (11.7) 61 (13.1) 81 (12.5) 135 (15.7)* 24 (14.9) 86 (18.9)* 
Sleeps ≤ 5 hours/night – n (%)  40 (4.6) 26 (5.6) 45 (6.9) 80 (9.3)* 11 (6.8) 48 (10.6)* 
Has illness that greatly limits moderate or vigorous activity – n (%)  236 (27.3) 150 (32.2) 195 (30.0) 328 (38.1)* 80 (49.7)* 245 (53.8)* 
Systolic blood pressure (mmHg)  121.2 (14.6) 130.9 (16.2)* 124.2 (13.7)* 129.5 (16.6)* 125.7 (14.3)* 130.4 (15.4)* 
Diastolic blood pressure (mmHg)  67.9 (9.1) 70.7 (10.3)* 70.7 (9.2)* 71.1 (10.1)* 73.2 (9.1)* 72.5 (9.7)* 
Fasting glucose (mmol/l)  5.0 (0.4) 5.7 (1.5)* 5.1 (0.4) 5.8 (1.6)* 5.1 (0.4) 6.1 (2.0)* 
HOMA insulin resistance  1.2 (0.7) 2.7 (3.2)* 1.9 (1.0)* 3.9 (6.5)* 2.5 (1.3)* 6.4 (10.2)* 
Triglycerides (mmol/l)  0.9 (0.4) 1.1 (0.6)* 1.1 (0.4)* 1.4 (0.8)* 1.1 (0.3)* 1.6 (0.9)* 
HDL cholesterol (mmol/l)  1.9 (0.5) 1.7 (0.5)* 1.6 (0.4)* 1.5 (0.4)* 1.7 (0.4)* 1.4 (0.4)* 
Body mass index (kg/m²) 
       Range 
22.6 (1.6) 
18.52-24.99 
23.3 (1.4)* 
18.57-24.99 
27.1 (1.4)* 
25.00-29.98 
27.3 (1.4)* 
25.01-29.98 
32.6 (2.6)* 
30.00-42.53 
33.6 (3.3)* 
30.01-49.43 
       
Data are mean (SD) unless otherwise noted.  *Different from healthy normal-weight (p<0.05) based on linear regression (continuous variables) or logistic regression (binary variables). 
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Table 13 (Continued) Characteristics of adults aged 60-82 at baseline (77% male) at phase 11 (2012/13) by metabolic and obesity status (n=3457) 
       
 Healthy normal-
weight  
(n=864) 
Unhealthy 
normal-weight 
(n=466) 
Healthy 
overweight 
(n=650) 
Unhealthy 
overweight 
(n=861) 
Healthy obese  
(n=161) 
Unhealthy obese  
(n=455) 
Questionnaire-assessed total physical activity (MET-hours/week)  50.8 (28.5) 47.7 (26.6)* 48.2 (26.7) 44.4 (25.8)* 43.8 (23.3)* 42.6 (25.9)* 
Questionnaire-assessed moderate-to-vigorous physical activity 
(hours/week) 
a   
3.25 (1.25-5.88) 3.13 (1.06-5.50) 3.28 (1.13-6.00) 2.63 (0.63-4.88) 2.00 (0.63-5.16) 2.00 (0.44-4.13) 
≥ 2.5 hrs/week of questionnaire-assessed moderate-to-vigorous 
activity – n (%) 
b  
 
509 (58.9) 270 (57.9) 385 (59.2) 447 (51.9)* 73 (45.3)* 201 (44.2)* 
Accelerometer-assessed total physical activity (mean 
acceleration/week, mg 
b
)  
25.8 (7.4) 23.3 (6.5)* 24 (6.1)* 22.5 (5.9)* 22.3 (6.0)* 20.6 (5.3)* 
Accelerometer-assessed moderate-to-vigorous physical activity 
(hours/week) 
a   
1.87 (0.66-3.98) 1.27 (0.36-2.71) 1.25 (0.31-2.96) 0.98 (0.20-2.39) 0.56 (0.00-2.15) 0.50 (0.00-1.64) 
≥ 2.5 hrs/week of accelerometer-assessed moderate-to-vigorous 
activity – n (%) 
c
 
368 (42.6) 128 (27.5)* 196 (30.2)* 201 (23.3)* 32 (19.9)* 74 (16.3)* 
       
Data are mean (SD) unless otherwise noted.  *Different from healthy normal-weight (p<0.05) based on linear regression (continuous variables) or logistic regression (binary variables).
  a 
Data are median (interquartile range) due to non-normal distribution; differences not tested. 
b 
Based on World Health Organization, 2010. 
c
 Units are milligravity (measure of mean 
weekly acceleration). 
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The correlation between self-reported and objectively assessed total physical activity was lower 
among obese adults than among normal-weight and overweight adults (Spearman’s 
correlation=0.233 vs. 0.311 and 0.320 respectively, all p<0.001). The correlation between self-
reported and objectively assessed total physical activity appeared to be non-differential 
between healthy normal-weight and healthy obese adults (Spearman’s correlation=0.300 and 
0.296, respectively, each p<0.001). This correlation was weaker within unhealthy obese adults, 
at 0.205, p<0.001.   
When using the questionnaire measure, total physical activity was lower among unhealthy 
overweight, healthy obese, and unhealthy obese adults compared with healthy normal-weight 
adults in models adjusted for age, sex, and ethnicity (Table 13). In models further adjusted for 
occupational position, health behaviours, and health status (Figure 6; Table 13), unhealthy 
overweight, healthy obese, and unhealthy obese adults showed -0.20 (-0.30, -0.10), -0.19 (-0.36, 
-0.02) and -0.22 (-0.34, -0.11) lower standard deviation units of total physical activity compared 
with healthy normal-weight adults respectively. Pairwise comparisons showed no differences in 
questionnaire-assessed total physical activity between metabolically healthy and unhealthy 
adults within any BMI category in fully adjusted models (Figure 6).  
When using the accelerometer measure, all groups showed lower total physical activity than the 
healthy normal-weight group in minimally adjusted models and after further adjustments for 
other covariates (Figure 6; Table 13), with total physical activity being -0.46 (-0.62, -0.31) 
standard deviation units lower in healthy obese adults and -0.72 (-0.83, -0.62) standard 
deviation units lower in unhealthy obese adults. Pairwise comparisons showed differences in 
accelerometer-assessed total physical activity between healthy and unhealthy groups within all 
BMI categories at both stages of adjustment, with healthy obese adults showing higher total 
physical activity than their unhealthy obese counterparts (p=0.002). Further adjustment for BMI 
did not remove significance of differences within any group (p<0.001 between normal-weight 
groups; p=0.01 between overweight groups; p=0.01 between obese groups). The overall fit of 
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the model was better with accelerometer- compared with questionnaire-based assessments 
(AIC for fully-adjusted models=9149.87 vs. 9707.06 respectively).   
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Table 14 Differences in questionnaire- and accelerometer-assessed total physical activity across metabolic and obesity groups (n=3457) 
     
 Questionnaire-assessed total physical activity Accelerometer-assessed total physical activity 
     
 Model 1 Model 2 Model 1 Model 2 
 β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
Metabolic and obesity status     
Healthy normal weight (n=864) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 
Unhealthy normal weight (n=466) -0.08 (-0.20, 0.03) -0.09 (-0.20, 0.03) -0.27 (-0.38, -0.17) -0.27 (-0.37, -0.17) 
Healthy overweight (n=650) -0.10 (-0.20, 0.00) -0.10 (-0.20, 0.00) -0.28 (-0.37, -0.19) -0.27 (-0.37, -0.18) 
Unhealthy overweight (n=861) -0.22 (-0.31, -0.12) -0.20 (-0.30, -0.10) -0.43 (-0.52, -0.34) -0.41 (-0.50, -0.32) 
Healthy obese (n=161) -0.25 (-0.42, -0.09) -0.19 (-0.36, -0.02) -0.54 (-0.70, -0.38) -0.46 (-0.62, -0.31) 
Unhealthy obese (n=455) -0.29 (-0.40, -0.18) -0.22 (-0.34, -0.11) -0.79 (-0.90, -0.69) -0.72 (-0.83, -0.62) 
     
(Reference group reversed)     
Unhealthy obese (n=455) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 
Healthy obese (n=161) 0.04 (-0.14, 0.22) 0.03 (-0.15, 0.21) 0.25 (0.09, 0.42) 0.26 (0.10, 0.43) 
Unhealthy overweight (n=861) 0.07 (-0.04, 0.19) 0.02 (-0.09, 0.14) 0.36 (0.25, 0.47) 0.32 (0.21, 0.42) 
Healthy overweight (n=650) 0.19 (0.07, 0.31) 0.12 (0.00, 0.24) 0.51 (0.40, 0.62) 0.45 (0.34, 0.56) 
Unhealthy normal weight (n=466) 0.21 (0.08, 0.34) 0.13 (0.00, 0.26) 0.52 (0.40, 0.64) 0.45 (0.33, 0.57) 
Healthy normal weight (n=864) 0.29 (0.18, 0.40) 0.22 (0.11, 0.34) 0.79 (0.69, 0.90) 0.72 (0.62, 0.83) 
     
AIC 9764.09 9707.06 9284.09 9149.87  
     
Standardised measures of questionnaire and accelerometer data (Z scores) were used (mean=0.00; standard deviation=1.00). Model 1 adjusted for 
age, sex, and ethnicity. Model 2 additionally adjusted for occupational position, diet quality, smoking status, alcohol consumption, sleep duration, 
and presence of an illness which limits moderate or vigorous activity 
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Figure 6 Differences in questionnaire- and accelerometer-assessed total physical activity across metabolic and obesity groups (n=3457) 
 
Data are standardised Z-scores to allow comparability between measures. Model fit was better with accelerometer- compared with questionnaire-
based assessments (AIC for fully-adjusted models=9149.87 vs. 9707.06 respectively). Models adjusted for age, sex, ethnicity, occupational position, diet 
quality, smoking status, alcohol consumption, sleep duration, and presence of an illness which limits moderate or vigorous activity
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A reduced prevalence of obesity and of each individual metabolic risk factor was observed for a 
standard deviation increase in total physical activity, and these associations were consistently 
stronger with accelerometer- compared with questionnaire-based assessments (Figure 7; Table 
14). Insulin resistance showed the greatest reduction in prevalence with higher accelerometer-
assessed total physical activity (PR=0.55, 95% CI=0.49, 0.63 for 1 standard deviation increase in 
total physical activity).
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Table 15 Associations of questionnaire- and accelerometer-assessed total physical activity 
with prevalence of individual metabolic risk factors (n=3457) 
   
 Questionnaire-assessed 
total physical activity 
Accelerometer-assessed 
total physical activity 
   
 Prevalence ratio 
 (95% CI) 
Prevalence ratio 
 (95% CI) 
Metabolic risk factors   
No hypertension (n=1296) 1.00 (reference) 1.00 (reference) 
Hypertension (n=2161) 0.94 (0.92, 0.97) 0.88 (0.86, 0.91) 
   
Normal HDL (n=1864) 1.00 (reference) 1.00 (reference) 
Low HDL (n=1593) 0.94 (0.90, 0.97) 0.86 (0.82, 0.90) 
   
Normal triglycerides (n=2885) 1.00 (reference) 1.00 (reference) 
High triglycerides (n=572) 0.87 (0.79, 0.95) 0.72 (0.66, 0.79) 
   
Normal blood glucose (n=2386) 1.00 (reference) 1.00 (reference) 
High blood glucose (n=1071) 0.95 (0.91, 1.00) 0.88 (0.83, 0.93) 
   
No insulin resistance (n=3113) 1.00 (reference) 1.00 (reference) 
Insulin resistance (n=344) 0.77 (0.68, 0.88) 0.55 (0.49, 0.63) 
   
No obesity (n=2841) 1.00 (reference) 1.00 (reference) 
Obesity (n=616) 0.85 (0.78, 0.92) 0.59 (0.54, 0.64) 
   
Standardized measures of questionnaire and accelerometer data (Z scores) were used 
(mean=0.00; standard deviation=1.00). Models are adjusted for age, sex, and ethnicity. 
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Figure 7 Association of questionnaire- and accelerometer-assessed total physical activity and individual metabolic risk factors (n=3457) 
 
 
Data are standardised Z-scores to allow comparability between measures. Case numbers (n) are as follows: Hypertension=2161; Low HDL=1593; High 
triglycerides=572; High blood glucose=1071; Insulin resistance=344; Obesity=616. Reference groups are the absence of each individual metabolic risk 
factor under consideration. Models are adjusted for age, sex, and ethnicity.
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Objective 5: Cross-sectional differences in the likelihood of meeting recommendations for 
moderate-to-vigorous physical activity, based on questionnaire and accelerometer 
assessments, between healthy and unhealthy normal-weight, overweight, and obese adults 
 
Analyses for this section are based on the same participants included in the analytical sample for 
the previous section examining differences in total physical activity (n=3457), and thus 
descriptive characteristics and comparisons between excluded and included participants are the 
same. However, those excluded from analyses (n=1423) were additionally found to be less likely 
to meet recommendations for moderate-to-vigorous physical activity as assessed by 
questionnaire (47.5% vs. 54.5%, p<0.001) and by accelerometer (21.3% vs. 28.9%, p<0.001) 
compared with those included (n=3457).  
When using the questionnaire measure, the prevalence of meeting recommendations for 
moderate-to-vigorous physical activity was lower among unhealthy overweight, healthy obese, 
and unhealthy obese adults compared with healthy normal-weight adults, adjusting for age, sex, 
and ethnicity (Table 15). After adjustment for additional covariates, unhealthy overweight 
(PR=0.91, 95% CI=0.84, 0.99) and unhealthy obese adults (PR=0.85, 95% CI=0.76, 0.96) showed 
reduced prevalence, while healthy obese adults were not less likely to meet recommendations 
than healthy normal-weight adults. Models with unhealthy obese adults as the reference group 
indicated that healthy obese adults were not more likely to report ≥ 2.5 hours of moderate-to-
vigorous physical activity per week than unhealthy obese adults. 
When using the accelerometer measure with a 100mg cut-point and a 10-minute bout criteria to 
define moderate-to-vigorous physical activity, the prevalence of undertaking ≥ 2.5 hours/week 
of moderate-to-vigorous activity was lower in all groups compared with healthy normal-weight 
adults at both stages of adjustment (Table 15). Compared with healthy normal-weight adults, 
this prevalence was 0.59 (95% CI=0.43, 0.79) times lower in healthy obese adults and 0.46 (95% 
CI=0.37, 0.58) times lower in unhealthy obese adults after adjustment for all covariates. Models 
with the unhealthy obese as the reference group indicated that healthy obese adults were not 
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more likely to perform ≥ 2.5 hours/week of accelerometer-assessed moderate-to-vigorous 
physical activity than unhealthy obese adults. The overall fit of the model was better when using 
accelerometer compared with questionnaire assessments (AIC=4183.95 vs. 5963.40 in 
multivariable-adjusted models respectively). 
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Table 16 Likelihood of meeting 2010 World Health Organization recommendations for moderate-to-vigorous physical activity compared with 
healthy normal-weight adults, based on questionnaire and accelerometer assessments (n=3457) 
    
 Meets physical activity recommendations  
based on questionnaire 
 Meets physical activity recommendations  
based on accelerometer (100 mg, 10 min bouts) 
    
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
Metabolic and obesity status      
Healthy normal weight (n=864) 1.00 (reference) 1.00 (reference)  1.00 (reference) 1.00 (reference) 
Unhealthy normal weight (n=466) 1.00 (0.91, 1.10) 1.01 (0.92, 1.11)  0.74 (0.63, 0.87) 0.75 (0.64, 0.89) 
Healthy overweight (n=650) 0.98 (0.90, 1.07) 1.01 (0.93, 1.10)  0.69 (0.60, 0.79) 0.71 (0.62, 0.81) 
Unhealthy overweight (n=861) 0.88 (0.81, 0.95) 0.91 (0.84, 0.99)  0.59 (0.51, 0.68) 0.63 (0.55, 0.72) 
Healthy obese (n=161) 0.82 (0.69, 0.98) 0.89 (0.75, 1.06)  0.50 (0.37, 0.68) 0.59 (0.43, 0.79) 
Unhealthy obese (n=455) 0.77 (0.68, 0.86) 0.85 (0.76, 0.96)  0.39 (0.32, 0.49) 0.46 (0.37, 0.58) 
      
(Reference group reversed)      
Unhealthy obese (n=455) 1.00 (reference) 1.00 (reference)  1.00 (reference) 1.00 (reference) 
Healthy obese (n=161) 1.07 (0.88, 1.30) 1.05 (0.87, 1.27)  1.28 (0.90, 1.83) 1.26 (0.89, 1.80) 
Unhealthy overweight (n=861) 1.14 (1.01, 1.29) 1.07 (0.95, 1.21)  1.51 (1.20, 1.90) 1.35 (1.07, 1.70) 
Healthy overweight (n=650) 1.28 (1.14, 1.44) 1.19 (1.05, 1.34)  1.75 (1.39, 2.21) 1.53 (1.22, 1.93) 
Unhealthy normal weight (n=466) 1.30 (1.15, 1.48) 1.19 (1.05, 1.35)  1.88 (1.47, 2.41) 1.63 (1.27, 2.08) 
Healthy normal weight (n=864) 1.30 (1.16, 1.46) 1.18 (1.05, 1.32)  2.54 (2.05, 3.15) 2.16 (1.74, 2.68) 
      
AIC 5992.47 5963.40  4226.51 4183.95 
      
Physical activity recommendations based on 2010 World Health Organization guideline of ≥ 2.5 hrs/week of moderate-to-vigorous physical 
activity in bouts of at least 10 minutes. Model 1 adjusted for age, sex, and ethnicity. Model 2 further adjusted for occupational position, diet 
quality, smoking status, alcohol consumption, sleep duration, and presence of an illness which limits moderate or vigorous activity 
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Sensitivity analyses using a more stringent 120 mg cut-point for accelerometer-assessed 
moderate-to-vigorous physical activity in 10-minute bouts produced results of a similar pattern 
and magnitude as main analyses (Table 16). Healthy obese adults were not more likely to 
perform ≥ 2.5 hours/week of moderate-to-vigorous activity than unhealthy obese adults 
(PR=1.22, 95% CI=0.77, 1.92). However, when considering bouts of at least 1 minute in addition 
to the more stringent 120 mg cut-point, healthy obese adults were more likely than unhealthy 
obese adults to meet recommendations for moderate-to-vigorous activity (PR=1.31, 95% 
CI=1.05, 1.64 after multivariable-adjustment; Table 17). This difference was not evident when 
using 1-minute bouts with the 100 mg cut-point.
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Table 17 Likelihood of meeting 2010 World Health Organization recommendations 
for moderate-to-vigorous physical activity across metabolic and obesity groups 
based on a 120 mg cut-point accelerometer assessment (n=3457) 
  
 Meets physical activity recommendations  
based on accelerometer (120 mg, 10 min bouts) 
  
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
Metabolic and obesity status   
Healthy normal weight (n=864) 1.00 (reference) 1.00 (reference) 
Unhealthy normal weight (n=466) 0.71 (0.57, 0.88) 0.73 (0.59, 0.91) 
Healthy overweight (n=650) 0.68 (0.57, 0.81) 0.70 (0.59, 0.84) 
Unhealthy overweight (n=861) 0.54 (0.45, 0.65) 0.58 (0.48, 0.70) 
Healthy obese (n=161) 0.47 (0.31, 0.71) 0.57 (0.38, 0.85) 
Unhealthy obese (n=455) 0.38 (0.29, 0.50) 0.47 (0.36, 0.62) 
   
(Reference group reversed)   
Unhealthy obese (n=455) 1.00 (reference) 1.00 (reference) 
Healthy obese (n=161) 1.24 (0.78, 1.98) 1.22 (0.77, 1.92) 
Unhealthy overweight (n=861) 1.41 (1.05, 1.91) 1.24 (0.92, 1.67) 
Healthy overweight (n=650) 1.78 (1.33, 2.39) 1.50 (1.12, 2.02) 
Unhealthy normal weight (n=466) 1.85 (1.35, 2.55) 1.56 (1.13, 2.14) 
Healthy normal weight (n=864) 2.62 (1.99, 3.44) 2.13 (1.61, 2.82) 
   
AIC 3256.79 3216.37 
   
Physical activity recommendations based on 2010 World Health Organization 
guideline of ≥ 2.5 hrs/week of moderate-to-vigorous physical activity in bouts of at 
least 10 minutes. Model 1 adjusted for age, sex, and ethnicity. Model 2 further 
adjusted for occupational position, diet quality, smoking status, alcohol 
consumption, sleep duration, and presence of an illness which limits moderate or 
vigorous activity 
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Table 18 Likelihood of meeting 2010 World Health Organization recommendations for moderate-to-vigorous physical activity compared 
with healthy normal-weight adults based on 1-minute bout accelerometer assessments (n=3457) 
    
 Meets physical activity recommendations  
based on accelerometer (100 mg, 1 min bouts) 
 Meets physical activity recommendations  
based on accelerometer (120 mg, 1 min bouts) 
    
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
Metabolic and obesity status      
Healthy normal-weight (n=864) 1.00 (reference) 1.00 (reference)  1.00 (reference) 1.00 (reference) 
Unhealthy normal-weight (n=466) 0.98 (0.92, 1.04) 0.98 (0.92, 1.05)  0.89 (0.81, 0.98) 0.90 (0.82, 0.99) 
Healthy overweight (n=650) 0.92 (0.87, 0.97) 0.93 (0.88, 0.98)  0.81 (0.75, 0.89) 0.83 (0.77, 0.90) 
Unhealthy overweight (n=861) 0.86 (0.81, 0.91) 0.88 (0.83, 0.93)  0.75 (0.68, 0.81) 0.77 (0.71, 0.84) 
Healthy obese (n=161) 0.70 (0.61, 0.80) 0.74 (0.64, 0.85)  0.63 (0.52, 0.77) 0.70 (0.58, 0.85) 
Unhealthy obese (n=455) 0.66 (0.61, 0.72) 0.71 (0.65, 0.78)  0.47 (0.41, 0.55) 0.53 (0.46, 0.61) 
      
(Reference group reversed)      
Unhealthy obese (n=455) 1.00 (reference) 1.00 (reference)  1.00 (reference) 1.00 (reference) 
Healthy obese (n=161) 1.05 (0.90, 1.23) 1.04 (0.89, 1.22)  1.33 (1.06, 1.67) 1.31 (1.05, 1.64) 
Unhealthy overweight (n=861) 1.29 (1.18, 1.42) 1.24 (1.13, 1.36)  1.57 (1.35, 1.82) 1.45 (1.25, 1.68) 
Healthy overweight (n=650) 1.39 (1.26, 1.52) 1.31 (1.19, 1.44)  1.71 (1.48, 1.99) 1.56 (1.35, 1.81) 
Unhealthy normal-weight (n=466) 1.47 (1.33, 1.62) 1.38 (1.26, 1.53)  1.88 (1.61, 2.20) 1.69 (1.45, 1.98) 
Healthy normal-weight (n=864) 1.51 (1.38, 1.64) 1.41 (1.29, 1.54)  2.11 (1.83, 2.42) 1.88 (1.63, 2.16) 
      
AIC 6412.84 6405.07  5561.03 5531.27 
      
Physical activity recommendations based on 2010 World Health Organization guideline of ≥ 2.5 hrs/week of moderate-to-vigorous physical 
activity in bouts of at least 1 minute. Model 1 adjusted for age, sex, and ethnicity. Model 2 further adjusted for occupational position, diet 
quality, smoking status, alcohol consumption, sleep duration, and presence of an illness which limits moderate or vigorous activity 
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In main analyses, health behaviour covariate data were used at the most recent study phase 
before 2012/13 for a small proportion of participants (n=84, or 2% of the sample). In order to 
examine potential for bias in results due to covariate data used from earlier phases, multivariate 
analyses were repeated on a sample of participants whose health behaviour data were used 
only from the 2012/13 assessment (n=3373), the results of which are shown in Tables 18, 19, 
and 20 below. Trends in physical activity measures were unchanged, with differences in total 
physical activity between healthy and unhealthy obese groups evident only when using 
accelerometer assessments, and with healthy obese adults more likely than unhealthy obese 
adults to meet moderate-to-vigorous physical activity guidelines only when considering 1-
minute bout durations and the more stringent 120 mg accelerometer cut-point.  
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Table 19 Differences in questionnaire- and accelerometer-assessed total physical activity across metabolic and obesity groups 
based on participants with complete covariate data in 2012/13 (n=3373) 
     
 Questionnaire-assessed  
total physical activity 
Z score 
Accelerometer-assessed  
total physical activity  
Z score 
     
 Model 1 Model 2 Model 1 Model 2 
 β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
Metabolic and obesity status     
Unhealthy obese (n=442) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 
Healthy obese (n=156) 0.05 (-0.13, 0.23) 0.04 (-0.14, 0.22) 0.22 (0.05, 0.39) 0.23 (0.06, 0.40) 
Unhealthy overweight (n=838) 0.07 (-0.05, 0.18) 0.02 (-0.10, 0.13) 0.35 (0.24, 0.45) 0.30 (0.19, 0.41) 
Healthy overweight (n=633) 0.19 (0.07, 0.31) 0.12 (-0.00, 0.24) 0.50 (0.39, 0.62) 0.44 (0.33, 0.55) 
Unhealthy normal-weight (n=457) 0.22 (0.09, 0.35) 0.14 (0.01, 0.28) 0.52 (0.39, 0.64) 0.45 (0.33, 0.57) 
Healthy normal-weight (n=847) 0.30 (0.18, 0.41) 0.22 (0.11, 0.34) 0.78 (0.68, 0.89) 0.71 (0.61, 0.82) 
     
Standardised measures (Z scores) of questionnaire and accelerometer data were used. Model 1 adjusted for age, sex, and 
ethnicity. Model 2 adjusted for age, sex, ethnicity, occupational position, diet quality, smoking status, alcohol consumption, sleep 
duration, and presence of an illness which limits moderate or vigorous activity 
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Table 20 Likelihood of meeting 2010 World Health Organization recommendations for moderate-to-vigorous physical activity compared with 
unhealthy obese adults based on questionnaire and accelerometer assessments in the Whitehall II cohort study, using participants with 
complete covariate data in 2012/13 (n=3373) 
    
 Meets physical activity recommendations  
based on questionnaire 
 Meets physical activity recommendations  
based on accelerometer  
(100mg, 10 min bouts) 
    
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
Metabolic and obesity status      
Unhealthy obese (n=442) 1.00 (reference) 1.00 (reference)  1.00 (reference) 1.00 (reference) 
Healthy obese (n=156) 1.08 (0.89, 1.31) 1.06 (0.87, 1.28)  1.19 (0.83, 1.72) 1.18 (0.82, 1.68) 
Unhealthy overweight (n=838) 1.14 (1.01, 1.29) 1.06 (0.94, 1.20)  1.46 (1.15, 1.84) 1.30 (1.03, 1.63) 
Healthy overweight (n=633) 1.28 (1.13, 1.44) 1.18 (1.05, 1.33)  1.69 (1.34, 2.13) 1.48 (1.17, 1.87) 
Unhealthy normal-weight (n=457) 1.31 (1.15, 1.49) 1.19 (1.04, 1.35)  1.84 (1.44, 2.35) 1.58 (1.23, 2.02) 
Healthy normal-weight (n=847) 1.30 (1.16, 1.47) 1.17 (1.04, 1.32)  2.48 (2.00, 3.07) 2.10 (1.69, 2.60) 
      
Physical activity recommendations based on 2010 World Health Organization guideline of ≥ 2.5 hrs/week of moderate-to-vigorous physical 
activity in bouts of at least 10 mins. Model 1 adjusted for age, sex, and ethnicity. Model 2 further adjusted for occupational position, diet 
quality, smoking status, alcohol consumption, sleep duration, and presence of an illness which limits moderate or vigorous activity 
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Table 21 Likelihood of meeting 2010 World Health Organization recommendations 
for moderate-to-vigorous physical activity based on 1-minute bouts compared with 
unhealthy obese adults (n=3373) 
  
 Meets physical activity recommendations  
based on accelerometer using 1 min bouts 
  
 Model 1 
Prevalence Ratio  
(95% CI) 
Model 2 
Prevalence Ratio  
(95% CI) 
100 mg accelerometer cut-point   
   
Metabolic and obesity status   
Unhealthy obese (n=442) 1.00 (reference) 1.00 (reference) 
Healthy obese (n=156) 1.05 (0.89, 1.23) 1.04 (0.89, 1.22) 
Unhealthy overweight (n=838) 1.29 (1.18, 1.42) 1.24 (1.13, 1.36) 
Healthy overweight (n=633) 1.39 (1.27, 1.53) 1.32 (1.20, 1.45) 
Unhealthy normal-weight (n=457) 1.49 (1.35, 1.65) 1.40 (1.27, 1.54) 
Healthy normal-weight (n=847) 1.51 (1.39, 1.66) 1.42 (1.30, 1.55) 
   
120 mg accelerometer cut-point   
   
Metabolic and obesity status    
Unhealthy obese (n=442) 1.00 (reference) 1.00 (reference) 
Healthy obese (n=156) 1.29 (1.02, 1.63) 1.27 (1.01, 1.60) 
Unhealthy overweight (n=838) 1.56 (1.34, 1.81) 1.43 (1.23, 1.66) 
Healthy overweight (n=633) 1.69 (1.45, 1.96) 1.54 (1.33, 1.79) 
Unhealthy normal-weight (n=457) 1.87 (1.60, 2.19) 1.68 (1.44, 1.97) 
Healthy normal-weight (n=847) 2.09 (1.81, 2.41) 1.86 (1.61, 2.14) 
   
Physical activity recommendations based on 2010 World Health Organization 
guideline of ≥ 2.5 hrs/week of moderate-to-vigorous physical activity in bouts of at 
least 1 min. Model 1 adjusted for age, sex, and ethnicity. Model 2 further adjusted 
for occupational position, diet quality, smoking status, alcohol consumption, sleep 
duration, and presence of an illness which limits moderate or vigorous activity 
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4.2 Summary of key findings on physical activity 
and sedentary behaviour in relation to healthy 
obesity 
 
 
The first part of this thesis examined physical activity and sedentary behaviour in relation to 
healthy obesity, beginning by utilising self-reported measures of moderate-to-vigorous activity 
and leisure sitting that were available at early phases of the Whitehall II cohort study. After 
adjustment for covariates including basic demographics, health behaviours, and the presence of 
an activity-limiting illness, results showed that neither high moderate-to-vigorous physical 
activity nor low leisure sitting time was separately associated with a higher likelihood of being 
metabolically healthy among obese adults, while the combination of high moderate-to-vigorous 
physical activity and low leisure sitting time was marginally associated with an increased 
likelihood of being healthy among the obese (PR=1.55, 95% CI=1.00, 2.43). When examining 
prospective associations, high moderate-to-vigorous physical activity and low leisure sitting 
time, separately and in combination, were not associated with reduced incidence of metabolic 
risk factor clustering among obese adults over 15 years. Analyses comparing questionnaire and 
accelerometer assessments of total physical activity in relation to healthy obesity showed higher 
total physical activity among healthy versus unhealthy obese groups to be evident only when 
measured using the accelerometer (p=0.72 for difference based on questionnaire; p=0.002 for 
difference based on accelerometer). Healthy obese adults were not more likely than unhealthy 
obese adults to meet recommendations for moderate-to-vigorous physical activity when this 
activity was limited to traditional bouts of at least 10 minutes and an accelerometer cut-point of 
100 mg; however, healthy obese adults were more likely than unhealthy obese adults to meet 
recommendations when considering bouts of at least 1 minute and when using a more stringent 
120 mg accelerometer cut-point to define moderate-to-vigorous activity (PR=1.31, 95% CI=1.05, 
1.64).  
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4.3 Part 2: Healthy obesity and metabolic decline 
 
 
This second part of the results section begins by providing a brief rationale for studies of healthy 
obesity and future metabolic decline, followed by results according to each study objective. For 
each objective, a flow chart outlining the selection of the analytical sample is provided, followed 
by descriptive characteristics of the analytical sample, followed then by results of main statistical 
models. 
 
 
Rationale 
 
Whether healthy obesity represents a stable state or a transient phase of metabolic decline has 
not been well described using repeat clinical data over long follow-ups. Furthermore, the 
individual metabolic risk factors most responsible for progressions from healthy to unhealthy 
obesity have not been identified over long follow-ups, and thus the key targets for managing 
healthy obesity in clinical practice have not been clear. Studies suggest that healthy obese adults 
have an increased risk of developing type 2 diabetes compared with healthy normal-weight 
adults, but the literature to date has not been systematically searched and meta-analysed in 
order to establish the consistency and magnitude of this excess risk. Furthermore, it has not 
been previously examined whether healthy obese adults with 0 metabolic risk factors (those 
who are strictly healthy) also show excess risk for type 2 diabetes.  
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Objective 1: To describe the proportion of healthy obese adults who develop metabolic risk 
factor clustering over 20 years of follow-up using repeat clinical measures, and to compare the 
likelihood of development with that of healthy normal-weight adults 
 
Anthropometric and metabolic risk factor data were first measured at phase 3 (1991/94) of the 
Whitehall II cohort study, and this therefore served as the baseline for this analysis. A flow chart 
illustrating the selection of the analytical sample is provided in Figure 8.
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Figure 8 Selection of the analytical sample for the study of the natural course of healthy obesity 
over 20 years 
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Table 21 shows descriptive characteristics of healthy and unhealthy normal-weight, overweight, 
and obese adults at baseline (1993/4). Of 2474 participants with necessary anthropometric and 
metabolic risk factor data at baseline and all 4 follow-ups, 81.2% (n=1073) of normal-weight 
adults, 57.5% (n=559) of overweight adults, and 36.5% of obese adults were considered healthy 
(having <2 metabolic risk factors). The overall sample was 75% male, aged 39-62. At baseline, 
42.4% of healthy obese adults were male, this proportion being lower than among healthy 
normal-weight adults (42.4% vs. 72.9% respectively, p<0.05). 15.2% of healthy obese adults 
were of a non-white ethnicity, this proportion being higher than among healthy normal-weight 
adults (5.7%, p<0.05). Healthy obese adults showed higher systolic and diastolic blood pressure 
and higher insulin resistance at baseline than healthy normal-weight adults (all p<0.05), while 
fasting glucose and blood lipids did not differ between groups.  
Compared with those included in the analytic sample (n=2474), those excluded (n=7834) were 
more likely to be female (36.0% vs. 24.1% respectively, p<0.001), of a non-white ethnicity (12.1% 
vs.7.3 % respectively, p<0.001), to be older (mean=50.3 years vs. 48.5 years respectively, 
p<0.001), more likely to be obese at baseline (11.1% vs.7.3 % respectively, p<0.001), and less 
likely to be metabolically healthy at baseline (63.2% vs. 68.6% respectively, p<0.001). 
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Table 22 Characteristics of the sample of adults at phase 3 (1993/4) (aged 39-62, 75% male) by metabolic and obesity status (n=2474) 
       
 
Healthy  
normal-weight  
(n=1073) 
Unhealthy  
normal-weight  
(n=248) 
Healthy 
overweight 
  (n=559) 
Unhealthy 
overweight  
(n=413) 
Healthy 
obese 
  (n=66) 
Unhealthy 
obese  
(n=115) 
Baseline characteristics       
Male – n (%)  782 (72.9) 223 (89.9)* 412 (73.7) 360 (87.2)* 28 (42.4)* 73 (63.5)* 
Age (years)  47.8 (5.7) 48.8 (5.7)* 48.8 (5.6)* 49.6 (5.8)* 47.5 (5.5) 48.8 (5.5) 
Non-white ethnicity – n (%)  61 (5.7) 29 (11.7)* 34 (6.1) 37 (9)* 10 (15.2)* 9 (7.8) 
Systolic blood pressure (mmHg)  115.4 (11.5) 124.9 (13.8)* 118.5 (10.3)* 126.4 (13.1)* 119.5 (13.6)* 129.2 (12.2)* 
Diastolic blood pressure (mmHg)  75.9 (8.0) 82.9 (8.8)* 79.3 (7.6)* 85.6 (8.6)* 79.2 (7.8)* 85.9 (8.2)* 
Fasting glucose (mmol/l)  5.1 (0.4) 5.6 (0.6)* 5.1 (0.4) 5.5 (0.6)* 5.0 (0.4) 5.6 (0.6)* 
HOMA insulin resistance  1.0 (1.0) 1.9 (1.1)* 1.3 (0.7)* 2.5 (1.9)* 1.7 (1.0)* 3.3 (1.5)* 
Triglycerides (mmol/l)  1.0 (0.4) 2.0 (1.1)* 5.1 (0.4)* 2.2 (1.2)* 1.1 (0.4) 2.2 (1.1)* 
HDL cholesterol (mmol/l)  1.5 (0.4) 1.2 (0.3)* 1.5 (0.3)* 1.2 (0.3)* 1.5 (0.4) 1.2 (0.3)* 
Body mass index (kg/m²)  
       Range 
22.6 (1.5) 
18.56-24.99 
23.5 (1.2)* 
18.53-24.00 
26.7 (1.3)* 
25.00-29.99 
27.2 (1.4)* 
25.04-29.98 
32.2 (2.7)* 
30.11-41.84 
33.0 (3.1)* 
30.01-45.52 
       
Data are mean (standard deviation) unless otherwise noted. *Different from healthy normal-weight (p<0.05) based on linear (continuous 
variables) or logistic regression (binary variables).  
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Among the 66 healthy obese adults at baseline, 21 (31.8%) were unhealthy obese after 5 years, 
and 27 (40.9%), 23 (34.8%), and 34 (51.5%) were unhealthy obese after 10, 15, and 20 years 
respectively (Table 22 and Table 23). The proportion of healthy obese adults who were healthy 
normal-weight after 5, 10, 15, and 20 years was 1.5%, 0%, 1.5%, and 1.5% respectively.  
In contrast, among 1073 healthy normal-weight adults at baseline, 3 (0.3%) were unhealthy 
obese at the 5-year follow-up, and 9 (0.8%), 14 (1.3%), and 19 (1.8%) were unhealthy obese at 
10-, 15-, and 20-year follow-ups, respectively. The age-, sex-, and ethnicity-adjusted incidence of 
unhealthy obesity after 5 years was 102.66 (95% CI=30.88-341.30) times higher in initially 
healthy obese compared with initially healthy normal-weight adults. The corresponding 
incidence ratio for unhealthy obesity among initially healthy obese vs. initially healthy normal-
weight adults was 45.27 (21.61, 94.81) at 10 years follow-up, 25.36 (13.37, 48.09) at 15 years 
follow-up, and 26.61 (15.85, 44.69) at 20 years follow-up.  
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Table 23 Changes, % (n), in metabolic and obesity statuses over 20 years among adults aged 39-62 years at baseline (n=2474) 
    
 Status at follow-up  
     
 Healthy  
normal-weight 
Unhealthy 
normal-weight 
Healthy 
overweight 
Unhealthy 
overweight 
Healthy 
obese 
Unhealthy 
obese 
Incidence ratio for 
unhealthy obesity at 
follow-up* 
(95% CI) 
       
 5-year follow-up 
Status at baseline        
Healthy normal-weight (n=1073) 68.5% (735) 7.6% (82) 18.1% (194) 5.5% (59) 0% (0) 0.3% (3) 1.00 (reference) 
Unhealthy normal-weight (n=248) 36.3% (90) 30.2% (75) 11.7% (29) 21.8% (54) 0% (0) 0% (0) NAa 
Healthy overweight (n=559) 7.5% (42) 0.5% (3) 59.7% (334) 16.1% (90) 9.3% (52) 6.8% (38) 25.46 (7.94, 81.69) 
Unhealthy overweight (n=413) 2.7% (11) 2.4% (10) 28.3% (117) 46.5% (192) 5.8% (24) 14.3% (59) 58.12 (18.60, 181.59) 
Healthy obese (n=66) 1.5% (1) 0% (0) 4.5% (3) 0% (0) 62.1% (41) 31.8% (21) 102.66 (30.88, 341.30) 
Unhealthy obese (n=115) 0.9% (1) 0% (0) 7% (8) 7.8% (9) 17.4% (20) 67% (77) NAa 
 
10-year follow-up 
 
  
Healthy normal-weight (n=1073) 56% (601) 9.9% (106) 23.6% (253) 9.4% (101) 0.3% (3) 0.8% (9) 1.00 (reference) 
Unhealthy normal-weight (n=248) 26.2% (65) 27% (67) 12.5% (31) 33.9% (84) 0% (0) 0.4% (1) 0.54 (0.07, 4.23) 
Healthy overweight (n=559) 3.6% (20) 0.5% (3) 50.3% (281) 20.4% (114) 13.1% (73) 12.2% (68) 15.22 (7.69, 30.13) 
Unhealthy overweight (n=413) 2.4% (10) 2.2% (9) 21.5% (89) 45.5% (188) 3.4% (14) 24.9% (103) 33.99 (17.67, 65.38) 
Healthy obese (n=66) 0% (0) 1.5% (1) 4.5% (3) 0% (0) 53% (35) 40.9% (27) 45.27 (21.61, 94.81) 
Unhealthy obese (n=115) 0% (0) 0% (0) 8.7% (10) 7.8% (9) 18.3% (21) 65.2% (75) NAa 
    
*Models exclude unhealthy obese individuals at baseline (remaining n=2359), and are adjusted for age, sex, and ethnicity. a Not applicable 
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Table 24 Changes, % (n), in metabolic and obesity statuses over 20 years among adults aged 39-62 years at baseline (n=2474) 
    
 Status at follow-up  
     
 Healthy  
normal-weight 
Unhealthy 
normal-weight 
Healthy 
overweight 
Unhealthy 
overweight 
Healthy 
obese 
Unhealthy 
obese 
Incidence ratio for 
unhealthy obesity at 
follow-up* 
(95% CI) 
       
 15-year follow-up 
Status at baseline        
Healthy normal-weight (n=1073) 59.8% (642) 7% (75) 22.7% (244) 8.7% (93) 0.5% (5) 1.3% (14) 1.00 (reference) 
Unhealthy normal-weight (n=248) 27.4% (68) 29% (72) 14.9% (37) 27.8% (69) 0% (0) 0.8% (2) 0.69 (0.16, 3.00) 
Healthy overweight (n=559) 6.3% (35) 1.1% (6) 49% (274) 17.7% (99) 13.8% (77) 12.2% (68) 9.89 (5.63, 17.36) 
Unhealthy overweight (n=413) 4.6% (19) 2.2% (9) 25.7% (106) 39% (161) 5.6% (23) 23% (95) 20.17 (11.77, 34.58) 
Healthy obese (n=66) 1.5% (1) 1.5% (1) 4.5% (3) 3% (2) 54.5% (36) 34.8% (23) 25.36 (13.37, 48.09) 
Unhealthy obese (n=115) 0% (0) 0.9% (1) 10.4% (12) 2.6% (3) 19.1% (22) 67% (77) NAa 
 
20-year follow-up 
 
  
Healthy normal-weight (n=1073) 54.6% (586) 9.4% (101) 20.4% (219) 13.1% (141) 0.7% (7) 1.8% (19) 1.00 (reference) 
Unhealthy normal-weight (n=248) 25.8% (64) 28.6% (71) 14.5% (36) 29.8% (74) 0% (0) 1.2% (3) 0.77 (0.23, 2.59) 
Healthy overweight (n=559) 7.7% (43) 2% (11) 42.8% (239) 20.6% (115) 12.3% (69) 14.7% (82) 8.82 (5.44, 14.31) 
Unhealthy overweight (n=413) 4.1% (17) 4.8% (20) 20.3% (84) 41.4% (171) 4.8% (20) 24.5% (101) 16.06 (10.02, 25.73) 
Healthy obese (n=66) 1.5% (1) 0% (0) 9.1% (6) 0% (0) 37.9% (25) 51.5% (34) 26.61 (15.85, 44.69) 
Unhealthy obese (n=115) 0.9% (1) 0.9% (1) 7.8% (9) 12.2% (14) 18.3% (21) 60% (69) NAa 
    
*Models exclude unhealthy obese individuals at baseline (remaining n=2359), and are adjusted for age, sex, and ethnicity. a Not applicable 
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As shown in Table 24 and Table 25, results based on maximum samples were similar to those of 
main analyses which were based on complete cases. Among 389 healthy obese adults with 5-
year data, 35.2% were unhealthy obese at 5 years follow-up. This proportion was 34.7% at 10 
years follow-up (healthy obese sample n=317), 37.9% at 15 years follow-up (healthy obese 
sample n=224), and 48.1% at 20 years follow-up (healthy obese sample n=106). Once again, 
these proportions were lower for baseline healthy normal-weight adults. Among 1955 healthy 
obese adults with 5-year data, 0.2% were unhealthy obese at 5 years follow-up, 0.7% were 
unhealthy obese at 10 years follow-up (healthy normal-weight sample n=2215), 1.2% were 
unhealthy obese at 15 years follow-up (healthy normal-weight sample n=2043), and 1.7% were 
unhealthy obese at 20 years follow-up (healthy normal-weight sample n=1664). 
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Table 25 Changes, % (n), in metabolic and obesity statuses over 20 years among adults based on maximum samples 
  
 Status at follow-up 
    
 Healthy  
normal-weight 
Unhealthy 
normal-weight 
Healthy 
overweight 
Unhealthy 
overweight 
Healthy 
obese 
Unhealthy 
obese 
       
 5-year follow-up 
Status at baseline       
Healthy normal-weight (n=1955) 64.8% (1266) 9.4% (184) 19.1% (374) 6.5% (127) 0.1% (1) 0.2% (3) 
Unhealthy normal-weight (n=659) 37.6% (248) 33.8% (223) 9.7% (64) 18.5% (122) 0.3% (2) 0% (0) 
Healthy overweight (n=1744) 11% (192) 1.4% (24) 55.3% (964) 20.5% (357) 5.9% (103) 6% (104) 
Unhealthy overweight (n=1565) 4% (62) 3.9% (61) 23.3% (364) 40.2% (629) 2.1% (33) 26.6% (416) 
Healthy obese (n=389) 0.8% (3) 0% (0) 10.8% (42) 3.3% (13) 49.9% (194) 35.2% (137) 
Unhealthy obese (n=618) 0.5% (3) 0.2% (1) 5.3% (33) 10.4% (64) 16.3% (101) 67.3% (416) 
 
10-year follow-up 
 
Healthy normal-weight (n=2215) 53.7% (1189) 10.6% (235) 23.2% (514) 11.4% (252) 0.5% (10) 0.7% (15) 
Unhealthy normal-weight (n=652) 33.9% (221) 29.6% (193) 10.3% (67) 25.9% (169) 0% (0) 0.3% (2) 
Healthy overweight (n=1691) 9.4% (159) 1.8% (31) 47.3% (799) 21.7% (367) 9.2% (155) 10.6% (180) 
Unhealthy overweight (n=1287) 4.3% (55) 4% (51) 22.5% (289) 47.2% (607) 3.3% (43) 18.8% (242) 
Healthy obese (n=317) 0.9% (3) 0.3% (1) 13.6% (43) 4.7% (15) 45.7% (145) 34.7% (110) 
Unhealthy obese (n=538) 0% (0) 0% (0) 6.9% (37) 10.4% (56) 15.8% (85) 66.9% (360) 
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Table 26 Changes, % (n), in metabolic and obesity statuses over 20 years among adults based on maximum samples 
  
 Status at follow-up 
    
 Healthy  
normal-weight 
Unhealthy 
normal-weight 
Healthy 
overweight 
Unhealthy 
overweight 
Healthy 
obese 
Unhealthy 
obese 
       
 15-year follow-up 
Status at baseline       
Healthy normal-weight (n=2043) 55.8% (1140) 8% (163) 24.1% (493) 10.1% (207) 0.7% (15) 1.2% (25) 
Unhealthy normal-weight (n=527) 32.4% (171) 28.5% (150) 13.9% (73) 24.5% (129) 0% (0) 0.8% (4) 
Healthy overweight (n=1366) 9.7% (132) 1.7% (23) 45.3% (619) 20.6% (281) 10.7% (146) 12.1% (165) 
Unhealthy overweight (n=976) 4.3% (42) 4.7% (46) 23.3% (227) 42.1% (411) 5.3% (52) 20.3% (198) 
Healthy obese (n=224) 1.3% (3) 0.4% (1) 10.7% (24) 5.4% (12) 44.2% (99) 37.9% (85) 
Unhealthy obese (n=362) 0.8% (3) 0.6% (2) 6.6% (24) 6.6% (24) 19.6% (71) 65.7% (238) 
 
20-year follow-up 
 
Healthy normal-weight (n=1664) 53.2% (885) 9.7% (161) 21.9% (365) 12.5% (208) 1% (16) 1.7% (29) 
Unhealthy normal-weight (n=359) 28.1% (101) 27.6% (99) 13.9% (50) 28.4% (102) 0% (0) 1.9% (7) 
Healthy overweight (n=880) 7.6% (67) 2.2% (19) 42% (370) 20.6% (181) 11.7% (103) 15.9% (140) 
Unhealthy overweight (n=612) 4.4% (27) 4.9% (30) 19.6% (120) 42.5% (260) 4.4% (27) 24.2 (148) 
Healthy obese (n=106) 1.9% (2) 0% (0) 7.5% (8) 2.8% (3) 39.6% (42) 48.1% (51) 
Unhealthy obese (n=177) 1.7% (3) 0.6% (1) 5.1% (9) 11.3% (20) 16.4% (29) 65% (115) 
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Objective 2: Incidence of individual metabolic risk factors over 20 years among initially healthy 
obese adults using repeat clinical measures, and comparison of incidence with that of healthy 
normal-weight adults    
 
Among 2878 adults with anthropometric and metabolic risk factor data at each time point, 1120 
adults (aged 39-61 years; 68% male) were free of all metabolic risk factors at baseline. A flow 
chart illustrating the selection of the analytical sample is provided in Figure 9. 
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Figure 9 Selection of the analytical sample for the study of incidence of individual metabolic risk 
factors among initially healthy obese adults over 20 years 
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Table 26 shows descriptive characteristics of normal-weight, overweight, and obese adults who 
had none of the 5 metabolic risk factors of interest at baseline (1993/4), and were considered 
strictly healthy (n=1120). This strictly healthy status was rarer among higher BMI groups, 
representing 51.5%, 25.8%, and 13.4% of normal-weight, overweight, and obese adults in the 
wider cohort respectively. The proportion of healthy obese adults who were male was 32.1%, 
compared with 69.7% of healthy normal-weight adults (p<0.05).  Healthy obese and healthy 
normal-weight adults did not differ in age. Just over 2% of healthy obese adults were of a non-
white ethnicity, compared with 5% of healthy normal-weight adults (p<0.05). Healthy obese 
adults had higher insulin resistance and triglycerides than healthy normal-weight adults; other 
metabolic risk factors did not differ. 
Compared with those included in the analytic sample (n=1120), those excluded (n=7695) did not 
differ by gender (33.2% female vs. 32.3% female, p=0.55), but were more likely to be of a non-
white ethnicity (11.5% vs.6.3%, p<0.001), were more likely to be older (mean=50.1 years vs. 47.6 
years, p<0.001), and were more likely to be obese at baseline (11.1% vs.2.5% respectively, 
p<0.001). All participants in this analysis were strictly metabolically healthy at baseline (0 
metabolic risk factors) and so metabolic health status was not compared between included and 
excluded groups. 
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Table 27 Characteristics of the sample of initially healthy adults at phase 3 (1991/94) aged 
39-61, 68% male, with healthy status defined as having 0 metabolic risk factors (n=1120) 
    
 Healthy  
normal-weight  
(n=806) 
Healthy 
overweight  
(n=286) 
Healthy 
obese 
(n=28)  
Baseline characteristics    
Male – n (%)  562 (69.7) 187 (65.4) 9 (32.1)* 
Age (years)  47.4 (5.5) 48.3 (5.3)* 47.7 (5.6) 
Non-white ethnicity – n (%)  40 (5) 25 (8.7)* 6 (2.1)* 
Systolic blood pressure (mmHg)  111.7 (8.7) 113.5 (7.5)* 112.9 (8.0) 
Diastolic blood pressure (mmHg)  73.5 (6.2) 75.4 (5.5)* 74.4 (6.3) 
Fasting glucose (mmol/l)  5.0 (0.3) 5.0 (0.3) 5.0 (0.3) 
HOMA insulin resistance  0.9 (0.5) 1.1 (0.6)* 1.4 (0.7)* 
Triglycerides (mmol/l)  0.9 (0.3) 1.0 (0.3)* 1.01 (0.3)* 
HDL cholesterol (mmol/l)  1.6 (0.4) 1.5 (0.3)* 1.6 (0.3) 
Body mass index (kg/m²)  
       Range 
22.4 (1.6) 
18.56-24.99 
26.7 (1.3)* 
25.00-29.99 
32.3 (2.6)* 
30.15-41.84 
    
Data are mean (standard deviation) unless otherwise noted. *Different from healthy 
normal-weight (p<0.05) based on linear (continuous variables) or logistic regression (binary 
variables). 
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The first set of results show the number of metabolic risk factors that were present at each 
follow-up (possible range being 0 to 5 risk factors) among normal-weight, overweight, and obese 
adults who initially had 0 metabolic risk factors. Of initially healthy obese adults, 57.1% had at 
least one metabolic risk factor at 5-years follow-up (Table 27); this corresponding proportion 
was 64.3% at 10- and 15-years follow-up and 78.6% at 20-years follow-up (Table 28). These 
proportions were smaller (32.8%, 46.7%, 44%, and 60.3%) among initially healthy normal-weight 
participants. 
Incidence ratios indicated that initially healthy obese adults were 1.70 (95% CI=1.22, 2.36) times 
more likely to have at least 1 metabolic risk factor at 5 years follow-up compared with initially 
healthy normal-weight adults. This excess risk among initially healthy obese adults was 1.37 
(95% CI=1.03, 1.82) times higher at 10 years follow-up, 1.46 (95% CI=1.10, 1.94) times higher at 
15 years follow-up, and 1.30 (95% CI=1.07, 1.58) times higher at 20 years follow-up. Excess risk 
was also consistently observed among initially healthy overweight adults compared with initially 
healthy normal-weight adults, these being lower than that of the healthy obese. 
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Table 28 Changes in metabolic status over 20 years among adults aged 39-61 years (68% male) at baseline (n=1120), with baseline healthy status defined 
as having 0 metabolic risk factors 
  
 Number of metabolic risk factors at follow-up  
   
  
0 
 
1 
 
2 
 
3 
 
4 
 
5 
Incidence ratio (95% CI) 
for having at least 1 risk 
factor at follow-up* 
 5-year follow-up  
Status at baseline        
Healthy normal-weight (n=806) 67.2% (542) 25.3% (204) 5.8% (47) 1.5% (12) 0.1% (1) 0% (0) 1.00 (reference) 
Healthy overweight (n=286) 51.7% (148) 33.6% (96) 10.8% (31) 3.5% (10) 0.3% (1) 0% (0) 1.45 (1.25, 1.70) 
Healthy obese (n=28) 42.9% (12) 25% (7) 14.3% (4) 14.3% (4) 3.6% (1) 0% (0) 1.70 (1.22, 2.36) 
        
 10-year follow-up  
     
Healthy normal-weight (n=806) 53.3% (430) 32.6% (263) 10.7% (86) 2.7% (22) 0.6% (5) 0% (0) 1.00 (reference)  
Healthy overweight (n=286) 36% (103) 41.3% (118) 13.6% (39) 6.6% (19) 2.1% (6) 0.3% (1) 1.36 (1.21, 1.52) 
Healthy obese (n=28) 35.7% (10) 32.1% (9) 17.9% (5) 10.7% (3) 3.6% (1) 0% (0) 1.37 (1.03, 1.82) 
        
* Models adjusted for age, sex, and ethnicity. Risk factors include hypertension, low HDL cholesterol, high triglycerides, insulin resistance, and high blood 
glucose 
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Table 29 Changes in metabolic status over 20 years among adults aged 39-61 years (68% male) at baseline (n=1120), with baseline healthy status defined as 
having 0 metabolic risk factors 
  
 Number of metabolic risk factors at follow-up  
   
  
0 
 
1 
 
2 
 
3 
 
4 
 
5 
Incidence ratio (95% CI) 
for having at least 1 risk 
factor at follow-up* 
 15-year follow-up  
Status at baseline        
Healthy normal-weight (n=806) 56% (451) 31.4% (253) 9.2% (74) 3.1% (25) 0.4% (3) 0% (0) 1.00 (reference) 
Healthy overweight (n=286) 40.9% (117) 36.7% (105) 12.6% (36) 8% (23) 1.4% (4) 0.3% (1) 1.33 (1.18, 1.51) 
Healthy obese (n=28) 35.7% (10) 32.1% (9) 10.7% (3) 17.9% (5) 3.6% (1) 0% (0) 1.46 (1.10, 1.94) 
        
 20-year follow-up  
     
Healthy normal-weight (n=806) 39.7% (320) 41.2% (332) 13.2% (106) 4.7% (38) 1% (8) 0.2% (2) 1.00 (reference) 
Healthy overweight (n=286) 26.9% (77) 43.4% (124) 19.9% (57) 7% (20) 1.7% (5) 1% (3) 1.20 (1.10, 1.31) 
Healthy obese (n=28) 21.4% (6) 28.6% (8) 17.9% (5) 28.6% (8) 3.6% (1) 0% (0) 1.30 (1.07, 1.58) 
        
* Models adjusted for age, sex, and ethnicity. Risk factors include hypertension, low HDL cholesterol, high triglycerides, insulin resistance, and high blood 
glucose 
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The proportion of initially healthy normal-weight, overweight, and obese adults who developed 
each metabolic risk factor at 5, 10, 15, and 20-years follow-up are shown in Table 29 and Table 
30. Among 28 initially healthy obese adults at baseline, 32.1% were insulin resistant at 5-years 
follow-up, while 21.4% had high blood glucose, 39.3% had hypertension, 7.1% had high 
triglycerides, and 10.7% had low HDL cholesterol. These proportions remained a similar 
magnitude after 10 and 15 years follow-up. At the 20-year follow-up, proportions increased for 
insulin resistance (46.4%), high blood glucose (42.9%), and hypertension (64.3%), while no 
incident cases of low HDL cholesterol and few cases of high triglycerides were evident.  
The proportion of initially healthy normal-weight adults who developed each risk factor over 
time was small; I.e. 6.2% were insulin resistant at 5 years follow-up, rising to 12.4% at 20 years 
follow-up. Incident hypertension was highest among healthy normal-weight adults at all follow-
up points, being 17.6% at 5 years follow-up, rising to 46.8% at 20 years follow-up. Incidence of 
each metabolic risk factor among initially healthy overweight adults was at an intermediate level 
between that of initially healthy normal-weight and obese adults.  
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Table 30 Incidence, % (n), of individual metabolic risk factors over 20 years among initially healthy adults aged 39-61 years (n=1120) 
 
 Insulin resistance High blood 
glucose 
Hypertension Low HDL High triglycerides 
  
 5-year follow-up 
Status at baseline  
Healthy normal-weight (n=806) 6.2% (50) 6.9% (56) 17.6% (142) 5.2% (42) 6% (48) 
Healthy overweight (n=286) 10.1% (29) 9.8% (28) 25.9% (74) 8.7% (25) 12.6% (36) 
Healthy obese (n=28) 32.1% (9) 21.4% (6) 39.3% (11) 7.1% (2) 10.7% (3) 
      
 10-year follow-up 
  
Healthy normal-weight (n=806) 5.6% (48) 18% (145) 29.3% (236) 2.4% (19) 9.1% (73) 
Healthy overweight (n=286) 18.2% (52) 22.4% (64) 37.4% (107) 5.9% (17) 14.7% (42) 
Healthy obese (n=28) 28.6% (8) 25% (7) 39.3% (11) 3.6% (1) 17.9% (5) 
      
Baseline healthy status defined as having 0 of 5 metabolic risk factors (hypertension, low HDL cholesterol, high triglycerides, insulin 
resistance, and high blood glucose) 
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Table 31 Incidence, % (n), of individual metabolic risk factors over 20 years among initially healthy adults aged 39-61 years (n=1120) 
 
 Insulin resistance High blood 
glucose 
Hypertension Low HDL High triglycerides 
  
 15-year follow-up 
Status at baseline  
Healthy normal-weight (n=806) 5.6% (45) 12% (97) 33.5% (270) 2.5% (20) 6.9% (56) 
Healthy overweight (n=286) 13.3% (38) 20.3% (58) 42.3% (121) 3.8% (11) 13.6% (39) 
Healthy obese (n=28) 32.1% (9) 21.4% (6) 46.4% (13) 3.6% (1) 17.9% (5) 
      
 20-year follow-up 
  
Healthy normal-weight (n=806) 12.4% (100) 18.5% (149) 46.8% (377) 1.7% (14) 7.4% (60) 
Healthy overweight (n=286) 22% (63) 23.4% (67) 57.3% (164) 4.9% (14) 8.7% (25) 
Healthy obese (n=28) 46.4% (13) 42.9% (12) 64.3% (18) 0% (0) 10.7% (3) 
      
Baseline healthy status defined as having 0 of 5 metabolic risk factors (hypertension, low HDL cholesterol, high triglycerides, insulin 
resistance, and high blood glucose) 
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Incidence ratios for individual metabolic risk factors between groups are shown in Table 31, 
Table 32, and Figure 10. At the 5-year follow-up, compared with initially healthy normal-weight 
adults, initially healthy obese adults were 4.41 (95% CI=2.33, 8.34) times more likely to be insulin 
resistant, 3.35 (95% CI=1.54, 7.30) times more likely to have high blood glucose, and 1.92 (95% 
CI=1.14, 3.22) times more likely to be hypertensive. Insulin resistance remained most commonly 
incident among all metabolic risk factors at subsequent follow-ups among initially healthy obese 
compared with initially healthy normal-weight adults. At the 20-year follow-up, compared with 
initially healthy normal-weight adults, initially healthy obese adults were 3.78 (95% CI=2.38, 
5.99) times more likely to be insulin resistant, 2.27 (95% CI=1.43, 3.61) times more likely to have 
high blood glucose, and 1.35 (95% CI=1.03, 1.77) times more likely to be hypertensive. 
Differences between initially healthy obese and initially healthy normal-weight adults for low 
HDL cholesterol and high triglycerides were non-significant at all follow-ups, with the exception 
of high triglycerides among initially healthy obese adults at 15-years follow-up (IR=2.69, 95% 
CI=1.13, 6.43). 
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Table 32 Incidence ratios for individual metabolic risk factors over 20 years (n=1120) 
 
 Insulin resistance 
 
Incidence Ratio  
(95% CI) 
High blood glucose 
 
Incidence Ratio  
(95% CI) 
Hypertension 
 
Incidence Ratio  
(95% CI) 
Low HDL 
 
Incidence Ratio 
(95% CI) 
High triglycerides 
 
Incidence Ratio  
(95% CI) 
  
 5-year follow-up 
Status at baseline  
Healthy normal-weight (n=806) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Healthy overweight (n=286) 1.63 (1.06, 2.52) 1.43 (0.92, 2.21) 1.37 (1.08, 1.75) 1.57 (0.96, 2.55) 2.20 (1.46, 3.32) 
Healthy obese (n=28) 4.41 (2.33, 8.34) 3.35 (1.54, 7.30) 1.92 (1.14, 3.22) 1.06 (0.30, 3.69) 2.15 (0.71, 6.55) 
      
 10-year follow-up 
  
Healthy normal-weight (n=806) 1.00 (reference)  1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Healthy overweight (n=286) 3.03 (2.09, 4.38) 1.26 (0.97, 1.63) 1.20 (1.00, 1.45) 2.56 (1.33, 4.96) 1.70 (1.19, 2.42) 
Healthy obese (n=28) 4.90 (2.47, 9.74) 1.63 (0.85, 3.15) 1.11 (0.68, 1.82) 1.40 (0.20, 9.58) 2.08 (0.89, 4.83) 
      
Models are adjusted for age, sex, and ethnicity. Baseline healthy status defined as having 0 of 5 metabolic risk factors (hypertension, low HDL 
cholesterol, high triglycerides, insulin resistance, and high blood glucose) 
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Table 33 Incidence ratios for individual metabolic risk factors over 20 years (n=1120) 
 
 Insulin resistance 
 
Incidence Ratio  
(95% CI) 
High blood glucose 
 
Incidence Ratio 
(95% CI) 
Hypertension 
 
Incidence Ratio  
(95% CI) 
Low HDL 
 
Incidence Ratio  
(95% CI) 
High triglycerides 
 
Incidence Ratio  
(95% CI) 
  
 15-year follow-up 
Status at baseline  
Healthy normal-weight (n=806) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Healthy overweight (n=286) 2.35 (1.56, 3.55) 1.69 (1.25, 2.28) 1.22 (1.03, 1.44) 1.57 (0.77, 3.22) 2.10 (1.44, 3.07) 
Healthy obese (n=28) 5.30 (2.80, 10.02) 1.74 (0.82, 3.70) 1.30 (0.85, 1.99) 1.49 (0.23, 9.77) 2.69 (1.13, 6.43) 
      
 20-year follow-up 
  
Healthy normal-weight (n=806) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Healthy overweight (n=286) 1.78 (1.34, 2.36) 1.27 (0.98, 1.64) 1.19 (1.05, 1.35) 2.78 (1.27, 6.11) 1.27 (0.82, 1.97) 
Healthy obese (n=28) 3.78 (2.38, 5.99) 2.27 (1.43, 3.61) 1.35 (1.03, 1.77) NA 1.39 (0.47, 4.13) 
      
Models are adjusted for age, sex, and ethnicity. Baseline healthy status defined as having 0 of 5 metabolic risk factors (hypertension, low HDL cholesterol, 
high triglycerides, insulin resistance, and high blood glucose) 
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Figure 10 Incidence of metabolic risk factors among initially healthy obese compared with initially healthy normal-weight adults over 20 years (n=1120) 
 
 
Baseline healthy status defined as having 0 metabolic risk factors (hypertension, low HDL cholesterol, high triglycerides, insulin resistance, and high 
blood glucose). Models are adjusted for age, sex, and ethnicity. Little difference in HDL-cholesterol or triglycerides was observed between groups, and 
these are not shown due to small case numbers.
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As shown in Table 33 and Table 34, results of metabolic risk factor incidence based on maximum 
samples were similar to results of main analyses which were based on complete cases. Among 
80 healthy obese adults with 5-year data on all metabolic risk factors, at 5-years follow-up, 35% 
developed insulin resistance, 25% developed high blood glucose, 47.5% developed hypertension, 
6.3% developed low HDL cholesterol, and 18.8% developed high triglycerides. Among 41 healthy 
obese adults with 20-year data on all metabolic risk factors, at 20-years follow-up, 41.5% 
developed insulin resistance, 36.6% developed high blood glucose, 65.9% developed 
hypertension, 0% developed low HDL cholesterol, and 7.3% developed high triglycerides.  
Incidence of each metabolic risk factor tended to be lower among initially healthy normal-weight 
adults, with 11.7% developing insulin resistance, 17.6% developing high blood glucose, 44.7% 
developing hypertension, 2% developing low HDL cholesterol, and 7.4% developing high 
triglycerides after 20-years follow-up (sample n=1061).   
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Table 34 Incidence, % (n), of individual metabolic risk factors over 20 years among initially healthy adults using maximum samples  
 
 Insulin resistance High blood glucose Hypertension Low HDL High triglycerides 
  
 5-year follow-up 
Status at baseline  
Healthy normal-weight (n=1229) 9.2% (113) 16.4% (202) 37.3% (458) 6.5% (80) 10.3% (126) 
Healthy overweight (n=618) 15% (93) 19.7% (122) 39.3% (243) 8.9% (55) 14.6% (90) 
Healthy obese (n=80) 35% (28) 25% (20) 47.5% (38) 6.3% (5) 18.8% (15) 
      
 10-year follow-up 
  
Healthy normal-weight (n=1304) 9.5% (124) 21.2% (276) 40.6% (529) 3.2% (42) 12.3% (160) 
Healthy overweight (n=619) 19.9% (123) 22% (136) 45.7% (283) 6% (37) 14.9% (92) 
Healthy obese (n=70) 32.9% (23) 25.7% (18) 47.1% (33) 2.9% (2) 12.9% (9) 
      
Baseline healthy status defined as having 0 of 5 metabolic risk factors (hypertension, low HDL-cholesterol, high triglycerides, insulin resistance, and high 
blood glucose) 
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Table 35 Incidence, % (n), of individual metabolic risk factors over 20 years among initially healthy adults using maximum samples 
 
 Insulin resistance High blood glucose Hypertension Low HDL High triglycerides 
  
 15-year follow-up 
Status at baseline  
Healthy normal-weight (n=1228) 8.6% (106) 15.6% (192) 40.9% (502) 3.2% (39) 7.6% (93) 
Healthy overweight (n=536) 17.5% (94) 21.3% (114) 45.9% (246) 4.7% (25) 11.6% (62) 
Healthy obese (n=62) 35.5% (22) 33.9% (21) 51.6% (32) 1.6% (1) 14.5% (9) 
      
 20-year follow-up 
  
Healthy normal-weight (n=1061) 11.7% (124) 17.6% (187) 44.7% (474) 2% (21) 7.4% (79) 
Healthy overweight (n=397) 23.4% (93) 22.9% (91) 54.9% (218) 4% (16) 9.8% (39) 
Healthy obese (n=41) 41.5% (17) 36.6% (15) 65.9% (27) 0% (0) 7.3% (3) 
      
Baseline healthy status defined as having 0 of 5 metabolic risk factors (hypertension, low HDL-cholesterol, high triglycerides, insulin resistance, and 
high blood glucose) 
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Objective 3: Systematic search of literature for published prospective studies on the risk of 
incident type 2 diabetes among obese adults who are metabolically healthy 
 
As shown in Figure 10, the initial search of Medline and Embase retrieved 1068 results. Two 
additional studies were identified through other sources (51, 238). After removing duplications, 
168 studies remained, 159 of which were excluded due to irrelevant exposure or outcome based 
on abstract screening. Nine studies were identified after screening as potentially relevant, and 
full-text articles were assessed for eligibility. Of these, 2 studies were excluded for assessing 
participants under 18 years of age at baseline (239, 240). Seven published studies therefore met 
our full criteria for inclusion (51, 167, 186, 187, 238, 241, 242). Hand-searching through 
reference lists within those 7 included studies identified 6 additional potentially relevant studies, 
but none of these met the full inclusion criteria. For instance one study assessed cross-sectional 
type 2 diabetes prevalence but not prospective incidence (243). A flow chart illustrating the 
systematic literature search for the meta-analysis is provided in Figure 11.  
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Figure 11 Outline of the systematic literature search for the meta-analysis 
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Including ELSA, a total of 8 studies contributed to the meta-analysis. Two studies reported effect 
estimates for type 2 diabetes separately by sex (238, 241), and were presented accordingly. The 
studies included in the meta-analysis represented a geographically diverse set of populations; 
however ethnic composition was not specifically reported in any study. Age at baseline ranged 
from 18 years in three studies (51, 167, 241), to 99 years in ELSA. All studies defined metabolic 
health based on metabolic clustering, with the least comprehensive measure considering only 
insulin resistance, triglycerides, and fasting glucose (167). All studies used an objective fasting 
blood or plasma glucose measure to diagnose incident type 2 diabetes except ELSA which used 
self-reported physician diagnosis. Average length of follow-up ranged from 5 years in Kim et al. 
(242) to 20 years in Arnlov et al. (187).  
The reference category was a metabolically healthy normal-weight group in all studies; however 
specific BMI cut-offs varied, with one study using a broad ‘non-obese’ group as the reference 
(BMI < 30 kg/m2) (167), while ELSA and others excluded overweight individuals from the 
reference group by setting the cut-off as BMI < 25 kg/m2 (186, 187, 238, 242). Still others 
excluded both overweight and underweight adults in their reference group (51, 241). Overall, 
there appeared to be variability in effect estimates for type 2 diabetes, ranging from 2.09 (95% 
CI=0.87-5.03) in Appleton et al. (51), to 14.60 (95% CI=3.23-65.50) in Hwang at el. (women) 
(241). However, all relative risk estimates were positive and exceeded the reference value of 
one, and none reported a reduced risk of type 2 diabetes in healthy obese adults. Detailed 
characteristics of studies identified through the systematic literature search are described in 
Table 35.
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Table 36 Characteristics of studies included in the meta-analysis 
 
Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
Meigs et al. 
2006 
N=2902 
 
Mean 52 years (MHO 
group) 
 
51.3% male (MHO 
group) 
 
Free of type 2 diabetes 
or CVD 
 
United States 
 
Community-based 
236 
(37%) 
Criteria 1: ≤ 2 ATP3 metabolic 
syndrome criteria: fasting plasma 
glucose 5.6-6.9 mmol/L, waist 
circumference > 102 cm in men or 
> 88 cm in women, fasting 
triglycerides ≥ 1.7 mmol/L, HDL-
cholesterol < 1.0 mmol/L in men or 
< 1.3 mmol/L in women, blood 
pressure ≥ 130/85 mmHg or 
current treatment for hypertension 
 
Criteria 2: HOMA-IR [(fasting 
glucose x fasting insulin)/22.5] < 
75
th
 percentile 
 
BMI ≥ 30 kg/m
2
 
Fasting plasma 
glucose ≥ 7.0 
mmol/L or new use 
of hypoglycemic 
drug therapy 
Mean 6.8 
years 
 
7 cases 
Criteria 1 
 
Model 1: 
RR=2.40 (0.94, 6.12) 
 
Model 2: 
RR=2.19 (0.85, 5.60) 
 
Reference: BMI < 25 
kg/m
2 
without metabolic 
syndrome 
 
Criteria 2 
 
Model 1: 
RR=3.79 (1.66, 8.62) 
 
Model 2: 
RR=3.28 (1.44, 7.50) 
 
Reference: BMI < 25  
kg/m
2 
and insulin 
sensitive 
Model 1: Age, 
sex 
 
Model 2: 
Further 
adjusted for 
family history 
of diabetes, IGT 
 
 
 
5 
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Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
Hadaegh et 
al. 2011 
N=5250 
 
≥ 20 years 
 
41.6% male 
 
Free of diabetes 
 
Tehran 
 
Nationally 
representative 
452 
(37.5%) 
≤ 2 of: waist circumference ≥ 94.5 
cm, HDL-cholesterol < 1.04 mmol/L 
in men and <1.03 mmol/L in 
women, triglycerides ≥ 1.7 mmol/L 
or lipid lowering drug use, blood 
pressure ≥ 130/85 mmHg or 
hypertension treatment, fasting 
glucose ≥ 5.5 mmol/L or previously 
diagnosed diabetes 
 
Obese BMI ≥ 30 kg/m
2
 
 
Fasting plasma 
glucose ≥ 7 mmol/L 
or 2 hour post-
challenge plasma 
glucose ≥ 11.1 
mmol/L or diabetes 
medication use 
6.5 years 
 
7 cases 
(men)
a 
 
11 cases 
(women)
a
 
Men 
 
Model 1: 
OR=3.80 (1.70, 8.90) 
 
Model 2: 
OR=3.60 (1.50, 8.40) 
 
Women 
 
Model 1: 
OR=2.20 (1.00, 4.70) 
 
Model 2: 
OR=2.20 (1.00, 4.70) 
 
Reference: BMI < 25 
kg/m
2
, metabolically 
healthy 
Model 1: Age 
 
Model 2: 
Further 
adjusted for 
family history 
of diabetes, 
history of 
cardiovascular 
disease, 
education, 
smoking, 
lifestyle 
intervention 
received 
7 
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Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
Arnlov et al. 
2011 
N=1675 
 
50 years 
 
100% male 
 
Free of type 2 diabetes 
 
Sweden 
 
Community-based 
 
28 
(31.8%) 
Modified NCEP ATP3  
 
≤ 2 of: fasting blood glucose ≥ 5.6 
mmol/L (corresponding to fasting 
plasma glucose ≥ 6.1 mmol/L), 
blood pressure ≥ 130/85 mmHg or 
treatment, triglycerides ≥ 1.7 
mmol/L, HDL-cholesterol <1.04 
mmol/L, body mass index ≥ 29.4 
kg/m
2
. 
 
BMI > 30 kg/m
2
 
Fasting blood 
glucose ≥ 6.1 
mmol/L 
(corresponding to 
fasting plasma 
glucose ≥ 7.0 
mmol/L) or use of 
antidiabetes 
medication 
20 years 
 
9 cases 
Whole  sample (n=1675) 
 
Crude 
OR=12.15 (5.10, 28.96) 
 
Adjusted 
OR=11.73 (4.88, 28.16) 
 
Sensitivity: Normal 
fasting glucose at 
baseline (n=1541) 
 
Crude 
OR=13.35 (5.55, 32.11) 
 
Adjusted 
OR=13.19 (5.42, 32.09) 
 
Reference: BMI < 25 
kg/m
2
 without metabolic 
syndrome 
Age, smoking, 
physical activity 
6 
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Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
Kim et al. 
2012 
 
 
 
 
 
 
 
 
 
 
 
N=8748 
 
20-79 years 
 
65.2% male 
 
Free of self-reported 
history of physician 
diagnosed diabetes, or 
taking 
antihyperglycemic 
medication, fasting 
blood glucose ≥ 126 
mg/dL, HbA1c ≥ 6.5% 
 
Korea 
 
Clinic-based 
59 (41%) 
≤ 2 of: fasting plasma glucose ≥ 100 
mg/dL or antidiabetic treatment, 
blood pressure ≥ 130/85 mmHg, or 
antihypertensive treatment, 
plasma triglycerides ≥ 150 mg/dL, 
plasma HDL-cholesterol < 40 mg/dL 
in men and < 50 mg/dL in women, 
waist circumference ≥ 90 cm in 
men and ≥ 80 cm in women. 
 
BMI ≥ 30 kg/m
2 
and repeated with 
Asian specific cut off – BMI ≥ 27.5 
kg/m
2
 
Fasting plasma 
glucose ≥ 126 
mg/dL, HbA1c > 
6.5%, or on 
antihyperglycemic 
medication 
5 years 
 
5 cases 
Crude 
OR=5.31 (2.08, 13.56) 
 
Adjusted 
OR=4.93 (1.90, 12.79) 
 
Reference: BMI < 25  
kg/m
2 
metabolically 
healthy 
 
Asian specific 
 
Crude 
OR=4.57 (2.57, 8.10) 
 
Adjusted 
OR=4.31 (2.36, 7.86) 
 
Reference: BMI < 23 
kg/m
2 
metabolically 
healthy 
Age, sex, 
smoking, 
alcohol, 
physical activity 
7 
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Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
Hwang et al. 
2012 
N=1547 
 
18-59 years 
 
40.7% male 
 
Free of type 2 diabetes, 
hypertension, history of 
stroke, and metabolic 
abnormalities except 
central adiposity 
 
Taiwan 
 
Nationally 
representative 
38 
(28.5%) 
AHA criteria modified for Asian 
populations 
 
≤ 2 of: waist circumference ≥ 90cm 
for men and ≥ 80 cm for women, 
triglycerides ≥ 1.7 mmol/L, HDL-
cholesterol <1.0 mmol/L for men 
and <1.3 mmol/L for women, 
systolic blood pressure ≥ 130 
mmHg or diastolic blood pressure ≥ 
85 mmHg or current use of 
antihypertensive drugs, and fasting 
plasma glucose ≥ 5.6 mmol/L or 
current use of antihyperglycemic  
drugs 
 
BMI ≥ 27 kg/m
2
 
Fasting plasma 
glucose ≥ 7.0 
mmol/L or HbA1C > 
6.5% or use of 
antihyperglycemic 
mediation 
Mean 
5.4 years 
 
3 cases 
(men)
a 
 
5 cases 
(women)
a
 
Men 
HR=14.30 (1.21, 168.00) 
 
Women 
HR=14.60 (3.23, 65.50) 
 
Total (men and women) 
HR=11.50 (3.38, 39.10) 
 
Reference: BMI 18.5 – 
22.9 kg/m
2
 metabolically 
healthy 
Age, smoking 
status, alcohol 
intake, 
exercise, family 
history of 
diabetes or 
hypertension 
8 
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Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
Soriguer et al. 
2013 
N=1051 
 
18-65 years 
 
37.7 % male 
 
Free of type 2 diabetes 
 
Spain 
 
Nationally 
representative 
105 
(48.4%) 
HOMA-IR < 90
th
 percentile, 
triglycerides < 150 mg/dl, fasting 
glucose < 110 mg/dl 
 
BMI ≥ 30 kg/m
2
 
Fasting plasma 
glucose ≥ 7 mmol/L 
6 and 11 
years 
 
17 cases 
(6-year 
follow-up) 
 
11 cases 
(11-year 
follow-up) 
After 6 years 
 
Model 1: 
OR=3.62 (1.83, 7.17) 
 
Model 2: 
OR=2.16 (1.07, 4.36) 
 
After 11 years 
 
Model 1: 
OR=6.76 (2.58, 17.69) 
 
Model 2: 
OR=4.12 (1.82, 9.34) 
 
Reference: metabolically 
healthy BMI < 30 kg/m
2
 
Model 1: 
Unadjusted 
 
Model 2: Age, 
sex, weight 
change, 
abnormal 
glucose 
regulation (IFG, 
IGT) 
4 
Appleton et 
al. 2013 
N=3743 
 
≥ 18 years 
 
39% male (MHO group) 
 
Free of CVD/stroke and 
not underweight 
 
Australia 
 
Nationally 
representative 
454 
(44.2%) 
< 2 IDF metabolic syndrome 
criteria: triglycerides ≥ 1.7 mmol/L, 
HDL-cholesterol < 1 mmol/L in men 
or <1.3 mmol/L in women or lipid-
lowering medication use, blood 
pressure ≥ 130/85 mmHg or 
antihypertensive medication use, 
fasting glucose ≥ 5.6 mmol/L or 
self-reported diabetes 
 
BMI ≥ 30 kg/m
2
 
Self-reported 
doctor diagnosis or 
fasting plasma 
glucose ≥ 7 mmol/L 
Median 
8.2 years 
 
11 cases 
OR=2.09 (0.87, 5.03) 
 
Reference: metabolically 
healthy BMI 18-5 - 24.9 
kg/m
2
) 
 
Age, sex, 
household 
income, family 
history of 
diabetes 
6 
166 
 
Study Baseline sample 
Baseline 
healthy 
obese 
 
n (% of 
obese) 
Metabolically healthy obese 
criteria 
Type 2 diabetes 
criteria 
Follow-up 
length 
 
Diabetes 
cases for 
healthy 
obese 
 
Estimate (95% CI) 
 
 
Covariates 
 
Quality 
score 
(/11)* 
ELSA 2013 
N=3066 
 
Mean age 64.6 
 
43.3% male 
 
Free from physician 
diagnosed diabetes 
 
England 
 
Nationally 
representative 
 
308 
(38.3%) 
< 2 of: hypertension risk (clinic BP 
>130/85 mmHg, or hypertension 
diagnosis, or use of anti-
hypertensive medication); diabetes 
risk (HbA1c > 6%); low grade 
inflammation (CRP ≥ 3mg/L); 
adverse HDL cholesterol profile 
(<1.03 mmol/l in men and <1.30 
mmol/l women); adverse 
triglycerides (≥ 1.7 mmol/l). 
 
BMI ≥ 30 kg/m
2
 
Self-reported 
physician diagnosis, 
based on fasting 
plasma glucose ≥ 7 
mmol/L 
Mean 5.9 
years 
 
12 cases 
Model 1: 
HR=9.30 (2.60, 32.70) 
 
Model 2: 
HR=8.60 (2.40, 30.40) 
 
Reference: metabolically 
healthy BMI < 25 kg/m
2
) 
 
Model 1: Age, 
sex 
 
Model 2: 
Further 
adjusted for 
cigarette 
smoking, 
frequency of 
alcohol intake, 
physical 
activity, wealth, 
depressive 
symptoms 
7 
*Study quality assessed according to the rigor of study exposure, outcome, and model adjustment strategy. Points were assigned as follows: 2 points if the study considered metabolic 
clustering; 1 point if the study considered insulin profile alone. 2 points if diabetes diagnosis was based on objective clinical measurement (ie. blood glucose level); 1 point if diabetes 
diagnosis was based on self-report only.1 point if each of the following covariates were considered: family history of diabetes, ethnicity, alcohol consumption, smoking status, physical 
activity, dietary sugar intake, socioeconomic status. Studies were scored out of 11 possible points. 
a
Estimated from published cumulative incidence (%) figure. 
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Objective 4: Synthesis of estimates obtained from the literature using random-effects meta-
analysis and examination of whether age, ethnicity, duration of follow-up, and study quality 
explain any observed between-study heterogeneity in effects 
 
Figure 12 presents results of the random effects meta-analysis which modelled the log of odds 
ratios, risk ratios, hazard ratios, and confidence intervals pooled from respective studies. The 
summary relative risk for healthy obese adults was 4.03 (95% CI=2.66, 6.09), indicating over 4 
times higher risk of incident type 2 diabetes than healthy normal-weight adults. In comparison, 
the corresponding pooled relative risk in the unhealthy obese group was 8.93 (95% CI=6.86, 
11.62) (Figure 13) and the corresponding pooled relative risk in the unhealthy normal-weight 
group was 4.46 (95% CI=3.38, 5.88) (Figure 14). There was evidence of variability in effect sizes 
for the healthy obese group (I2=49.8%; p=0.03), although relative risks were consistently positive 
and exceeded one in every study. Meta-regression was performed to test the extent to which 
specific study-level factors explained the between-study heterogeneity in effects, chosen a priori 
(244) as age, ethnicity, length of follow-up, and study quality. However no study reported the 
ethnic composition of their sample, preventing examination of that factor. Neither study quality 
(p=0.33), length of follow-up (p=0.29), nor age (p=0.97) significantly predicted heterogeneity in 
effect estimates, indicating that the variation in the strength of association observed between 
studies was not explained by these study-level factors. The summary relative risks of incident 
type 2 diabetes for each metabolic group relative to the healthy normal-weight group are 
illustrated in Figure 15. 
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Figure 12 Healthy obesity and adjusted relative risk of incident type 2 diabetes 
 
 
Reference group is healthy normal-weight 
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Figure 13 Unhealthy obesity and adjusted relative risk of incident type 2 diabetes 
 
 
Reference group is healthy normal-weight. Analysis excludes Hwang et al. (2012) as authors considered metabolically healthy participants at baseline 
only.  
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Figure 14 Unhealthy normal-weight and adjusted relative risk of incident type 2 diabetes 
 
 
Reference group is metabolically healthy normal-weight. Analysis excludes Hwang et al. (2012) as authors considered metabolically healthy participants 
at baseline only. Normal-weight considered BMI < 30 kg/m² in Soriguer et al. (2013).  
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Figure 15 Metabolic and obesity groups and adjusted relative risk of incident type 2 diabetes based on summary estimates from meta-analyses 
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Objective 5: Original effect estimate for the risk of incident type 2 diabetes among obese 
adults who initially have 0 metabolic risk factors (a strictly healthy sample) 
 
Phase 3 (1991/94) served as the baseline for this study with incident type 2 diabetes data 
extending to phase 11 (2012/13), affording a 20-year follow-up period. A flow chart illustrating 
the selection of the analytical sample is provided in Figure 16. 
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Figure 16 Selection of the analytical sample for the study of incident type 2 diabetes among 
obese adults who initially have 0 metabolic risk factors 
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Two sets of descriptive characteristics are provided for this sample; the first with health defined 
as having <2 metabolic risk factors, and the second with health defined as having 0 metabolic 
risk factors. Based on the first definition of health (Table 36), of 5469 adults in the sample, 167 
were healthy obese, representing 36.5% of the obese. The proportion of normal-weight and 
overweight adults who were considered healthy was 82.2% and 57%, respectively. Over one-
third of healthy obese adults were male (37.1%), compared with 68.2% of healthy normal-
weight adults (p<0.05). Healthy obese adults were slightly older than healthy normal-weight 
adults (49.7 vs 48.6 years, p<0.05), and had a higher proportion being of a non-white ethnicity 
(15% vs 6.1%, p<0.05). Nearly one-quarter (24%) of healthy obese adults were of the lowest 
occupational class, compared with just one-tenth of healthy normal-weight adults (11.1%, 
p<0.05). Healthy obese adults reported a lower mean weekly duration of moderate-to-vigorous 
physical activity than healthy normal-weight adults (2.6 hours/week vs. 3.7 hours/week, p<0.05). 
Other health behaviours did not differ between groups. Healthy obese adults showed more 
adverse levels of all metabolic risk factors than healthy normal-weight adults (all p<0.05) with 
the exception of fasting glucose. 13.8% of initially healthy obese adults developed type 2 
diabetes over a median follow-up time of 20.2 years, compared with 4.4% of initially healthy 
normal-weight adults, over a similar amount of time.   
Compared with those included in the analytic sample (n=5469), those excluded (n=4839) were 
more likely to be female (38.7% vs. 28.2%, p<0.001), of a non-white ethnicity (14.7% vs. 7.6%, 
p<0.001), of an older age (mean=50.4 years vs. 49.4 years, p<0.001), of the lowest occupational 
position (24.4% vs. 12.8%, p<0.001), and had lower moderate to vigorous physical activity (3.3 
hours/week vs. 3.6 hours/week respectively, p=0.01). Compared with those included in analyses, 
those excluded were also more likely to be obese (13.2% vs. 8.4% respectively, p<0.001) and 
were less likely to be metabolically healthy as defined as having <2 metabolic risk factors (60.6% 
vs. 68.8% respectively, p<0.001).  
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Table 37 Characteristics of the sample of adults at phase 3 (1991/94)  by metabolic and obesity status who are initially free of type 2 diabetes (aged 39-63, 72% male), with 
baseline healthy status defined as having <2 metabolic risk factors (n=5469) 
       
 Healthy  
normal-weight  
(n=2407) 
Unhealthy 
normal-weight 
(n=522) 
Healthy 
overweight 
(n=1186) 
Unhealthy 
overweight 
(n=896) 
Healthy 
obese  
(n=167) 
Unhealthy 
obese  
(n=291) 
Baseline characteristics       
Male – n (%)  1642 (68.2) 452 (86.6)* 827 (69.7) 757 (84.5)* 62 (37.1)* 187 (64.3) 
Age (years)  48.6 (6) 50.1 (6.1)* 49.6 (5.9)* 50.7 (6.1)* 49.7 (5.7)* 49.8 (5.8)* 
Non-white ethnicity – n (%)  147 (6.1) 57 (10.9)* 82 (6.9) 77 (8.6)* 25 (15)* 29 (10)* 
Lowest occupational class – n (%)  268 (11.1) 49 (9.4) 178 (15)* 113 (12.6) 40 (24)* 54 (18.6)* 
Consumes fruit and vegetables < daily – n (%)  792 (32.9) 205 (39.3) 444 (37.4) 381 (42.5) 48 (28.7) 128 (44) 
Current smoker – n (%)  273 (11.3) 65 (12.5) 143 (12.1) 109 (12.2) 20 (12) 37 (12.7) 
High alcohol consumption in previous week – n (%)  331 (13.8) 94 (18)* 205 (17.3)* 177 (19.8)* 29 (17.4) 49 (16.8) 
Hours of moderate-to-vigorous activity per week  3.7 (4.2) 3.6 (3.9) 3.5 (4.0) 3.7 (4.1) 2.6 (2.9)* 2.9 (3.1)* 
Has illness that greatly limits moderate or vigorous activity – n (%)  361 (15) 98 (18.8)* 208 (17.5) 184 (20.5)* 51 (30.5)* 100 (34.4)* 
Systolic blood pressure (mmHg)  115.6 (11.8) 127.0 (14.1)* 118.4 (11.1)* 127.8 (12.9)* 121.8 (13.4)* 130.1 (12.0)* 
Diastolic blood pressure (mmHg)  75.9 (8.2) 83.6 (9.0)* 78.9 (7.9)* 85.6 (8.4)* 80.5 (8.8)* 86.8 (8.3)* 
Fasting glucose (mmol/l)  5.1 (0.4) 5.4 (0.5)* 5.1 (0.4)* 5.4 (0.5)* 5.0 (0.4) 5.5 (0.5)* 
HOMA insulin resistance  1.5 (1.1) 2.7 (2.9)* 1.9 (1.4)* 3.5 (5.2)* 2.4 (1.2)* 6.5 (12.8)* 
Triglycerides (mmol/l)  1.0 (0.4) 2.0 (1.1)* 1.2 (0.5)* 2.2 (1.2)* 1.2 (0.4)* 2.3 (1.2)* 
HDL cholesterol (mmol/l)  1.6 (0.4) 1.2 (0.4)* 1.5 (0.3)* 1.2 (0.3)* 1.5 (0.3)* 1.2 (0.3)* 
Body mass index (kg/m²)  
       Range 
22.6 (1.6) 
18.50-25.00 
23.5 (1.2)* 
18.53-24.99 
26.7 (1.3)* 
25.00-29.99 
27.2 (1.4)* 
25.00-29.99 
32.6 (2.7)* 
30.00-41.99 
33.2 (3.3)* 
30.00-48.48 
       
Incident type 2 diabetes       
Cases – n (%)  106 (4.4) 84 (16.1)* 84 (7.1)* 202 (22.5)* 23 (13.8)* 109 (37.5)* 
Median length of follow-up a 20.3 20.2* 20.3* 20.1* 20.2* 16.4* 
       
Data are mean (standard deviation) unless otherwise noted. *Different from healthy normal-weight (p<0.05) based on linear (continuous variables) or logistic regression 
(binary variables). a Significance test based on mean 
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Table 37 presents descriptive characteristics of participants according to the strict definition of 
metabolic health (0 metabolic risk factors). The total sample size did not differ from that based 
on the previous definition of metabolic health (n=5469), however the proportion of obese adults 
who were now considered healthy at baseline according to this strict definition was lower, at 
12.7% (n=58; compared with 36.5% based on the previous definition allowing for 1 metabolic 
risk factor). The proportion of normal-weight and overweight adults who were considered 
healthy based on this strict definition was 50.1% and 25.1%, respectively.  
Over one-quarter of healthy obese adults were male (27.6%), compared with 64% of healthy 
normal-weight adults (p<0.05). Age did not differ between healthy obese and healthy normal-
weight adults, while a higher proportion of healthy obese adults were of a non-white ethnicity 
(15.5% vs 5.9%, p<0.05). Twice as many healthy obese adults were of the lowest occupational 
class than were healthy normal-weight adults (20.7% vs 11.1%, p<0.05). One-quarter of healthy 
obese adults reported an illness which greatly limits their moderate or vigorous physical activity, 
compared with 13% of healthy normal-weight adults (p<0.05). Healthy obese adults on average 
reported 2.5 hours/week of moderate-to-vigorous physical activity, which was lower than for 
healthy normal-weight adults (3.7 hours/week, p<0.05). Other health behaviours did not differ 
between groups. Healthy obese adults did not show more adverse levels of any metabolic risk 
factor than healthy normal-weight adults at baseline. The proportion of initially healthy obese 
adults who developed type 2 diabetes over a median follow-up time of 20.2 years was 8.6%, 
compared with 3.2% of initially healthy normal-weight adults over a similar amount of time 
(p>0.05).  
Included (n=5469) and excluded (n=4839) participants did not differ on their likelihood of being 
metabolically healthy as defined as having 0 metabolic risk factors (35.2% vs. 37.4% respectively, 
p=0.30). Comparisons on other variables were the same as for the previous sample when 
defining a healthy status as having <2 metabolic risk factors.  
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Table 38 Characteristics of the sample of adults at phase 3 (1993/4) by metabolic and obesity status who are initially free of type 2 diabetes (aged 39-63, 72% male), with 
baseline healthy status defined as having 0 metabolic risk factors (n=5469) 
       
 Healthy  
normal-weight  
(n=1468) 
Unhealthy 
normal-weight 
(n=1461) 
Healthy 
overweight 
(n=522) 
Unhealthy 
overweight 
(n=1560) 
Healthy 
obese  
(n=58) 
Unhealthy 
obese  
(n=400) 
Baseline characteristics       
Male – n (%)  940 (64) 1154 (79)* 330 (63.2) 1254 (80.4)* 16 (27.6)* 233 (58.3) 
Age (years)  48.1 (5.8) 49.7 (6.1)* 49.1 (5.9)* 50.4 (6)* 48.9 (5.5) 49.8 (5.8)* 
Non-white ethnicity – n (%)  87 (5.9) 117 (8)* 36 (6.9) 123 (7.9) 9 (15.5)* 45 (11.3)* 
Lowest occupational class – n (%)  163 (11.1) 154 (10.5) 80 (15.3)* 211 (13.5)* 12 (20.7)* 82 (20.5)* 
Consumes fruit and vegetables < daily – n (%)  467 (31.8) 530 (36.3)* 201 (38.5)* 624 (40)* 15 (25.9) 161 (40.3)* 
Current smoker – n (%)  161 (11) 177 (12.1) 66 (12.6) 186 (11.9) 8 (13.8) 49 (12.3) 
High alcohol consumption in previous week – n (%)  193 (13.1) 232 (15.9)* 97 (18.6)* 285 (18.3)* 10 (17.2) 68 (17)* 
Hours of moderate-to-vigorous activity per week  3.7 (4.1) 3.7 (4.1) 3.7 (4.4) 3.6 (3.9) 2.5 (2.4)* 2.9 (3.1)* 
Has illness that greatly limits moderate or vigorous activity – n (%)  191 (13) 268 (18.3)* 85 (16.3) 307 (19.7)* 15 (25.9)* 136 (34)* 
Systolic blood pressure (mmHg)  111.6 (8.9) 123.8 (13.7)* 113.6 (8.0)* 125.4 (12.7)* 113.5 (7.7) 129 (12.6)* 
Diastolic blood pressure (mmHg)  73.3 (6.3) 81.3 (9.3)* 75.3 (5.5)* 84.0 (8.6)* 74.5 (5.5) 85.9 (8.5)* 
Fasting glucose (mmol/l)  5.0 (0.3) 5.3 (0.5)* 5.0 (0.3) 5.3 (0.5)* 5.0 (0.3) 5.4 (0.5)* 
HOMA insulin resistance  1.3 (0.6) 2.1 (2.2)* 1.6 (0.7)* 2.9 (4.2)* 2.1 (0.9) 5.4 (11.1)* 
Triglycerides (mmol/l)  0.9 (0.3) 1.5 (0.9)* 1.0 (0.3)* 1.9 (1.1)* 1.1 (0.3) 2.0 (1.2)* 
HDL cholesterol (mmol/l)  1.6 (0.4) 1.4 (0.4)* 1.5 (0.3)* 1.3 (0.4)* 1.6 (0.3) 1.2 (0.3)* 
Body mass index (kg/m²)  
       Range 
22.3 (1.6) 
18.51-25.00 
23.1 (1.4)* 
18.50-25.00 
26.7 (1.3)* 
25.01-29.99 
27.0 (1.4)* 
25.00-29.99 
32.5 (2.7)* 
30.04-41.84 
33.1 (3.2)* 
30.00-48.48 
       
Incident type 2 diabetes       
Cases – n (%) 47 (3.2) 143 (9.8)* 31 (5.9) 255 (16.3)* 5 (8.6) 127 (31.8)* 
Median length of follow-up a 20.4 20.3* 20.3* 20.2* 20.2 19.2* 
       
Data are mean (standard deviation) unless otherwise noted. *Different from healthy normal-weight (p<0.05) based on linear (continuous variables) or logistic regression 
(binary variables). a Significance test based on mean 
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Results of multivariable-adjusted analyses based on both definitions of metabolic health (<2 
metabolic risk factors and 0 metabolic risk factors) are presented in Table 38 and illustrated in 
Figure 17. When defining a healthy status as <2 metabolic risk factors, all groups showed 
increased risk for incident type 2 diabetes compared with healthy normal-weight adults after 
multivariable adjustment. This excess risk was 2.82 (95% CI=1.78, 4.46) times greater among 
healthy obese adults and 9.99 (95% CI=7.60, 13.14) times greater among unhealthy obese 
adults. 
When defining a healthy status as 0 metabolic risk factors, all groups except the healthy obese 
showed increased risk for incident type 2 diabetes compared with healthy normal-weight adults 
after multivariable adjustment. The hazard ratio for strictly healthy obese adults adjusting for 
age, sex, and ethnicity was 2.51 (95% CI=0.99, 6.32), and was 2.46 (95% CI=0.98, 6.22) when 
additionally adjusting for occupational position, cigarette smoking, alcohol consumption, 
frequency of fruit and vegetable consumption, moderate-to-vigorous physical activity, and 
presence of an illness which limits moderate or vigorous physical activity. Excess risk among 
unhealthy adults increased steadily with higher BMI groups, with unhealthy obese adults 
showing the highest risk compared with healthy normal-weight adults (HR=10.68, 95% CI=7.60, 
15.01 after multivariable adjustment).  
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Table 39 Risk of incident type 2 diabetes over 22 years among metabolic and obesity groups based on 2 definitions of metabolic health (n=5469) 
 
 Healthy (<2 risk factors)   Strictly healthy (0 risk factors) 
        
 Cases/N 
Model 1 
Hazard Ratio 
(95% CI) 
Model 2 
Hazard Ratio 
(95% CI) 
 
Cases/N 
Model 1 
Hazard Ratio 
(95% CI) 
Model 2 
Hazard Ratio 
(95% CI) 
        
Healthy normal-weight 106/2407 1.00 (reference) 1.00 (reference)  47/1468 1.00 (reference) 1.00 (reference) 
Unhealthy normal-weight 84/522 3.74 (2.80, 5.00) 3.63 (2.72, 4.86)  143/1461 3.05 (2.19, 4.24) 2.93 (2.10, 4.08) 
Healthy overweight 84/1186 1.61 (1.21, 2.15) 1.57 (1.18, 2.10)  31/522 1.88 (1.20, 2.96) 1.80 (1.14, 2.84) 
Unhealthy overweight 202/896 5.66 (4.46, 7.19) 5.37 (4.22, 6.84)  255/1560 5.31 (3.88, 7.26) 4.99 (3.64, 6.84) 
Healthy obese 23/167 2.86 (1.81, 4.51) 2.82 (1.78, 4.46)  5/58 2.51 (0.99, 6.32) 2.46 (0.98, 6.22) 
Unhealthy obese 109/291 10.74 (8.21, 14.04) 9.99 (7.60, 13.14)  127/400 11.54 (8.24, 16.15) 10.68 (7.60, 15.01) 
        
Incident diabetes defined by fasting glucose ≥ 7 mmol/l or self-reported doctor diagnosis or diabetic medication use. Model 1 adjusted for age, 
sex, and ethnicity. Model 2 additionally adjusted for occupational position, cigarette smoking, alcohol consumption, frequency of fruit and 
vegetable consumption, moderate-to-vigorous physical activity, and presence of an illness which limits moderate or vigorous physical activity 
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Figure 17 Risk of incident type 2 diabetes over 22 years among metabolic and obesity groups based on 2 definitions of metabolic health (n=5469) 
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4.4 Summary of key findings on healthy obesity and 
metabolic decline 
 
 
The second part of this thesis was concerned with the risk of future metabolic decline among 
healthy obese adults, specifically with regards to incident metabolic risk factor clustering and 
type 2 diabetes. Results showed that after 20 years, 52% of initially healthy obese adults were 
unhealthy obese, with initially healthy obese adults being 26.61 (95% CI=15.85, 44.69) times 
more likely to make this progression than initially healthy normal-weight adults. Analyses using a 
strict definition of metabolic health (having none of 5 metabolic risk factors) showed this to be 
rare among the obese at 13%, and to be highly susceptible to progressions to ill-health over 
time, with 78.6% of these strictly healthy obese becoming unhealthy at 20 years follow-up. 
Insulin resistance was most commonly incident among healthy obese compared with healthy 
normal-weight adults over time (IR=3.78, 95% CI=2.38, 5.99 at 20-years follow-up). A systematic 
review and meta-analysis of 8 prospective cohort studies indicated that healthy obese adults 
have 4.03 (95% CI=2.66, 6.09) times greater risk of incident type 2 diabetes compared with 
healthy normal-weight adults; this risk being half that of unhealthy obese adults. Original 
analyses of the Whitehall II cohort examining risk for incident type 2 diabetes among a strictly 
healthy obese group (those with 0 risk factors) indicated that this risk was not significantly 
elevated compared with strictly healthy normal-weight adults (HR=2.46, 95% CI=0.98, 6.22), but 
patterns of excess risk were otherwise the same across metabolic and obesity groups as when 
using the more common definition of metabolic health (<2 metabolic risk factors).  
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Section 5: Discussion 
 
 
This section will begin by interpreting results on physical activity and sedentary behaviour in 
relation to healthy obesity in the context of previous research, followed by a discussion of their 
strengths and limitations. Findings from results on healthy obesity and future metabolic decline 
will then be interpreted in light of previous research, again followed by a discussion of their 
strengths and limitations. This section will end with an overall conclusion considering both parts 
of this thesis and with implications of results for public health and clinical practice.    
 
5.1 Physical activity and sedentary behaviour in 
relation to healthy obesity: Interpretations of 
results in light of previous research 
 
 
The first part of this thesis aimed to determine whether physical activity and sedentary 
behaviour are distinguishing features, and thus potential modifiable determinants, of healthy 
obesity. This aim was addressed by first examining whether durations in moderate-to-vigorous 
physical activity and leisure sitting, both measured by self-report using a questionnaire, were 
associated cross-sectionally with a higher likelihood of being metabolically healthy among obese 
adults. These associations were examined separately in mutually adjusted models to examine 
potential independent associations of each behaviour, as well as in combination using pairs of 
activity-sitting tertiles to examine whether associations are interactive in relation to healthy 
obesity.   
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Results suggested that higher moderate-to-vigorous physical activity was separately associated 
with a greater likelihood of being healthy among normal-weight and among overweight adults, 
but not among obese adults. Trends for effect estimates of physical activity were in the expected 
positive direction among the obese, but statistical significance was not reached.  
In contrast, lower leisure sitting time was not separately associated with a greater likelihood of 
being healthy among normal-weight, overweight, or obese adults, and effect estimates did not 
show a clear pattern for any group. As discussed, sedentary behaviour is thought to represent a 
distinct state of muscle inactivity that may independently influence metabolic functioning 
through lipoprotein lipase or glucose pathways (78) or the expression of genes linked to 
inflammatory responses (132). Lower levels of sedentary behaviour were therefore 
hypothesised to help explain why some obese adults appear to be metabolically healthy, 
irrespective of their engagement in moderate-to-vigorous physical activity. This lack of 
association of sitting time among the obese does not support this hypothesis, and instead agrees 
with 2 previous studies finding no difference in self-reported sitting time between healthy and 
unhealthy obese adults (51, 65). 
When viewing combined associations, having both high moderate-to-vigorous physical activity 
and low leisure sitting time was associated with a greater likelihood of being metabolically 
healthy among overweight adults after adjusting for basic demographic factors, but associations 
were not observed among normal-weight or among obese adults. The effect size for this 
combined effect among overweight adults was greater than that seen for the separate effect of 
moderate-to-vigorous physical activity, but the relative difference in prevalence was only 
modest. After additional adjustment for health behaviours, this association became marginally 
significant among the obese, and showed a larger effect size than among normal-weight and 
among overweight groups, suggesting that low sitting time could amplify a beneficial effect of 
high moderate-to-vigorous physical activity among the obese in particular. The direction of 
effects was in the expected direction, suggesting a higher likelihood of having a healthy profile 
among each BMI group including the obese with more favourable combinations of physical 
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activity and sitting, but the predictability of these self-reported behavioural measures were 
generally weak.  
 Next, this thesis aimed to build upon cross-sectional examinations and determine whether 
favourable levels of moderate-to-vigorous physical activity and leisure sitting were protective 
against becoming metabolically unhealthy over time among initially healthy obese adults. As 
discussed, favourable levels of moderate-to-vigorous physical activity and leisure sitting have 
each been associated prospectively with reduced incidence of metabolic ill-health in previous 
work (162), but it has not been known whether these behaviours exert independent or 
interactive effects on risk of adverse metabolic change, or how they relate to initially healthy 
obese adults specifically. Furthermore, a broad measure of leisure sitting time has not been used 
to examine prospective associations, as measures used in previous studies have been context-
specific, considering activities such as TV viewing in isolation. Present results suggest that 
neither high moderate-to-vigorous physical activity nor low leisure sitting time were separately 
associated with reduced risk of becoming unhealthy over time among initially healthy obese 
adults. The same null result was seen among normal-weight and among overweight adults. 
Furthermore, in addition to being statistically non-significant, the magnitude of estimates were 
small-to-modest, and were not consistently in the expected direction, together suggesting a 
generally weak predictability of these behaviours for adverse metabolic change over time.  
There was some evidence of a protective effect for intermediate levels of both moderate-to-
vigorous physical activity and leisure sitting among overweight adults only; this apparent effect 
was robust to adjustment for potential confounders suggesting an advantage among overweight 
adults who avoid either too much or too little of both physical activity and leisure sitting. This 
was unexpected, and does not lead to obvious interpretations based on literature, and may 
therefore reflect a chance finding. Previous work using the Whitehall II cohort found that the 
same measures of high moderate-to-vigorous physical activity and low leisure sitting time 
interacted to greatly reduce risk of becoming obese over a 5 year period (245), while this 
combined effect on risk of developing metabolic risk factor clustering was unclear, again 
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suggesting a protective benefit of engaging in intermediate levels of both moderate-to-vigorous 
physical activity and leisure sitting. With regards to initially healthy obese adults in present 
analyses, the combination of high activity and low sitting did not confer a reduced risk of 
developing metabolic risk factor clustering compared with those combining low activity and high 
sitting (the least favourable combination), suggesting that incidence of ill-health among the 
obese may occur regardless of physical activity and sitting behaviour.  
Given that associations of sitting time are known to be most pronounced when using TV viewing 
time as an indicator (147, 148), TV viewing was examined in further analyses in replace of the 
broader leisure sitting time measure. This was examined cross-sectionally at the most recent 
phase of the Whitehall II cohort study only, owing to limitations of sitting data as assessed at 
earlier phases. Results of these analyses suggest that TV viewing was not separately associated 
with the likelihood of being healthy among obese adults, but did interact with moderate-to-
vigorous physical activity to produce a near doubling in likelihood of being healthy among those 
obese adults who report both high moderate-to-vigorous activity and low TV viewing, compared 
with those reporting both low activity and high TV viewing. However, this association was only 
observed when adjusting for age, sex, and ethnicity, and was attenuated to non-significance 
when additionally adjusting for health behaviours and the presence of a physically limiting 
illness, suggesting that this link may be partly explained by factors such as higher diet quality and 
the absence of a physically limiting illness which are associated with a higher engagement in 
moderate-to-vigorous activity and lower time spent viewing TV, rather than being due to the 
activity combination itself.  
Further analyses examined differences in TV viewing across metabolic and obesity groups in the 
Whitehall II cohort study and found that unhealthy obese adults viewed nearly 4.5 hours more 
TV per week than healthy normal-weight adults after adjusting for covariates including duration 
in moderate-to-vigorous physical activity. However differences in TV viewing were only evident 
between healthy and unhealthy normal-weight adults, and not between healthy and unhealthy 
obese adults. This agrees with results of a previous study based on older adults from the English 
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Longitudinal Study of Ageing (ELSA), which found sizable differences in TV viewing time across 
metabolic and obesity groups with unhealthy obese adults viewing over 8 more hours of TV per 
week than healthy normal-weight adults (246); but differences in TV viewing time were again 
only evident between healthy and unhealthy normal-weight adults and not between healthy and 
unhealthy obese adults. Together, this suggests that TV viewing time plays a role in promoting 
health among normal-weight adults, but not among obese adults. 
Thus, based on the current state of evidence drawn from studies in literature and results of this 
thesis, moderate-to-vigorous physical activity and sedentary behaviour have amassed little 
support as factors which distinguish or determine healthy obesity. Given the extensive literature 
reporting strong links between physical activity and sedentary behaviour with metabolic health 
among adults, a general lack of association of these behaviours in relation to prevalence and 
incidence of metabolic risk factor clustering observed in this thesis was unexpected, and could 
reflect several different possibilities.  
The first possibility is that analyses which are stratified by BMI impose limited statistical power 
within each group, and that this may mask true associations among the obese group in 
particular. When considering all adults collectively in a series of subsidiary analyses, associations 
between moderate-to-vigorous physical activity and metabolic health status were evident 
irrespective of BMI group, with no evidence that these associations differed by BMI group. 
Likewise, high moderate-to-vigorous physical activity combined with low leisure sitting time was 
associated with an even greater likelihood of being healthy among all adults collectively, 
irrespective of BMI group. Null results on moderate-to-vigorous physical activity observed 
among obese adults in BMI-stratified analyses may therefore be more of an artefact of lower 
statistical power within the relatively small obese group than a true lack of association. Leisure 
sitting time was not associated with metabolic health status among all adults collectively in 
subsidiary analyses; although low TV viewing was separately associated with health among 
adults irrespective of BMI, suggesting that lower TV viewing time may indeed help differentiate 
metabolic health status among the obese. Stratification by BMI in main analyses was planned a 
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priori with the purpose of isolating obese adults as a population of interest, and results should 
be interpreted together with those obtained from alternative methodologies to more 
completely understand the nature of these associations.  
A second possibility relates to the fact that both physical activity and sitting are behaviours 
which are subject to considerable change over time. A lack of discernible associations between 
membership in a certain physical activity or sitting group at baseline and metabolic health status 
at follow-up may reflect biases related to exposure misclassification – that is, participants may 
have changed their activity pattern over the duration of follow-up, and their baseline 
classification may no longer reflect their expected outcome. The risk of this bias may be 
especially high when examining long-term outcomes on the time scale of decades, as exposure 
groups may not track well into the distant future. This could result in regression dilution bias, in 
which regression lines fail to detect patterns and associations appear non-significant (247, 248). 
For example, those adults who began in the high activity-low sitting group may have reduced 
their usual activity and increased their usual sitting time, which would weaken any link this 
behaviour combination may otherwise have with incidence of ill-health over time. The outcome 
for incident metabolic risk factor clustering used in present analyses was cumulative, considering 
incidence 5 years later, or 10 years later, or 15 years later, and thus would have captured 
incidence at the shorter 5 year follow-up which is less prone to exposure misclassification. Still, 
the time unit of years is long when considering behaviours which are subject to change, 
especially given that participants advance their age considerably over the follow-up period and 
may change their lifestyles as they enter different life stages, such as retirement. However, this 
possibility would only be relevant to prospective analyses and would not explain null results of 
cross-sectional analyses.  
A third possibility for a lack of cross-sectional and prospective associations is a confounding role 
of BMI in associations of physical activity, sedentary behaviour, and metabolic health. Present 
results are stratified by, and are in essence adjusted for, BMI group, and higher adiposity has 
known bidirectional associations with low physical activity and high sitting levels (245, 249, 250). 
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For example, a lower likelihood of developing metabolic risk factor clustering with higher 
physical activity shown in previous studies could partly reflect the fact that adults who engage in 
high physical activity also tend to be of a lower BMI, which is itself protective against ill-health 
(186). 
Another possible reason for the apparent lack of associations is that participants of the 
Whitehall II cohort are relatively active compared with the general population, and such high 
underlying levels of physical activity could attenuate associations for both moderate-to-vigorous 
physical activity and leisure sitting time. Indeed, the proportion who report meeting national 
recommendations for moderate-to-vigorous activity is much higher among Whitehall II 
participants than among adults in the general population (58.2% of men and 33.9% of women in 
1997/99 in the Whitehall II cohort compared with 32% of men and 21% of women in the general 
population in England in 1997 (251)). Results may be affected for moderate-to-vigorous physical 
activity if the difference in risk of metabolic risk factor clustering between the most and the least 
active is not sizable enough to reveal an association. Likewise, a high underlying level of 
moderate-to-vigorous physical activity may attenuate associations of higher sitting time on 
metabolic outcomes, as suggested in previous studies (69, 144, 145). Thus, associations for both 
physical activity and sitting may be underestimated by the selectively active nature of the 
population under study, and it may be expected that these behaviours have greater roles in 
promoting metabolic health in the general population.  
A final and perhaps most likely explanation for a lack of associations is that the measures of 
moderate-to-vigorous physical activity and leisure sitting used in these analyses were both self-
reported, which may underestimate true associations if they are imprecise. Indeed, stronger 
associations have been seen between physical activity and metabolic risk factors when using 
objective measures compared with self-reported measures (252), while other reports show low-
to-moderate correlations between objective and self-reported assessments of physical activity 
(120); these correlations being lowest among the obese (123). Indeed, imprecision in 
behavioural measures are likely the greatest source of concern, as this may bias results 
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regardless of whether such results are examined among different BMI groups separately or 
among all adults collectively.  
As mentioned, prior evidence on physical activity in relation to healthy obesity is based on self-
reported measures of activity, which are prone to inaccuracies in recall and do not capture all 
movements which contribute to health. These are expected to be imprecise compared with 
objective accelerometer-based measures which monitor incidental movements in real-life 
settings. Thus, a further objective of this thesis was to examine differences in physical activity 
between healthy and unhealthy obese groups based on objective accelerometer assessments. 
Total physical activity serves as a useful starting point to assess differences in movement, as it 
captures the entire spectrum of physical activities, including those of light, moderate, and 
vigorous intensity, and also has practical advantages given that it is more normally distributed 
than moderate-to-vigorous physical activity, making it more suitable for standardisation and 
comparison with questionnaire-based measures.  
In present analyses, differences in total physical activity between healthy and unhealthy obese 
groups were indeed evident when using an accelerometer, but not when using a questionnaire, 
providing the first objective evidence that healthy obese adults are more physically active than 
their unhealthy obese counterparts. A hip-worn counts-based accelerometer has been used in a 
previous study to show that total physical activity was lower among healthy overweight and 
obese adults compared with healthy normal-weight adults (253), but no comparisons were 
made with unhealthy overweight or obese groups. One other study using a pedometer (step 
count) did not find differences in total physical activity between healthy and unhealthy obese 
groups, but this was based on a small sample of obese women (N=39) (118), and thus was likely 
underpowered to detect true differences. There was a low-to-moderate correlation between 
self-reported and objectively assessed total physical activity among all adults in the sample, in 
line with 2 previous reports from the same cohort (120, 122). The correlation was found to be 
lower among obese adults than among normal-weight and overweight adults in the present 
study, with an even lower correlation observed among unhealthy obese than among healthy 
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obese adults suggesting differential measurement error and a higher degree of recall bias among 
obese adults who are unhealthy. This might explain weak and inconsistent associations 
previously observed with self-reported physical activity among obese adults, as previous reports 
have not distinguished between metabolic types of obesity when examining correlations. 
Differences in total physical activity between healthy and unhealthy normal-weight, overweight, 
and obese groups were also evident after controlling for health behaviours including a summary 
indicator of diet quality, supporting associations of physical activity with metabolic risk factors 
which are independent of diet.  
As mentioned, total physical activity is a broad measure of overall body movement and is thus a 
good starting point for examining differences in objectively measured physical activity between 
obese groups. However, as a consequence, interpretations of present results are not straight-
forward as the 24-hour monitoring of the wrist-worn accelerometer captured all light, 
moderate, and vigorous intensity activities, and also reflects differences in time spent sitting and 
sleeping. Given that light physical activity (125) and sitting (133) are both associated with 
metabolic risk factor clustering independently of moderate-to-vigorous activity, it seems 
plausible that higher total physical activity among healthy obese adults could reflect either or all 
of higher moderate-to-vigorous activity, higher light intensity activity, lower sitting time, or 
higher sleeping time. Teasing apart the contributions of each activity component is necessary to 
understand which component is driving these associations, and thus where efforts to intervene 
would be best directed.  
To begin addressing this issue, differences in the likelihood of meeting moderate-to-vigorous 
physical activity recommendations based on accelerometer were compared between healthy 
and unhealthy obese adults. No clear differences were found, such that healthy obese adults 
were not more likely than unhealthy obese adults to meet recommendations for moderate-to-
vigorous physical activity when this activity requires 10-minute bouts as currently stipulated 
(142). However, in sensitivity analyses, the healthy obese were more likely than the unhealthy 
obese to meet recommendations when measuring moderate-to-vigorous physical activity with a 
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more stringent cut-point (which captures activities in the more intense end of the moderate-to-
vigorous distribution) and when also considering activity durations of at least 1 minute instead 
of at least 10 minutes. This suggests that healthy obese adults do engage in more moderate-to-
vigorous activity, but this is done in shorter durations which are unrecognised by current 
guidelines. Attention to the way in which moderate-to-vigorous activity is accumulated may be 
important for accurately assessing activity patterns among obese adults. It is plausible that short 
bouts of movement may contribute to health among the obese, as it has been shown previously 
that moderate-to-vigorous physical activity which is accumulated sporadically is associated with 
the same reduced prevalence of metabolic risk factor clustering as moderate-to-vigorous activity 
which is accumulated in traditional 10-minute bouts – the total amount of activity being equal 
(254). However sporadic activity was defined in this previous study simply as being less than 10 
minutes, and much of this activity may be just under the 10-minute mark and not of short (I.e. 1 
or 2 minute) durations. By the same token, the shorter bouts examined in present analyses were 
defined as being 1 minute or more, and much of this activity may be close to the 10-minute 
mark and not exclusively short. Additional research is needed to confirm present findings and to 
examine bouts which are exclusively short in duration, i.e. 1-5 minutes, to clarify the role of 
short activity bouts in metabolic health and their implications for public health 
recommendations.  
Given clear differences in total physical activity between healthy and unhealthy obese groups, 
and less clear differences in moderate-to-vigorous physical activity, it is possible that higher total 
activity among the healthy obese reflects more light intensity activity. As mentioned, there is 
some evidence that light activity, measured objectively, may reduce metabolic risk factor 
clustering independently of moderate-to-vigorous activity (125). A greater body of literature has 
examined the role of non-exercise activity thermogenesis (NEAT) which pertains to fidgeting-like 
activities that expend less energy than moderate intensity activities, but more energy than 
sedentary behaviour (255). Differences in NEAT are thought to explain a substantial proportion 
of daily movement and may help account for differences in the susceptibility to store fat in 
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humans (256), but NEAT has not been linked with reduced risk of having or developing metabolic 
risk factor clustering, and not among obese adults specifically. However recent studies 
examining breaks in sitting time may have revived this idea, with cross-sectional associations 
observed between breaking-up sitting time with lower plasma glucose and triglycerides in 
addition to lower waist circumference and BMI (257). An intervention study also recently 
demonstrated that breaking-up sitting every 20 minutes is associated with improved insulin and 
glucose responses to food (156). Such evidence supports the idea that energy expenditure and 
metabolic health may be promoted by simply ‘keeping the machinery running’ through frequent 
movement, rather than needing to segment activity into bouts of moderate-to-vigorous 
intensity. Such an idea seems attractive given data showing that that the largest proportion of 
the day for most adults is spent either sedentary or in light activities such as standing or slow 
walking, with a relatively small proportion being spent in moderate-to-vigorous activities (141, 
258). This idea is also attractive given wider theories of evolution, such as those describing 
environments of evolutionary adaptedness which demanded frequent physical activity to meet 
basic survival needs; although the energy historically expended in hunting and gathering food 
was likely more moderate-to-vigorous than light (255). The benefits of light intensity physical 
activity relative to sedentary time on cardiometabolic outcomes in free-living humans are 
plausible, but are currently an area of debate as this form of activity is harder to assess using 
self-report and objective measures (125, 259).  
Previous results of this thesis do not support sitting time as a factor related to the prevalence or 
incidence of metabolic risk factor clustering among the obese, and so lower sitting time seems 
an unlikely explanation for the observed difference in total physical activity between obese 
groups. However, as with physical activity, previous results were based on self-reported 
measures of sitting which are known to produce weaker associations with metabolic risk factors 
than objective measures (252). No objective measure of sitting time is currently available in the 
Whitehall II cohort, and so this could not be compared with self-reported measures. Future work 
could examine objectively measured leisure sitting time in relation to healthy obesity and its 
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contribution alongside moderate-to-vigorous activity in explaining total physical activity among 
obese adults.  
The development and use of objective measures of physical activity are important 
advancements which allow for valuable comparisons with widely used self-reported measures; 
however it is important to address some conceptual issues that arise when making these 
comparisons. First, the amount of moderate-to-vigorous physical activity that is recommended 
in national and international guidelines, 150 minutes or more per week, is based on self-
reported physical activity data. This guideline figure of 150 minutes therefore aims to summarise 
the amount of ‘self-reported minutes’ of moderate-to-vigorous physical activity that are 
required to reduce risk of morbidity and premature mortality. Given low-to-moderate 
correlations between self-reported and objective assessments of physical activity reported 
previously (120, 122) and again in this thesis, and given that the links between physical activity 
and health outcomes are based on self-reported physical activity data, it is not appropriate to 
assume that 150 ‘objective minutes’ are required to provide the same health benefit as 150 
‘self-reported minutes’. These measures capture conceptually different dimensions of 
movement; self-reported measures quantify the perceived duration of time devoted to activity 
(i.e. a 1-hour sporting session), while objective measures quantify the amount of time the body 
physically moves, which is expected to be less than the total time devoted to activity (i.e. only 
physically moving for half of that 1-hour sporting session) (260). The amount of objective 
minutes required to bring about the same reduction in health risks as self-reported minutes may 
be lower, although these estimates are not yet available.  
It is, however, appropriate to use both self-reported and objective measures of physical activity 
with the purpose of comparing the existence, magnitude, and patterning of associations as they 
relate to health indicators. Given that objective measures offer greater precision and reliability 
for the measurement of incidental movements which are not well-recalled from memory, 
objective measures can offer important insights into the role of physical activity to health 
outcomes that may otherwise go undetected. In this thesis, differences in total physical activity 
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between healthy and unhealthy obese groups are evident only when using objective 
assessments, indicating that physical activity has a greater role in healthy obesity than previously 
thought.  
Although less precise, self-reported measures do have their advantages. For instance, 
accelerometers are designed to detect the intensity and duration of activity performed, but they 
do not inform the researcher of the type of activity this actually is (I.e. running versus swimming 
versus other sports). Self-reported measures provide insight into these activity types as well as 
the social preferences and perceptions of activities, all of which are essential for designing and 
evaluating public health programmes (261). Thus it is recommended that objective measures be 
used as a complement to, and not as a replacement for, self-reported measures (262).  
 
5.1.1 Strengths and limitations in the study of physical activity 
and sedentary behaviour in relation to healthy obesity 
 
 
Strengths of this section include its use of large sample sizes and its use of both cross-sectional 
and prospective designs with follow-up extending to 15 years. Objective measures of metabolic 
risk factors and anthropometrics were used to define metabolic and obesity phenotypes. 
Metabolic health was defined in this study according to comprehensive criteria used in previous 
work on the general United States population [2], which had the advantage of including insulin 
resistance which is excluded from other widely used criteria (27, 28). However C-reactive protein 
(CRP) was excluded as part of the current definition for the sake of consistency, as it was not 
measured at later follow-up points. Systemic inflammation may help define healthy obesity (32) 
and should be considered in future studies when possible. 
The main self-reported measure of sitting was based on total leisure sitting time, which covers 
all types of sitting in a leisure setting and is thus more comprehensive than measures which 
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consider only specific activities such as TV viewing. However, as a consequence of this, there is 
the possibility that memory recall for total leisure sitting time is less accurate than recall for TV 
viewing time, resulting in greater recall bias and imprecision. Measures of sitting and physical 
activity used for prospective associations were self-reported, and thus may have introduced 
biases. In particular, self-reported sitting time tends to be only moderately correlated with 
objective assessments (263). However given that subjective measures of physical activity (264) 
and sitting have shown weaker and less consistent associations with metabolic risk factors 
compared with objective measures (252), associations observed in present analyses likely 
underestimate, rather than overestimate, true effects. Associations of moderate-to-vigorous 
physical activity and leisure sitting in relation to metabolic health among the obese were mainly 
inferred from BMI-stratified analyses, which as discussed, could limit statistical power among 
the relatively small obese group. Subsidiary analyses were performed which considered all 
adults collectively, providing contrasting results but ultimately interpretations which are based 
on more comprehensive methodology. This section used a tri-axial accelerometer device worn 
on the wrist to provide novel insights into the role of physical activity in healthy obesity based 
on precise effect estimates, and insights into the relative strength and utility of objective and 
self-reported assessments. Results pertaining to objective physical activity assessments are, 
however, based on a cross-sectional study design only, and future research is needed to 
examine prospectively whether increases in physical activity among unhealthy obese adults lead 
to a healthier status. Accelerometry results are subject to the specific brand and body placement 
used in the present study; however strong correlations have been found with VO2 for both 
GeneActiv and Actigraph accelerometers and for both wrist and hip placements (221).  
Participants were of an older age at later phases of data collection and results may not be 
readily generalisable to younger or middle-aged adults. The validity of BMI for assessing total 
body fat is known to be lower among older than among younger adults due to age-related 
changes in body composition including reductions in lean muscle mass (265, 266); subcutaneous 
fat also decreases while visceral fat becomes more prominent. Thus, although BMI is used in 
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present studies with the assumption that values indicate total body fat, differences in BMI 
between metabolic and obesity groups may also reflect differences in lean mass which may 
overestimate the role of body fat in metabolic health status (267).  
Health behaviour and health status covariates were based on self-reported data and are subject 
to measurement inaccuracies. Diet quality was assessed via frequency of fruit and vegetable 
consumption, type of milk consumed, and type of bread consumed, and thus cannot eliminate 
the possibility of residual confounding by other aspects of diet such as sugar intake (178). 
Snacking behaviour was not specifically considered as a covariate in studies of leisure sitting and 
TV viewing, which is known to commonly occur in such scenarios (157). Previous work has 
shown that associations between TV viewing and metabolic abnormalities persist after 
controlling for frequency of unhealthy food consumption (268), but this behaviour may indeed 
confound associations if underreported. However given that differences in TV viewing were not 
evident between healthy and unhealthy obese groups even before additional adjustments for 
dietary factors, this is not likely an issue. The questionnaire item used to assess TV viewing in 
Whitehall II have not been validated against objective measures, although a recent review 
concluded that questions focusing on TV viewing have the strongest reliability and validity 
among non-occupational sedentary behaviour questions (158). Self-reported TV viewing is a 
proxy measure of sedentary time as it assumes participants are in a sedentary position while 
viewing TV. Analyses on TV viewing were cross-sectional and thus cannot determine whether 
viewing time contributes to or results from phenotype status; however adjustment for the 
presence of an illness which limits moderate-to-vigorous physical activity partly controlled for 
reverse causation. The indicator of baseline health status used in these studies as a covariate 
was a derived indicator of whether the participant reported an illness which limits moderate or 
vigorous physical activity, which is not widely used in previous studies. This indicator did vary 
significantly across metabolic and obesity groups, with a higher proportion of unhealthy obese 
adults reporting that they were greatly limited than healthy normal-weight adults, as expected.  
This indicator directly addresses the issue of having a physical activity-limiting illness as judged 
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by the participants themselves, and a similar derived measure could be used in future studies 
based on other cohorts to confirm its validity.  
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5.2 Healthy obesity and metabolic decline: 
Interpretations of results in light of previous 
research 
 
 
The second part of this thesis investigated the risk of future metabolic decline among healthy 
obese adults. This aim was first addressed by describing progressions from healthy to unhealthy 
obesity and comparing the tendency for progression between initially healthy obese and initially 
healthy normal-weight adults. Results show that after 20 years, approximately half of initially 
healthy obese adults were unhealthy obese, while less than 2% were healthy normal-weight. 
Healthy obese adults were far more likely to progress to an unhealthy obese state at 20 years 
follow-up than were healthy normal-weight adults, and were consistently more likely to make 
this adverse transition than unhealthy normal-weight adults. The proportion of healthy obese 
adults who progressed to unhealthy obesity also increased steadily with increasing follow-up 
duration when using maximum samples of healthy obese adults. Previous studies in literature 
have attempted to examine the natural course of healthy obesity but were limited to shorter 
follow-up durations; the longest follow-up duration previously used being 10 years (170). 
Present results were based on follow-up durations which were up to a decade longer than 
previous studies, providing greater insight into the long-term nature of healthy obesity and more 
solid evidence to support the notion that healthy obesity is a temporary state which often 
progresses to ill-health. Long-term stability in healthy obesity does indeed exist, but this is now 
viewed as the exception, not the norm. 
The main outcome of interest for these descriptive analyses was becoming unhealthy obese 
over time, as evidence clearly indicates that this state carries the highest risk for cardiometabolic 
disease and early death (201, 202) and thus represents the ‘worst-case scenario’. To examine 
the issue of metabolic decline in depth, 2 definitions of ‘healthy’ were used for analyses; the first 
being the most common definition used in the literature, defined as having <2 metabolic risk 
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factors, thus allowing for 1 metabolic risk factor to be present; the second being a strict 
definition defined as having no metabolic risk factors at all. One key observation relates to the 
prevalence of healthy obesity according to these different definitions. While present results 
suggest that about 1 in 3 obese adults are considered healthy when defined as having <2 
metabolic risk factors, only about 1 in 10 obese adults are considered healthy when defined as 
having 0 metabolic risk factors. Interestingly, this latter prevalence is the same as the prevalence 
of obese adults in the general population who have a high level of cardiorespiratory fitness (113) 
(the so-called ‘fat and fit’), suggesting that there may be a considerable degree of overlap in 
these phenotypes.  
A second important observation relates to the rate of progression to ill-health based on these 
different definitions of ‘healthy’. If an initially healthy status is defined as having less than 2 
metabolic risk factors then about 50% of these initially healthy obese adults progress to ill-
health over a period of 20 years. However, if restricting the definition of ‘healthy’ to have 0 
metabolic risk factors at baseline, then about 80% of these initially healthy obese adults progress 
to ill-health over the same period of time. Together, this suggests that a strictly healthy type of 
obesity is exceptionally rare, and that maintenance of this strictly healthy obese state is rarer 
still. The tendency for metabolic decline was much higher among strictly healthy obese adults 
compared with their strictly healthy normal-weight counterparts, supporting the notion that 
healthy obesity is a transient phase and a high risk state for future decline.  
When examining incidence of specific metabolic risk factors among a subset of obese adults who 
are strictly healthy, the risk of developing insulin resistance, high blood glucose, and 
hypertension was 2-to-5 times higher among initially healthy obese compared with initially 
healthy normal-weight adults over 20 years follow-up, with incidence being evident after only 5 
years of follow-up. There was little difference in incidence of low HDL cholesterol or high 
triglycerides, suggesting that a strictly healthy type of obesity is fairly robust against the 
development of dyslipidaemia. However, as the use of lipid-lowering drugs was not considered 
in this set of analyses, it is unclear to what extent this observation represents a true lack of 
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incidence or widespread use of prescription drugs among this group. This is particularly an issue 
given that participants had reached an advanced age at the final measurement phase, when 
contact with medical services and prescription drug use is most common. Insulin resistance was 
consistently most common among healthy obese adults over time, both in terms of the 
magnitude and of the significance of the difference compared with healthy normal-weight 
adults. Insulin resistance is therefore supported as a key factor explaining the long-term decline 
of healthy obesity, and one which likely drives long-term progressions to an unhealthy obese 
state over time. 
The approach used in this section was descriptive, the aim being to describe the natural course 
of healthy obesity (whether it remains stable or gets progressively worse) and not to identify 
modifiable determinants of this progression. The only covariates considered in models 
comparing risk of unhealthy obesity and incidence of individual metabolic risk factors between 
initially healthy obese and initially healthy normal-weight adults were age, sex, and ethnicity. 
These factors were chosen as they are relevant to natural differences in the rate of metabolic 
decline and are expected to remain constant over time, or in the case of age, progress at a 
constant rate for all participants. Other factors such as social circumstances and health 
behaviours including physical activity may be hypothesised to modify the tendency to progress 
to ill-health among obese adults; however, these are subject to considerable change over the 
duration of follow-up, and simple baseline adjustments for these factors are not likely sufficient 
to capture their involvement. Examining behaviour patterns in stratified analyses would also 
likely introduce more missing data and reduce statistical power when using complete case 
analyses, ultimately reducing the validity of results. Furthermore, given earlier results of this 
thesis which provided no evidence for an association of either self-reported moderate-to-
vigorous physical activity or self-reported leisure sitting time with risk of becoming unhealthy 
among initially healthy obese adults, these factors are not strong candidates as modifiers of 
phenotype progression. Although physical activity was later associated with metabolic health 
among obese adults when measured objectively, objective measures of physical activity are not 
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available at earlier phases of the Whitehall II cohort; any prospective analyses would necessarily 
reply upon imprecise self-reported measures.  
This thesis next aimed to determine whether healthy obese adults face an excess risk for 
incident type 2 diabetes: a type of metabolic decline with high clinical importance. This aim was 
first addressed by systematically searching the literature on incident type 2 diabetes risk among 
healthy obese adults, and by synthesizing these estimates in a meta-analysis. Findings from the 
systematic literature search showed that healthy obese adults have, with few exceptions, a 
substantially increased risk for developing type 2 diabetes compared with healthy normal-weight 
adults. When prospective evidence was synthesised in a random effects meta-analysis (average 
length of follow-up ranging from 5 years in Kim et al. (242) to 20 years in Arnlov et al. (187)), 
healthy obese adults demonstrated over 4.0 times greater risk of developing type 2 diabetes; 
albeit this risk was approximately half that of unhealthy obese adults. The pooled relative risk for 
healthy obese adults was comparable to that for unhealthy normal weight adults (Summary 
RR=3.81, 95% CI=2.69, 5.39 for healthy obese vs. Summary RR=4.46, 95% CI=3.38, 5.88 for 
unhealthy normal-weight).  
Type 2 diabetes is often regarded as a state of chronic energy oversupply (194), and as such, 
dietary factors are expected to play a central role in disease risk. Despite this, no studies 
considered the influence of dietary factors, such as sugar intake, on the risk of type 2 diabetes 
for healthy obese adults. Likewise, only half of the studies considered any indicator of physical 
activity or cardiorespiratory fitness, which are also important protective factors against type 2 
diabetes development (180, 181). The healthy obese group is often defined according to use of 
drugs such as antihyperglycemic or antihypertensive medications, however a limited range of 
additional prescription drugs were considered in statistical adjustments, with the use of statins 
considered in only 2 studies (51, 238).  
Heterogeneity in excess risk for healthy obesity was observed between studies, with estimates 
ranging from about 2.0 times greater in Appleton et al. (51), to nearly 15.0 times greater in 
Hwang at el. (women) (241), and meta-regression provided no evidence to suggest that this was 
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explained by differences in participant age, duration of follow-up, or study quality. Such 
heterogeneity might stem from variations in phenotype criteria used across studies including 
inconsistencies in specific metabolic factors and their cut-points, statistical adjustment 
strategies, as well as differences inherent to populations such as ethnicity or participation in 
obesity management strategies such as lifestyle interventions or prescription drug use. 
However, with the small number of studies currently available, and with each measuring a 
different population, numbers within each factor group would likely be too small to draw 
meaningful conclusions about the source of heterogeneity.  A standard definition of what 
constitutes ‘health’ within obese populations would aid efforts to understand differences in 
effects due purely to specific demographic or lifestyle factors. It is important to note, however, 
that heterogeneity in this case refers only to the magnitude of effects, as all estimates exceeded 
the reference value of 1.0 and were in the positive direction, with no studies reporting a reduced 
risk of incident type 2 diabetes for healthy obese adults. Thus, the overall message is consistent 
– healthy obese adults are far more likely than healthy normal-weight adults to become diabetic 
over time.  
Results of previous meta-analyses indicate that healthy obese adults have greater risk for 
developing cardiovascular disease than healthy normal-weight adults, at a magnitude of about 
1.2 to 2.0 (201, 202). Present results therefore also suggest that the risk among healthy obese 
adults for developing type 2 diabetes is much greater than for developing cardiovascular disease 
(relative risk of about 4.0 vs 1.2-2.0). The multistage model of type 2 diabetes development 
discussed previously, where elevated blood glucose and type 2 diabetes diagnosis is preceded by 
a long period of insulin resistance (191), is indeed likely relevant to healthy obesity given that 
initially healthy obese adults show a consistently higher risk of developing insulin resistance over 
time, with this being evident even at relatively short follow-up periods. This strong tendency to 
become insulin resistant likely explains the substantially increased risk for future type 2 diabetes 
among healthy obese adults.   
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All studies identified in the literature search allowed for at least 1 metabolic risk factor to be 
present when defining healthy obesity. This 1 metabolic risk factor may well be insulin resistance 
or high blood glucose which is elevated just below the clinical cut-point for type 2 diabetes but 
still qualifying as prediabetic (193). To examine the potential for this definition to bias estimates 
of type 2 diabetes risk and to provide novel evidence on diabetes risk among obese adults who 
have a strictly healthy metabolic profile, original analyses of the Whitehall II cohort study were 
conducted which defined healthy obesity as having no metabolic risk factors at baseline. 
Analyses based on the more common definition of health (<2 metabolic risk factors) were also 
performed to allow comparison of results based on different definitions within the same 
population. Original results based on the common definition of health are in agreement with 
literature – a substantially increased risk of type 2 diabetes was found among healthy obese 
compared with healthy normal-weight adults, with the magnitude of this effect being high at 
nearly 4.0. Results based on the strict definition of health were less clear, with no significant 
difference in risk observed among strictly healthy obese compared with strictly healthy normal-
weight adults over the same 20-year follow-up period. The confidence interval boundary on this 
estimate was, however, only marginally crossing the reference point, and this should be 
interpreted in light of the smaller sample size and lower statistical power afforded by this strict 
definition of health. Additionally, when estimates for each metabolic and obesity group 
according to different health definitions are illustrated together, a consistent pattern across 
groups is visually evident. This should also be interpreted in light of previous results showing 
that after as little as 5 years, initially healthy obese adults have a substantially increased risk for 
developing insulin resistance, a known pre-curser to impaired glucose control (191), as well as 
high fasting glucose itself. Taken together, this single null finding on diabetes risk does not 
provide strong evidence that obese adults who are strictly healthy are really protected against 
developing type 2 diabetes in the long-term.  
A core assumption when modelling associations between exposure and outcome variables in 
standard regression models is that values of the exposure variable remain stable for the 
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duration of follow-up; if they do not, exposures can be misclassified, which can bias results. 
Given the strong tendency for healthy obesity to progress to unhealthy obesity over time, 
several recent studies have stratified analyses of healthy obesity and disease risk into those 
healthy obese adults who are stable for the duration of follow-up versus those who are not 
stable. For example, at least 2 studies have examined the risk of incident type 2 diabetes 
separately among those healthy obese adults who maintain their healthy status and those who 
progress to unhealthy obesity, both showing that increased diabetes risk is evident only among 
those who transition into unhealthy obesity over the follow-up period (51, 269). This seems 
obvious, as one would expect those who develop metabolic abnormalities over time to be the 
ones who eventually develop disease. There is therefore a conceptual concern with this 
stratification approach, as in the case of type 2 diabetes, progressions to ill-health in the form of 
insulin resistance and high blood glucose are part of the disease process itself, and would 
therefore be considered a mediator of disease and not a source of bias to be addressed as such. 
Given that the process of metabolic decline among healthy obese adults over time is now better 
known, this stratification approach seems less meaningful and may be less supported in future 
work. There are also practical challenges of working with small case numbers in analyses, as sub-
dividing an already small group to view stratified risk estimates may not yield reliable results due 
to low statistical power. This also requires consistent data on anthropometrics and metabolic 
risk factors for phenotype criteria at both baseline and follow-up, which may not always be 
available.  
Descriptive analyses from this as well as the previous section indicated that healthy obese adults 
had more adverse levels of individual metabolic risk factors than healthy normal-weight adults 
at respective baselines, an early sign that the healthy obese may progress to ill-health over time. 
Likewise, within the healthy obese group, it is possible that those unstable healthy obese adults 
who later progress to ill-health may have started with more adverse levels of metabolic risk 
factors at baseline than those who are stable, although this was not specifically tested in 
analyses. Although these differences may exist, these are viewed more as explanations of results 
205 
 
than sources of bias to be addressed as such. Indeed, it would be expected that healthy obese 
adults who later develop disease would show signs of such disease at an earlier point in time, 
and likewise, those healthy obese adults who progress to ill-health are expected to show more 
adverse levels of risk factors at baseline than those who do not progress. Differences in pre-
clinical disease burden may indicate that progressions are already in motion at the first 
measurement occasion.  
It is important to acknowledge however, that a sizable proportion, just over one-third, of healthy 
obese adults did remain healthy over the full 20-year period, appearing remarkably resistant 
against the progression to ill-health. This begs the question – what are they doing right? What is 
special about them? As previously discussed, a great deal of human metabolism has to do not 
just with the total amount of fat, but with where the fat is located. Maintenance of a favourable 
fat distribution may help explain stability among a subset of healthy obese adults, based on 
what is known at the ‘adipose tissue expandability’ theory. According to this theory, individuals 
differ in the robustness of their subcutaneous fat cells when accommodating for excess energy 
intake (195, 270). Incoming energy is initially stored in relatively safe subcutaneous stores as a 
matter of intention and if these subcutaneous stores are robust, they continue expanding as 
energy intake increases (271, 272). Adipose tissue is prevented from accumulating in visceral 
and ectopic sites, and tissues therefore remain insulin sensitive, affording such adults the 
appearance of a metabolically healthy profile. In adults whose subcutaneous fat stores are not 
robust, however, accumulating adipose tissue ‘spills over’ into sites such as the liver, muscle, 
arteries, and other vasculature, which contribute to visceral fat and increase the resistance of 
tissues to insulin, ultimately contributing to the classification of an unhealthy profile.  
Recent experimental evidence among healthy obese adults supports this view. In one study, 
obese adults who were considered metabolically healthy at baseline were protected from the 
short-term adverse effects of diet-induced weight gain by a superior ability to partition 
triglycerides and other lipids into subcutaneous stores, while those defined as unhealthy obese 
at the study outset were unable to partition fat in this manner, instead showing signs of visceral 
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fat accumulation (273). This subset of the healthy obese who are stable over time may also be 
expected to have robust pancreatic beta-cells which are able to compensate for minor 
impairments in insulin sensitivity (194, 195), which together with robust subcutaneous fat stores 
may help explain an ability to maintain a healthy status even after 20 years and avoid insulin 
resistance and subsequent pathology. 
As discussed, healthy obese adults have a more favourable fat distribution characterised by 
lower abdominal and visceral fat (56) along with favourable adipose tissue function and 
morphology (274). This has led some to investigate the extent to which fat distribution modifies 
a healthy obese adults’ risk of incident disease, with Appleton et al., 2013 (51) reporting that 
lower waist circumference was associated with maintaining metabolic health over time and 
protection against developing type 2 diabetes or cardiovascular disease. Higher waist 
circumference has also been associated with progressing from healthy to unhealthy obesity over 
a period of 8 years (169), while a more recent study reported that lower visceral and higher 
lower-body fat among obese adults significantly lowered the 10-year risk of incident 
cardiovascular events (275). A range of metabolic and cellular risk factors including inflammation 
and inefficient mitochondrial transcription are known to be closely aligned with the presence of 
liver fat (276), and recently, the presence of liver fat has been shown to modify the risk of 
incident type 2 diabetes among healthy obese adults, with increased risk found only among 
those healthy obese adults who had signs of liver fat, and not among those who did not (277). 
This protection was evident after adjusting for age, sex, parental history of diabetes, smoking, 
alcohol consumption, and self-reported engagement in physical activity.  
Although there is certainly heterogeneity in associated disease risk within the healthy obese 
group, a key contribution of this thesis is to provide a uniquely long-term view of the natural 
course of healthy obesity over time. Findings revealed a strong tendency for metabolic decline 
among the majority of healthy obese adults, indicating that for most, health gets worse over 
time. Although some healthy obese adults do remain healthy, the increasing proportion of 
healthy obese adults who decline over time indicates that the absolute number of obese adults 
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who can maintain an optimal balance of fat stores in the long-term is not high. An early 
implication of these findings is that weight loss is of paramount importance for obese adults, 
even those who appear to be metabolically healthy. However it is interesting to note that 
standard weight-loss interventions among healthy obese adults have so far experienced limited 
success. For example, healthy obese adults showed no improvement in blood lipids, 
inflammatory markers (278), and insulin sensitivity (279) in response to a diet and physical 
activity-based intervention, while other studies reported detrimental effects such as decreased 
insulin sensitivity (280). In another study, healthy obese adults who lost fat mass up to the point 
of resistance to further weight-loss experienced adverse physiological effects including 
worsened appetite regulation, decreased energy expenditure, and increased depressive 
symptoms (281); all of which may promote weight regain. It remains unknown whether such 
adverse physiological effects persist over time or whether weight-loss itself is more easily 
maintained among healthy compared with unhealthy obese adults. Targeted fat loss, focusing 
on reductions in abdominal and ectopic fat, may therefore be more appropriate for healthy 
obese adults. Indeed, several interventional studies report reductions in visceral fat among 
healthy obese men and women (279, 282, 283), while others show increased levels of 
cardiorespiratory fitness (282), improved insulin sensitivity, and improved fasting insulin levels 
(283).  
Importantly, physical activity has the potential to improve fat distribution by reducing visceral 
fat even in the absence of weight-loss (97), and such reductions in visceral fat, together with 
increases in muscle mass, may be key reasons why regular physical activity helps promote insulin 
sensitivity (1).  As discovered earlier in this thesis, total physical activity, measured objectively, 
was higher among healthy than among unhealthy obese adults, and higher total physical activity 
was also most strongly associated with a reduced likelihood of having insulin resistance. Physical 
activity may therefore be a key target for promoting stability of healthy obesity and for 
protecting against the onset of disease, but further research is needed with objective physical 
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activity measures and large samples to determine if physical activity truly reduces risk of future 
metabolic decline among healthy obese adults.  
Furthermore, although physical activity is important, previous studies suggest that it is not 
sufficient to remove the health risks of obesity completely. Previous studies of middle-aged 
women from the US Nurses’ Health Study examined interactive effects of physical activity and 
obesity status and reported that both physical activity and obesity are independently associated 
with risk of incident type 2 diabetes (284) and cardiovascular disease (285), with the excess risk 
attributed to obesity being much greater than attributed to low physical activity for both disease 
outcomes. Obesity and low physical activity were also independent predictors of all-cause and 
cardiovascular mortality in that same cohort (286). Results of this thesis go further to suggest 
that disease risks are cumulative with regards to obesity and metabolic ill-health, with having 
both obesity and metabolic ill-health conferring substantially greater risk than either component 
on its own. Conversely, having only one component, either obesity or metabolic ill-health, was 
not sufficient to protect against disease as excess risks are still evident among adults who are 
healthy obese or unhealthy normal-weight. This suggests that these components are inseparable 
and that focusing solely on promoting a normal-weight or a healthy metabolic profile is 
insufficient – both are required for optimal health.       
 
5.2.1 Strengths and limitations in the study of healthy obesity 
and metabolic decline 
 
 
This section examined the natural course of healthy obesity using consistent metabolic risk 
factor measures over the longest follow-up duration to date, 20 years, providing greater insights 
into long-term trends within and between groups than were previously possible. This section 
also included the first meta-analysis to summarise the risk of incident type 2 diabetes among 
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healthy obese adults and was the first to establish whether this apparently healthy group faces 
an increased risk for metabolic disease. This meta-analysis was supplemented with an original 
unpublished estimate from a nationally representative sample of older adults in England, 
affording a larger sample size and a more complete view of diabetes risk across adulthood. This 
meta-analysis also explored the impact of potential confounding factors of age, duration of 
follow-up, and study quality using meta-regression. 
The need for a standardised definition of ‘metabolically healthy’ obesity has been emphasised 
repeatedly, most recently in the World Obesity Forum’s 2013 Stock Report (287). A consistent 
definition of a ‘healthy’ metabolic profile was used throughout this thesis, data permitting, 
except for analyses of individual metabolic risk factor incidence and sensitivity analyses of 
incident type 2 diabetes, which was necessary to address current research objectives. The 
definition used in this thesis was based on independently proposed criteria which was used 
previously in the US NHANES study to determine national prevalence and correlated of healthy 
obesity (25). This criteria considers core metabolic risk factors of hypertension, blood lipids, and 
blood glucose, but additionally includes insulin resistance, which is excluded in widely used Adult 
Treatment Panel III criteria (27). Waist circumference was not considered for inclusion in this 
criteria as it is highly correlated with BMI (288), and would introduce an upward bias for the 
presence of metabolic risk factor clustering, given that most adults who are considered obese by 
BMI would also show a high waist circumference, and would therefore be automatically assigned 
1 metabolic risk factor without consideration of the other 5 risk factors of interest.  
Phenotype reference groups are not always consistent across published studies on healthy 
obesity, and within this thesis, reference groups used for analyses were consistently defined as 
healthy normal-weight based on a BMI range of 18.5-24.9 kg/m², which isolates normal-weight 
from overweight adults. This is expected to improve precision in effect estimates for disease risk, 
as differences between overweight and obese adults are likely smaller than differences between 
normal-weight and obese adults. Adults within this narrower BMI range are considered the 
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theoretically healthiest group based on large-scale individual-level analyses showing the lowest 
all-cause and cause-specific mortality risk (4, 5).  
BMI may be seen as a crude measure of adiposity as it does not distinguish fat from muscle, and 
it does not characterise the distribution of fat within the body. These are valid and important 
limitations, and when fat distribution is of special interest, complementary indicators of 
adiposity such as waist circumference are available, which estimate the amount of visceral fat in 
the abdominal region (37, 38). Given that BMI is most widely used in the literature to define 
healthy obesity, BMI was used throughout this thesis in order to make results comparable with 
previous studies. A meta-analysis previously concluded that the predictability of BMI for incident 
type 2 diabetes was comparable to waist circumference and the waist-to-hip ratio (172), while 
BMI has been found to better predict incident coronary heart disease over 3 years than waist 
circumference among adults under the age of 65 years at baseline (289). Although not perfect, 
BMI remains a suitable indicator of obesity and its metabolic consequences and one which will 
likely continue to be used in future.  
The definition of incident type 2 diabetes used in the Whitehall II cohort study was based on 
fasting blood glucose as recommended by both the World Health Organization in 2006 (224) and 
the American Diabetes Association in 2010 (225). Other diagnostic components do exist and 
have since been added to recommendations for diabetes diagnosis including oral glucose 
tolerance tests (OGTT) and glycated hemoglobin (HbA1c); however debate over the most 
effective and clinically appropriate method of diagnosis is on-going. Fasting glucose was recently 
shown to predict type 2 diabetes prevalence at a comparable level as fasting glucose combined 
with OGTT in a pooled analysis of 96 cohort studies (290), while HbA1c alone was found to 
underestimate diabetes prevalence. It is possible that some incident cases of type 2 diabetes are 
not captured by fasting glucose alone, however the number of such cases which are captured by 
other means and are not captured by fasting glucose is expected to be small, and any such bias 
introduced is expected to be minimal given that this small number of missed cases would be 
included in the relatively large control group. Fasting blood glucose was measured over all 
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clinical follow-up periods in the Whitehall II cohort and thus afforded a consistent definition of 
diabetes and a maximum follow-up duration, which is of greatest value for epidemiological 
investigations into the long-term clinical consequences of healthy obesity.  
Results are based on complete case analyses, which include only those participants who have 
observed data on all variables required to conduct respective analyses. This raises two issues. 
First, unless data are missing completely at random such that no systematic differences exist 
between observed and missing data, results may be biased due to the selective nature of 
participants being considered (281). Differences between observed and missing data on 
important characteristics were examined in present analyses, with results suggesting that 
participants excluded from analytical samples were less likely than those included to be 
metabolically healthy. There was also evidence of selective drop-out from analytical samples 
according to BMI, with obese adults being more likely than normal-weight adults to be excluded. 
Thus, while these differences may result in estimates of associations which are biased, given that 
participants included in analyses were a relatively healthy subset of obese adults in the wider 
cohort, the direction of this bias is expected to be towards the null, producing estimates which 
are, if anything, conservative.  
In addition to describing differences in characteristics between included and excluded 
participants in analytical samples, analyses in the first part of this thesis on physical activity and 
sedentary behaviour used a ‘last observation carried forward’ approach to fill in missing 
covariate data, while analyses in the second part of this thesis used a ‘participant observation’ 
approach to examine the natural course of healthy obesity over time using maximum samples. 
Both approaches yielded results which replicated patterns observed in complete cases analyses, 
building confidence that initial results were valid. Another method of handling missing data 
which was not attempted is multiple imputation, which aims to replace missing data values with 
values estimated from a distribution which is predicted by a range of other factors which are 
associated with the factor of interest. This approach assumes that any systematic differences 
between missing and observed data can be fully explained by differences in other observed data 
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(281), which, although a slightly more flexible assumption, is still not likely to hold given that 
missing metabolic risk factor data is likely systematically due to obesity and to adverse levels of 
metabolic risk factors among excluded participants themselves. Furthermore, given that missing 
data pertain mostly to clinical outcome variables and not to exposures or covariates, as well as 
given that the amount of missing data involved and the range of factors which may prevent 
participation in clinical assessments over a period of decades are both large, there is concern 
that imputation may induce biases in results which are at least as big as those induced from 
complete case analyses (281). 
The second issue arising from the use of complete case analyses is a reduction in statistical 
power to detect associations among limited numbers of participants remaining in samples; an 
issue amplified by the requirement of data on several long-term follow-up occasions. However, 
associations were observed in the latter part of this thesis and these were large in magnitude, 
with healthy obese adults showing a substantial excess risk for progressing to ill-health (at over 
20 times greater) and for developing type 2 diabetes (at over 4 times greater) compared with 
healthy normal-weight adults. The large magnitude of associations increases confidence that 
effects are genuine and not due largely to some form of bias, as this is expected to be more the 
case with smaller effect sizes which are closer to null reference values.  
Results from this thesis are based on an occupational cohort and not a nationally representative 
sample of the general population. However, there is evidence that traditional metabolic risk 
factors and health behaviours measured in occupational cohorts predict cardiovascular disease 
risk at a level comparable to nationally representative studies; a recent comparison between the 
Whitehall II occupational cohort study and the British Regional Heart Study, a nationally 
representative cohort (291), illustrated this clearly. Given that present results pertain to 
biological processes and common health behaviours, and not to social phenomena, they are 
likely sufficiently generalizable and useful to the population at large.    
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Section 6: Conclusions & Implications 
 
 
This final section will provide concluding remarks on the results and contributions of this thesis, 
ending with their implications for public health and clinical practice.  This is followed by a list of 
outputs generated from this thesis and full-text copies of peer-reviewed publications.  
 
6.1 Overall conclusions 
 
 
 
There has been considerable interest and confusion in recent years over an apparently healthy 
subset of the obese population – those who present without metabolic risk factor clustering and 
may therefore be protected from the adverse cardiometabolic consequences traditionally 
associated with obesity. This thesis first aimed to determine whether physical activity and 
sedentary behaviour are factors which distinguish healthy from unhealthy obesity, and which 
may therefore be modified to promote it. Results suggest that neither high moderate-to-
vigorous physical activity nor low leisure sitting time related to a higher likelihood of being 
healthy among obese adults; nor did they influence risk of becoming unhealthy among initially 
healthy obese adults over time. However, these measures were self-reported and may be 
imprecise. Total physical activity was later found to be higher among healthy versus unhealthy 
obese adults when measured objectively. Objective assessments also indicate that healthy obese 
adults engage in more moderate-to-vigorous intensity physical activity, but this is done in 
durations which are shorter than those recognised in current UK and international physical 
activity guidelines, and thus may have previously gone unnoticed. Thus, it is concluded that 
physical activity is a distinguishing feature of healthy obesity and may therefore be a modifiable 
factor for its promotion. 
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This thesis next aimed to further clarify the natural course of healthy obesity over time, and 
revealed that healthy obesity is a highly temporary state which often progresses to ill-health in 
the long-term. This declining metabolic status is likely driven by a strong tendency to become 
insulin resistant, which subsequently induces metabolic pathology. It was also established that 
healthy obese adults have a substantially increased risk for future type 2 diabetes compared 
with healthy normal-weight adults, and this excess risk is also likely present among obese adults 
who are strictly healthy, initially showing no signs of metabolic dysfunction. Interpreted together 
with previous work revealing a significantly increased risk of developing cardiovascular disease 
among healthy obese adults compared with healthy normal-weight adults, this firmly supports 
healthy obesity as a high risk state for future decline. There are exceptions, possibly explained by 
maintenance of higher physical activity and maintenance of a favourable fat distribution; 
however these cases are exceptionally rare. 
The foremost contribution of this thesis is to provide a more realistic view of healthy obesity, 
one which is informed by the long-term tendencies of healthy obese adults over time. Given the 
strong tendency for future decline and their intermediate disease risk, healthy obesity is now 
best regarded not as a state of absolute health – but one of relative health. Although health risks 
for this group may not be eliminated, sizable benefits may still be realised by promoting 
transitions from unhealthy obesity into its relatively healthy counterpart. This may be 
particularly important for individuals who are genetically predisposed to a high BMI, and for 
whom weight loss has not proved successful. However it should be understood that healthy 
obesity is still not ideal, and that both a healthy profile and a normal BMI are required for 
optimal health.  
There is more to understand on the topic of healthy obesity, such as how different types of 
physical activity contribute to health among the obese and how these different types may 
modify risk of metabolic decline, how the presence of obesity affects the maintenance of 
physical activity over time, and how long-term risk of non-metabolic health outcomes such as 
functional impairment, chronic pain, and cancer among healthy obese adults compares with that 
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of healthy normal-weight adults. Although these questions are worth pursuing, the core 
recommendation stemming from this thesis is that these pursuits should not distract from 
continued efforts to develop more effective and sustainable weight-loss solutions.  
 
6.2 Implications for public health and clinical 
practice 
 
Physical activity is currently being promoted aggressively in England, as outlined in several 
recent national strategy documents (142, 292). Given the limited success of weight-loss 
interventions, physical activity is likely viewed as a ‘winnable battle’, and one which is more 
politically neutral than tackling obesogenic food environments through taxation and market 
regulation of processed foods. Physical activity is certainly important for normal-weight and 
obese adults alike, and increasing political will is welcomed; however results of this thesis 
indicate that obesity itself should not be ignored, even when it exists alongside an apparently 
healthy metabolic profile, and that an equally high priority should be placed on promoting a 
healthy body weight as placed on increasing physical activity. Results of this thesis also 
demonstrate that disease risks are cumulative with regards to obesity and metabolic-ill health, 
with having both obesity and metabolic ill-health conferring substantially greater risk than 
having either component on its own. Conversely, having only one component, either obesity or 
metabolic ill-health, was not sufficient to protect against disease as excess risks are still evident 
among adults who are healthy obese or unhealthy normal-weight. The public health message 
therefore, is that attention should not be focused solely on promoting high physical activity or a 
normal BMI - both are required for optimal health.  
The benefits of physical activity are undoubtedly great, but they are also short lived – physical 
activity needs to be done on a regular basis for its benefits to last. It is a common sense view 
that physical activity is more easily performed and more easily maintained if BMI is lower, and 
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that carrying excess weight is a barrier to realising the full benefits of an active lifestyle; although 
this issue was not specifically examined in this thesis and requires further study. However, given 
that the tendency for decline among the healthy obese gets stronger over time, it may be 
speculated that if physical activity does has a role in promoting health among this group it is 
likely not well-maintained over time.  
When focusing their efforts and resources, clinicians and public health practitioners should be 
aware of the long-term tendencies for metabolic decline among healthy obese adults, and that 
these tendencies are much greater than among healthy or unhealthy normal-weight adults. This 
inseparable link between excess body fat and excess type 2 diabetes risk is becoming better 
appreciated by public health practitioners in England, as indicated by plans for a national 
Diabetes Prevention Programme delivered by the National Health Service (NHS) in collaboration 
with NHS England and Public Health England. Although still under development as of late 2015, 
this programme aims to identify patients seen routinely in primary care who have blood glucose 
within the prediabetic range, and to provide intensive and sustained behaviour change support 
to these patients in an effort to delay the onset of or entirely prevent type 2 diabetes (293). The 
programme’s components are said to be informed by findings of a recent systematic review and 
meta-analysis conducted by academics on behalf of Public Health England on the effectiveness 
of behavioural interventions in primary care settings for reducing incidence of type 2 diabetes 
among high-risk individuals (294). Recommendations from this review include the measurement 
of blood glucose, weight, physical activity, and other metabolic risk factors both at baseline and 
at least 9 months follow-up, with at least 16 hours of contact with a professional counsellor 
included in the interim. Weight-loss is therefore identified as a core priority in addition to 
increased physical activity, which is encouraging given results of this thesis. Maintenance of both 
weight loss and high physical activity among high-risk patients is crucial to the long-term success 
of this programme, and it is therefore important for both factors to be monitored for as long as 
feasible.  
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A separate but complementary public health programme in England is the NHS Health Check, a 
free screening service offered through primary care to adults aged 40-74 (295). This screening 
involves fairly routine examinations of blood and anthropometric factors including BMI, which 
aim to inform individuals of their risk of developing type 2 diabetes, cardiovascular diseases 
including stroke, kidney disease, and dementia (295). Given previous discussions, it would be 
ideal if one’s level of insulin resistance was also measured alongside blood glucose, as this may 
provide an even earlier indication of future risk of type 2 diabetes. Nevertheless, this 
programme is useful for identifying middle aged adults who may not be aware of their 
prediabetic or overweight status, and who could then be directed into the Diabetes Prevention 
Programme once it is rolled out nationally. There is, however, some concern that the lower age 
threshold for automatic enrolment into the Health Checks programme is high, at 40, given that 
obesity and type 2 diabetes are developing increasingly early in life, in adolescence and even 
childhood, and given that contact with health services tends to be lower among these younger 
groups. Furthermore, although components of both programmes are informed by scientific 
evidence, the programmes themselves are still new, and their effectiveness will undoubtedly 
depend on how they are delivered; namely what practical and financial challenges arise and how 
they are overcome. Research should therefore not just measure the health conditions of interest 
but also the process of programme delivery, as good intentions are simply not enough to 
improve the public’s health.    
Public health practitioners are encouraged to maintain a focus on obesity prevention and 
management, and clinicians who encounter healthy obese adults in practice are likewise 
encouraged to make weight-loss a continued priority; however discretion and common sense 
should still be applied at the individual-level. For instance, it may be clear for some patients that 
BMI is elevated due to large muscle mass and not excess fat, and if these patients maintain an 
active lifestyle with a balanced diet, then weight-loss is likely not a suitable target for that 
patient. Ultimately, it is understood that lasting success in obesity prevention and management 
will come from improvements to the food system which determines which forms of energy are 
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accessible, affordable, and convenient, as well as from improvements to built and social 
environments which determine the level of physical activity required to support daily living. 
These are beyond the scale of individual-level interventions and require national and 
international cooperation together with bold public health initiatives.  
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Appendices 
 
Appendix 1 Original questionnaire items forming the self-reported assessment of total and 
moderate-to-vigorous physical activity (Page 20 of Phase 5 Questionnaire)  
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Appendix 1 (Continued): Original questionnaire items forming the self-reported assessment of 
total and moderate-to-vigorous physical activity (Page 21 of Phase 5 Questionnaire) 
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Appendix 2 Examples of reported physical activities and associated MET values 
(based on Ainsworth et al. Med Sci Sports Exerc. 2011) as part of the self-reported 
assessment of total and moderate-to-vigorous physical activity 
  
Reported physical activity 2011 MET value 
Walking (general) 2.9 
Bicycling (general for leisure) 5 
Swimming (general) 6 
Football (general) 8 
Golf (general) 4.8 
Mowing lawn, walk, power mower 4.5 
Gardening (general) 3.8 
Weeding, cultivating the garden 4.5 
Painting, decorating 3.3 
Carrying 4.8 
Cooking 2 
Washing the car 4 
Do-it-yourself activity (other) 3 
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Appendix 3 Separate associations of moderate-to-vigorous physical activity 
and leisure sitting with health among adults aged 45-69 at baseline (n=4177) 
    
  Prevalence of being healthy 
   
  Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Moderate-to-vigorous 
physical activity level* 
 
  
Lowest  1.00 (reference) 1.00 (reference) 
Intermediate  1.06 (1.01, 1.11) 1.05 (1.00, 1.10) 
Highest  1.12 (1.06, 1.17) 1.10 (1.04, 1.15) 
p-interaction with BMI group  0.77 0.58 
    
Leisure sitting time level*    
Highest  1.00 (reference) 1.00 (reference) 
Intermediate  1.02 (0.97, 1.06) 1.01 (0.96, 1.05) 
Lowest  1.01 (0.96, 1.06) 1.00 (0.95, 1.05) 
p-interaction with BMI group  0.05 0.05 
    
* Associations are mutually adjusted. Model 1 adjusted for age, sex, and 
ethnicity, and BMI group. Model 2 additionally adjusted for occupational 
position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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 Appendix 4 Separate associations of moderate-to-vigorous physical activity 
and leisure sitting with health among adults aged 45-69 (n=4177), based on 
continuously measured behaviours 
    
  Prevalence of being healthy 
   
  Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
    
Moderate-to-vigorous physical 
activity (per 1 hr/wk)* 
 
1.01 (1.01, 1.02) 1.01 (1.01, 1.02) 
p-interaction with BMI  0.34 0.26 
    
Leisure sitting time (per 1 
hr/wk)* 
 
1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 
p-interaction with BMI  0.09 0.10 
    
p-interaction (moderate-to-
vigorous physical activity X 
leisure sitting) 
 
0.62 0.66 
    
* Associations are mutually adjusted. Model 1 adjusted for age, sex, and 
ethnicity, and BMI. Model 2 additionally adjusted for occupational position, 
alcohol, smoking, diet quality, and presence of an illness which limits moderate 
or vigorous physical activity 
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Appendix 5 Combined associations of moderate-to-vigorous physical activity and leisure sitting 
with health among adults aged 45-69 at baseline (n=4177) 
 
  Prevalence of being healthy 
   
  Model 1 
Prevalence Ratio 
(95% CI) 
   
  Leisure sitting time level 
Moderate-to-vigorous  
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.01 (0.93, 1.10) 1.02 (0.93, 1.11) 
Intermediate  1.07 (0.99, 1.16) 1.10 (1.02, 1.19) 1.03 (0.95, 1.12) 
Highest  1.11 (1.02, 1.20) 1.12 (1.03, 1.21) 1.17 (1.08, 1.27) 
p-interaction   0.58 
p-interaction with BMI group  0.15 
   
  Model 2 
Prevalence Ratio 
(95% CI) 
   
  Leisure sitting time level 
Moderate-to-vigorous  
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.01 (0.93, 1.09) 1.01 (0.92, 1.10) 
Intermediate  1.06 (0.98, 1.15) 1.09 (1.00, 1.18) 1.01 (0.93, 1.09) 
Highest  1.09 (1.01, 1.18) 1.08 (1.00, 1.17) 1.14 (1.05, 1.24) 
p-interaction    0.61  
p-interaction with BMI group    0.12  
   
Model 1 adjusted for age, sex, and ethnicity, and BMI group. Model 2 additionally adjusted for 
occupational position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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Appendix 6 Separate associations of moderate-to-vigorous physical activity 
and leisure sitting with incident metabolic risk factor clustering among initially 
healthy adults aged 45-69 at baseline (n=2128) 
    
  Risk of incident metabolic risk factor 
clustering over 15 years 
   
  Model 1 
Incidence Ratio 
(95% CI) 
Model 2 
Incidence Ratio 
(95% CI) 
Moderate-to-vigorous 
physical activity level* 
 
  
Lowest  1.00 (reference) 1.00 (reference) 
Intermediate  0.96 (0.87, 1.05) 0.97 (0.89, 1.07) 
Highest  1.01 (0.93, 1.11) 1.04 (0.95, 1.14) 
p-interaction with BMI group  0.48 0.53 
    
Leisure sitting time level*    
Highest  1.00 (reference) 1.00 (reference) 
Intermediate  0.90 (0.82, 0.98) 0.91 (0.83, 0.98) 
Lowest  0.97 (0.89, 1.06) 0.98 (0.89, 1.07) 
p-interaction with BMI group  0.09 0.16 
    
* Associations are mutually adjusted. Follow-up duration is cumulative, 
considering incidence after 5, 10, or 15 years. Model 1 adjusted for age, sex, 
and ethnicity, and BMI group. Model 2 additionally adjusted for occupational 
position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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Appendix 7 Separate associations of moderate-to-vigorous physical activity 
and leisure sitting with incident metabolic risk factor clustering among adults 
aged 45-69 at baseline (n=2128), based on continuously measured behaviours 
    
  Incident metabolic risk factor clustering 
   
  Model 1 
Incidence Ratio 
(95% CI) 
Model 2 
Incidence Ratio 
(95% CI) 
    
Moderate-to-vigorous physical 
activity (per 1 hr/wk)* 
 
1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 
p-interaction with BMI  0.74 0.67 
    
Leisure sitting time (per 1 
hr/wk)* 
 
1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 
p-interaction with BMI  0.19 0.30 
    
p-interaction (moderate-to-
vigorous physical activity X 
leisure sitting) 
 
0.42 0.54 
    
* Associations are mutually adjusted. Follow-up duration is cumulative, 
considering incidence after 5, 10, or 15 years. Model 1 adjusted for age, sex, 
and ethnicity, and BMI. Model 2 additionally adjusted for occupational 
position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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Appendix 8 Combined associations of moderate-to-vigorous physical activity and leisure sitting 
with incident metabolic risk factor clustering over 15 years among initially healthy adults aged 
45-69 at baseline (n=2128) 
 
  Risk of incident metabolic risk factor clustering 
 over 15 years 
   
  Model 1 
Incidence Ratio 
(95% CI) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 0.94 (0.80, 1.09) 0.98 (0.84, 1.15) 
Intermediate  1.03 (0.90, 1.19) 0.85 (0.73, 1.00) 0.90 (0.76, 1.06) 
Highest  1.00 (0.87, 1.14) 0.93 (0.81, 1.07) 1.05 (0.91, 1.22) 
p-interaction  0.48 
p-interaction with BMI group  0.27 
   
  Model 2 
Incidence Ratio 
(95% CI) 
   
  Leisure sitting time level 
Moderate-to-vigorous 
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 0.94 (0.81, 1.10) 0.99 (0.85, 1.16) 
Intermediate  1.05 (0.92, 1.20) 0.87 (0.75, 1.02) 0.92 (0.78, 1.09) 
Highest  1.02 (0.90, 1.17) 0.96 (0.83, 1.10) 1.09 (0.93, 1.26) 
p-interaction   0.50  
p-interaction with BMI group   0.34  
   
Follow-up duration is cumulative, considering incidence after 5, 10, or 15 years. Model 1 
adjusted for age, sex, and ethnicity, and BMI group. Model 2 additionally adjusted for 
occupational position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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 Appendix 9 Separate associations of moderate-to-vigorous physical activity 
and TV viewing with health among adults aged 45-69 (n=4141) 
    
  Prevalence of being healthy 
   
  Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
Moderate-to-vigorous 
physical activity level* 
 
  
Lowest  1.00 (reference) 1.00 (reference) 
Intermediate  1.08 (1.00, 1.17) 1.07 (1.00, 1.16) 
Highest  1.18 (1.09, 1.27) 1.16 (1.07, 1.25) 
p-interaction with BMI group  0.12 0.08 
    
TV viewing level*    
Highest  1.00 (reference) 1.00 (reference) 
Intermediate  1.06 (0.98, 1.15) 1.06 (0.97, 1.14) 
Lowest  1.13 (1.05, 1.21) 1.12 (1.04, 1.20) 
p-interaction with BMI group  0.28 0.25 
    
* Associations are mutually adjusted. Model 1 adjusted for age, sex, and 
ethnicity, and BMI group. Model 2 additionally adjusted for occupational 
position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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 Appendix 10 Separate associations of moderate-to-vigorous physical activity 
and TV viewing with health among adults aged 45-69 (n=4141), based on 
continuously measured behaviours 
    
  Prevalence of being healthy 
   
  Model 1 
Prevalence Ratio 
(95% CI) 
Model 2 
Prevalence Ratio 
(95% CI) 
    
Moderate-to-vigorous physical 
activity (per 1 hr/wk)* 
 
1.02 (1.01, 1.03) 1.02 (1.01, 1.02) 
p-interaction with BMI  0.20 0.12 
    
TV viewing time (per 1 hr/wk)*  1.00 (0.99, 1.00) 1.00 (1.00, 1.00) 
p-interaction with BMI  0.63 0.55 
    
p-interaction (moderate-to-
vigorous physical activity X TV 
viewing time) 
 
0.92 0.77 
    
* Associations are mutually adjusted. Follow-up duration is cumulative, 
considering incidence after 5, 10, or 15 years. Model 1 adjusted for age, sex, 
and ethnicity, and BMI group. Model 2 additionally adjusted for occupational 
position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
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Appendix 11 Combined associations of moderate-to-vigorous physical activity and TV viewing 
with health among adults aged 45-69 (n=4141) 
 
  Prevalence of being healthy 
   
  Model 1 
Prevalence Ratio 
(95% CI) 
   
  TV viewing level 
Moderate-to-vigorous  
physical activity level 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.10 (0.95, 1.27) 1.13 (0.98, 1.29) 
Intermediate  1.12 (0.98, 1.29) 1.13 (0.98, 1.29) 1.23 (1.09, 1.40) 
Highest  1.16 (1.00, 1.34) 1.28 (1.11, 1.46) 1.35 (1.19, 1.53) 
p-interaction   0.75 
p-interaction with BMI group  0.29 
   
  Model 2 
Prevalence Ratio 
(95% CI) 
   
  TV viewing level 
Moderate-to-vigorous  
physical activity level 
 
Highest Intermediate Lowest 
Lowest  1.00 (reference) 1.09 (0.94, 1.27) 1.12 (0.98, 1.29) 
Intermediate  1.12 (0.97, 1.29) 1.11 (0.97, 1.28) 1.21 (1.06, 1.38) 
Highest  1.15 (0.99, 1.33) 1.25 (1.09, 1.43) 1.31 (1.15, 1.49) 
p-interaction    0.84  
p-interaction with BMI group    0.28  
   
Model 1 adjusted for age, sex, and ethnicity, and BMI group. Model 2 additionally adjusted for 
occupational position, alcohol, smoking, diet quality, and presence of an illness which limits 
moderate or vigorous physical activity 
